help button home button Endocrine Society Endocrine Reviews
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrine Reviews, doi:10.1210/er.2003-0022
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints, Permissions and Rights
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mruk, D. D.
Right arrow Articles by Cheng, C. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mruk, D. D.
Right arrow Articles by Cheng, C. Y.
Endocrine Reviews 25 (5): 747-806
Copyright © 2004 by The Endocrine Society

Sertoli-Sertoli and Sertoli-Germ Cell Interactions and Their Significance in Germ Cell Movement in the Seminiferous Epithelium during Spermatogenesis

Dolores D. Mruk and C. Yan Cheng

Population Council, Center for Biomedical Research, New York, New York 10021

Correspondence: Address all correspondence and requests for reprints to: Dolores D. Mruk, Ph.D., or C. Yan Cheng, Ph.D., Population Council, Center for Biomedical Research, 1230 York Avenue, New York, New York 10021. E-mail: D-Mruk{at}popcbr.rockefeller.edu or Y-Cheng{at}popcbr.rockefeller.edu


    Abstract
 Top
 Abstract
 I. Introduction
 II. Sertoli Cells
 III. Sertoli-Sertoli and Sertoli...
 IV. Mechanism of Germ...
 V. Concluding Remarks
 References
 
Spermatogenesis is the process by which a single spermatogonium develops into 256 spermatozoa, one of which will fertilize the ovum. Since the 1950s when the stages of the epithelial cycle were first described, reproductive biologists have been in pursuit of one question: How can a spermatogonium traverse the epithelium, while at the same time differentiating into elongate spermatids that remain attached to the Sertoli cell throughout their development? Although it was generally agreed upon that junction restructuring was involved, at that time the types of junctions present in the testis were not even discerned. Today, it is known that tight, anchoring, and gap junctions are found in the testis. The testis also has two unique anchoring junction types, the ectoplasmic specialization and tubulobulbar complex. However, attention has recently shifted on identifying the regulatory molecules that "open" and "close" junctions, because this information will be useful in elucidating the mechanism of germ cell movement. For instance, cytokines have been shown to induce Sertoli cell tight junction disassembly by shutting down the production of tight junction proteins. Other factors such as proteases, protease inhibitors, GTPases, kinases, and phosphatases also come into play. In this review, we focus on this cellular phenomenon, recapping recent developments in the field.

I. Introduction
A. Cell junctions in the testis

II. Sertoli Cells
A. Sertoli cell structure
B. Sertoli cell functions

III. Sertoli-Sertoli and Sertoli-Germ Cell Interactions
A. Cell junctions present in the testis

IV. Mechanism of Germ Cell Movement
A. Theories of germ cell movement
B. Additional comments
C. Regulation of cell junction dynamics in the testis by cytokines
D. Regulation of cell junction dynamics in the testis by proteases and protease inhibitors
E. Regulation of cell junction dynamics in the testis by protein kinases and phosphatases
F. Regulation of cell junction dynamics in the testis by cAMP and cGMP
G. Regulation of cell junction dynamics in the testis by GTPases
H. Regulation of cell junction dynamics in the testis by calcium

V. Concluding Remarks


    I. Introduction
 Top
 Abstract
 I. Introduction
 II. Sertoli Cells
 III. Sertoli-Sertoli and Sertoli...
 IV. Mechanism of Germ...
 V. Concluding Remarks
 References
 
THE PROCESS OF spermatogenesis involves an array of complex biochemical, molecular, and cellular events. For instance, during spermatogenesis in the rat, spermatogonia residing outside of the blood-testis barrier must differentiate into preleptotene/leptotene spermatocytes, which migrate from the basal to the adluminal compartment of the seminiferous epithelium, traversing the blood-testis barrier in late stage VIII–early stage IX (for reviews, see Refs.1, 2, 3, 4). Although one may consider these processes to be simple biological events that are well understood, the contrary is true. Many questions remain unanswered. For example, what is the mechanism by which developing germ cells traverse the epithelium? What signaling events determine the time for germ cells to translocate from one site to another? What interactions between Sertoli and germ cells take place during this translocation? What are the events leading to the formation and disruption of Sertoli-germ cell junctions? What are the participating molecules? Only recently, data from several laboratories, including ours, have begun to provide answers to some of these fundamental questions, largely with the use of Sertoli cell cultures and Sertoli-germ cell cocultures, as well as several in vivo models, which examine Sertoli-Sertoli and Sertoli-germ cell junction dynamics. For instance, an in vitro report demonstrated that there were changes in the activity of proteases and protease inhibitors during germ cell attachment to Sertoli cells (5), mimicking the phase of germ cell movement in which germ cells, after they have translocated from one site to another, must reattach to the seminiferous epithelium by establishing adherens junctions, such as ectoplasmic specializations (for reviews, see Refs.6 and 7) with Sertoli cells. These studies are significant because an interference of cell-cell interactions in the testis can affect germ cell movement within the epithelium. This can lead to the development of novel male contraceptives (for review, see Ref.4). For example, germ cells, if induced to release into the tubule lumen prematurely, will be unable to fertilize the ovum. On the other hand, if germ cells are forced to remain attached to the seminiferous epithelium for a period of time longer than necessary to complete their development, they will degenerate and eventually be phagocytosed by Sertoli cells. Therefore, results obtained from studies utilizing Sertoli-germ cell cocultures in vitro can provide investigators with key information on the underlying regulatory mechanism(s) of germ cell migration in the seminiferous epithelium. In addition, other studies that use Sertoli cells cultured in vitro as a model to study Sertoli cell tight junction dynamics and several in vivo models of blood-testis barrier damage in the rat have also helped us to gain insight on how Sertoli cell tight junction dynamics are regulated.

On this note, we attempt to provide a balanced but informative treatment of Sertoli and germ cells in the testis, in particular the functions of Sertoli cells, and the interactions taking place that confer germ cell movement (e.g., cell junction restructuring) during spermatogenesis. Although brief accounts are given in many subject areas, readers are encouraged to refer to the excellent review articles cited throughout the text and to references cited therein, in particular the role of Sertoli and germ cell proteins in cell-cell interactions and the regulation of spermatogenesis (for reviews, see Refs.4 and 8, 9, 10, 11, 12). We focus our discussion largely on Sertoli-Sertoli and Sertoli-germ cell interactions at the level of cell junctions rather than the paracrine and/or autocrine factors used by these cells for communication because this latter subject area has recently been reviewed (for reviews, see Refs.8 , 9 , and 11). Furthermore, recent advances in the field have clearly shown that most, if not all, of the junction types found in the testis are nonstatic structural entities. In other words, they are dynamic structures that serve as platforms for signal transduction events that regulate the opening and closing of these junctions (see Section III). As such, we first briefly introduce the different types of junctions found in the testis (Table 1Go). A detailed discussion on the structure and functions of Sertoli cells is found in Section II, which is followed by in-depth discussions on the different types of junctions, their constituent proteins, and regulation. These are followed by a description of a current biochemical model that regulates the movement of germ cells not only across the blood-testis barrier but also the remaining seminiferous epithelium during spermatogenesis.


View this table:
[in this window]
[in a new window]
 
TABLE 1. Functional classification of cell junctions and their likely protein components in the testis

 
A. Cell junctions in the testis
Specialized junctions occur at sites of cell-cell and cell-matrix contact in all tissues (for reviews, see Refs.13 and 14). They are the means by which cells communicate with each other and their environment. Several decades of research have demonstrated that there are three morphologically and functionally distinct types of cell junctions present in epithelia: 1) occluding junctions (e.g., tight junctions); 2) anchoring (or adhering) junctions (consist of four types: cell-cell actin-based adherens junctions; cell-matrix actin-based focal contacts; cell-cell intermediate filament-based desmosomes; and cell-matrix intermediate filament-based hemidesmosomes); and 3) communicating junctions (e.g., gap junctions) (Table 1Go). As such, the term adherens junction refers only to one of the four types of anchoring junctions. In addition, the ectoplasmic specialization and tubulobulbar complex are two of the best-studied adherens junction types in the testis (Table 1Go). Although their presence in the testis has been demonstrated, they remain to be poorly characterized (Table 1Go) (for reviews, see Refs.15, 16, 17, 18). For example, it is known that germ cells, such as pachytene spermatocytes and round spermatids, must remain attached to Sertoli cells throughout the 14 stages of the epithelial cycle in the rat, yet the molecules that confer this adhesiveness are not all known (for reviews, see Refs.15 and 18).

In the following sections, we will limit our discussion to the biology of Sertoli-Sertoli and Sertoli-germ cell interactions at the level of cell junctions, emphasizing recent advances in the field. We will also highlight specific areas that deserve additional investigation. We begin by summarizing the three junction types found in the testis and the proteins that constitute these junctions, which will be discussed in greater detail (see Section III) after a discussion on the structure and function of Sertoli cells. This is done because until recently much of the information on junction dynamics in the testis was derived from studies using Sertoli cells (for reviews, see Refs.4 , 6 , 19 , and 20). Figure 1Go is a schematic drawing of the seminiferous epithelium in the rat testis illustrating the relative locations of the different types of junctions found between Sertoli cells, as well as between Sertoli and germ cells. Figure 2Go is an electron micrograph showing the intimacy between the seminiferous epithelium and the basement membrane (21). As shown in Fig. 1Go, Sertoli cell tight junctions that create the blood-testis barrier also anatomically divide the seminiferous epithelium into basal and adluminal compartments (for review, see Ref.3). Although it is obvious that the current biochemical architecture of tight and adherens junctions in the testis will be rapidly updated, it is our intention to summarize recent advances in this rapidly evolving field so that this review can serve as a guide for future studies. Every effort was made to credit original investigators with their findings, but because of the large number of references, we often chose to cite reviews rather than original articles. As such, we apologize to investigators in the field for possible oversights on our part.



View larger version (32K):
[in this window]
[in a new window]
 
FIG. 1. Schematic drawing illustrating the relative locations of the different types of junctions found in the testis. Shown are tight, anchoring, and gap junctions. Also depicted are two testis-specific anchoring junction types: the ectoplasmic specialization and tubulobulbar complex. Tight junctions, basal ectoplasmic specializations, and tubulobulbar complexes that constitute the blood-testis barrier divide the seminiferous epithelium into a basal and adluminal compartment. Also notice the proximity of the blood-testis barrier to the basement membrane. This figure was prepared based on the following original research articles and reviews: (Refs.4 , 6 , 16 , 18 , 49 , 112 , 113 and 115 ).

 


View larger version (120K):
[in this window]
[in a new window]
 
FIG. 2. Electron micrograph of a cross-section of a seminiferous tubule from an adult rat testis morphologically divided into the seminiferous epithelium and tunica propria. This figure illustrates the intimate morphological relationship between a Sertoli and germ cell, and the tunica propria. The tunica propria is composed of an acellular zone and a cellular zone. The acellular zone is composed of the basement membrane (a specialized form of the extracellular matrix in the testis appearing as a homogenous electron-dense layer, which is largely constituted by type IV collagen laminin, heparan sulfate, proteoglycans, and entactin; see asterisks) and type I collagen (see arrowheads); whereas the cellular zone is composed of peritubular myoid cells, lymph, and the lymphatic endothelium. On the other hand, the seminiferous epithelium is composed of Sertoli cells and developing germ cells. Shown here are Sertoli (SC) and germ (GC) cell nuclei in the seminiferous epithelium. L, Lipid droplet; M, mitochondrion.

 
On this note, it is important to point out that virtually all of the studies on Sertoli cell tight junction dynamics are based on an in vitro model using Sertoli cells cultured at high density (~0.5–1.2 x 106 cells/cm2) on Matrigel-coated bicameral units or dishes (22, 23, 24, 25, 26, 27, 28, 29, 30). This model has been extensively characterized by different laboratories (30, 31, 32, 33, 34, 35, 36, 37). Studies on the regulation of blood-testis barrier dynamics are based on in vivo models of blood-testis barrier damage induced by cadmium chloride, glycerol, or occludin peptide (38, 39, 40, 41, 42, 43). These have also been previously characterized (for review, see Ref.44). For studies relating to the regulation of adherens junction dynamics, such as the ectoplasmic specialization (5, 45, 46, 47, 48, 49), an in vitro Sertoli-germ cell coculture system was used (5, 50, 51, 52). Unfortunately, no in vivo models to study adherens junction dynamics in the testis were available until recently (45, 49, 53, 54); these now include the use of 1-(2,4-dichlorobenzyl)-indazole-3-carbohydrazide (AF-2364; for review, see Ref.4) and androgen/estrogen implants to suppress the endogenous testosterone level (for review, see Ref.55). Both induce the loss of cell adhesion between Sertoli and germ cells, in particular spermatids. Detailed discussions on these in vitro and in vivo models are found in Sections III and IV.


    II. Sertoli Cells
 Top
 Abstract
 I. Introduction
 II. Sertoli Cells
 III. Sertoli-Sertoli and Sertoli...
 IV. Mechanism of Germ...
 V. Concluding Remarks
 References
 
Sertoli cells (Fig. 2Go), the somatic constituents that extend from the base to the apex of the seminiferous epithelium, interact directly with developing germ cells throughout spermatogenesis. To this end, several studies have shown that these cells have an indispensable role in the development and movement of germ cells (for reviews, see Refs.61, 62, 63, 64, 65, 66, 67, 68, 69). The following discussion on Sertoli cell structure and function will provide the foundation for the discussion of Sertoli-germ cell interactions.

A. Sertoli cell structure
Since their discovery in the late 1800s, Sertoli cells have been extremely difficult to study morphologically because they have a constantly changing, three-dimensional relationship with developing germ cells throughout the 14 stages of the epithelial cycle (for reviews, see Refs.6 , 67 , and 70), yet Sertoli cells continue to be one of the most-studied cell types in the seminiferous tubule. They are irregularly shaped, columnar cells that extend from the basal to the adluminal compartment and occupy a volume of approximately 17–19% in the seminiferous epithelium of adult rats (71, 72) (Fig. 2Go). Sertoli cells are in direct contact with the basement membrane, a modified form of the extracellular matrix in the testis (21) (Figs. 1Go and 2Go). They have an enormous surface area (Fig. 2Go), which allows them to sustain a vast number of developing germ cells at a Sertoli:germ cell ratio of approximately 1:50 in the adult rat testis (71, 73). This attribute, in itself, is crucial not only to spermatogenesis, but also to germ cell movement.

From a morphological standpoint, Sertoli cells at any one time can be classified into one of two categories: 1) type A, or 2) type B (for reviews, see Refs.18 , 67 , and 70). In type A Sertoli cells, mature spermatids ready for release into the tubule lumen are lodged deep within cytoplasmic crypts, whereas in type B Sertoli cells these cytoplasmic crypts are either barely visible or completely absent. Therefore, during the 14 stages of the epithelial cycle, type A Sertoli cells must transform themselves into type B Sertoli cells to adapt to the cellular changes that take place during germ cell development and movement. These observations have been supported by eloquent morphological studies in the rat, which have demonstrated that there are drastic changes in cell shape in stages II, VII, VIII, IX–XI, and XIII–XIV, illustrating that Sertoli cells function together with germ cells in forming the epithelial cycle (for reviews, see Refs.3 , 74 , and 75).

B. Sertoli cell functions
To date, several Sertoli cell functions, most of which are directly related to germ cell development and movement, have been described. These include: 1) providing structural support; 2) creating an impermeable and immunological barrier; 3) participating in germ cell movement and spermiation; 4) nourishing germ cells via their secretory products, and several others (for reviews, see Refs.62 , 66 , 69 , and 74), all of which are discussed in the following sections. It must be noted, however, that several of these functions were determined by studies using Sertoli cells cultured in vitro, and the physiological relevance of some of these functions in Sertoli cells in vivo remains to be determined.

1. Structural support.
Sertoli cells provide support for developing germ cells within the seminiferous epithelium by participating directly in the deposition of extracellular matrix components and permitting the formation of specialized cell junctions. Another striking feature of Sertoli cells is their well-developed cytoskeleton, which is responsible for the collective organization of the seminiferous epithelium (for reviews, see Refs.3 , 7 , 15 , 16 , 18 , and 70). Morphological studies have shown that the Sertoli cell cytoskeleton: 1) maintains shape; 2) positions and transports organelles within the cell; 3) forms and stabilizes the cell membrane at sites of cell-cell and cell-extracellular matrix contact; 4) positions, anchors, and aids in the movement of developing germ cells; and 5) participates in the release of mature spermatids from the seminiferous epithelium at spermiation. It consists of three major components, namely actin, intermediate filaments, and microtubules, with each component having a unique pattern of distribution that changes in association with the 14 stages of the epithelial cycle (for reviews, see Refs.7 , 67 , and 76). Collectively, these components play a crucial role in facilitating germ cell movement.

a. Actin.
Actin filaments are composed of actin monomers of molecular mass (Mr) 42 kDa, each of which polymerizes into a linear chain with a helical twist approximately 8-nm wide (for reviews, see Refs.77 and 78) and exists in six different isoforms in mammalian tissues (79, 80). In the Sertoli cell, actin plays an extremely important role in maintaining structure and conferring cell contractility, but its presence at the cell periphery at sites of cell contact also suggests that it participates in motility-related processes. There are two pools of actin, namely monomeric G-actin and polymeric F-actin, that coexist in equilibrium in all eukaryotic cells, including Sertoli cells. The predominance of one pool affects the overall status of the cytoskeleton by causing polymerization or depolymerization of actin filaments. This, in turn, affects cell shape and movement (for reviews, see Refs.81 and 82). Figure 3AGo depicts a typical Sertoli cell cultured in vitro. Notice the F-actin filaments (green) that were visualized by using Oregon Green 488 phalloidin. Also shown in this figure is immunoreactive vinculin (red), an adaptor protein (Section III.A.5.b), and the Sertoli cell nucleus, which was stained with DAPI (blue). Figure 3BGo shows two typical Sertoli cells cultured in vitro for approximately 7 d and immunostained for zyxin (green), another adaptor protein found at the focal contact and leading edge of cytoplasmic processes. Recently, zyxin was demonstrated to associate with actin in Sertoli cells by immunoprecipitation (83). Actin filaments are also major components of ectoplasmic specializations and tubulobulbar complexes, modified anchoring junction types present between Sertoli cells, as well as between Sertoli and germ cells, illustrating that both of these junctions participate in the movement of developing germ cells (for reviews, see Refs.7 and 67). It is also of interest that mouse haploid germ cells express two unique actins designated T-actin 1 and T-actin 2, which share 40% homology with other actins (84). T-actin 1 is confined to the spermatid cytoplasm, whereas T-actin 2 is restricted to the sperm head and tail (84), suggesting that these germ cell-specific actins are important to the morphogenesis of germ cells during spermiogenesis.



View larger version (13K):
[in this window]
[in a new window]
 
FIG. 3. Immunofluorescent localization of F-actin and actin-associated adaptor proteins, vinculin and zyxin, in Sertoli cells cultured in vitro. Sertoli cells were cultured at 5 x 104 cells/cm2 for 4 d before staining with DAPI (blue) to visualize Sertoli cell nuclei, as shown in A and B. F-actin (green) was detected by using Oregon Green 488 phallotoxin (A). Vinculin (red) was visualized by using a mouse antivinculin monoclonal primary antibody (cat. no. V-9131, lot no. 072K4803, Sigma, St. Louis, MO), followed by a goat antimouse IgG-Cy3 secondary antibody (A). Zyxin (green) was visualized by using a rabbit antizyxin polyclonal primary antibody (cat. no. sc-6437, lot no. G060, Santa Cruz Biotechnology, Inc., Santa Cruz, CA), followed by a goat antirabbit IgG-FITC secondary antibody (B). All images were acquired by using an Olympus BX 40 fluorescent microscope (Olympus Corp., Tokyo, Japan) equipped with an Olympus MicroPublisher Cooled Digital Camera and the QCapture software package (version 2.6; QImaging, Burnaby, British Columbia, Canada). Data were compiled by using Adobe Photoshop (version 7.0; Adobe Systems, Inc., San Jose, CA). Scale bars, 10 µm.

 
b. Intermediate filaments.
Intermediate filaments are localized at sites of cell-cell and cell-extracellular matrix attachment where they associate with two types of anchoring junctions, desmosomes and hemidesmosomes, respectively (for reviews, see Refs.85 and 86). Several types of intermediate filaments are known to exist, and their presence has been demonstrated in the testis (Table 2Go) because they confer desmosome-like junctions between Sertoli cells and between Sertoli cells-spermatocytes/round spermatids (for review, see Ref.87). Although the exact role of intermediate filaments in Sertoli cells is not entirely known, their distribution within these cells suggests that they participate in maintaining the integrity of the seminiferous epithelium (88, 89, 90).


View this table:
[in this window]
[in a new window]
 
TABLE 2. Types of intermediate filaments in the testis

 
c. Microtubules.
Microtubules are constituted by tubulins. To date, at least six tubulins have been identified, including {alpha}, ß, {delta}, {epsilon}, {gamma}, and {zeta} (104), but the major building blocks of the microtubule cytoskeleton are {alpha}- and ß-tubulins (105). In general, microtubules appear to have a much clearer role in Sertoli cell function (for reviews, see Refs.7 and 106, 107, 108). They are known to: 1) maintain a columnar shape; 2) position and transport intracellular organelles; 3) translocate spermatids within the seminiferous epithelium; and 4) adjust the contour of the Sertoli cell membrane to adapt to the irregularly shaped spermatid heads that are lodged within crypts during spermatogenesis (for reviews, see Refs.6 and 7). It is not surprising, therefore, that the most striking changes in microtubule organization occur when mature spermatids associate with Sertoli cells (109). Microtubules are also found at the site of the ectoplasmic specialization (110, 111). Although the presence of actin, intermediate filaments, and microtubules in the testis has been implicated in the events of germ cell movement, the mechanisms underlying the regulation of the Sertoli cell cytoskeleton during different stages of the epithelial cycle and germ cell movement remain to be investigated.

2. Create an impermeable barrier.
The blood-testis barrier (also known as the seminiferous epithelial barrier), a modified occluding junction, is formed by approximately 15–18 d of age in the rat as constituted by Sertoli cell tight junctions located in the basal third of the seminiferous epithelium (Refs.2 and 112, 113, 114, 115 ; for reviews, see Refs.116, 117, 118) (Fig. 1Go). The blood-testis barrier compartmentalizes the epithelium into two (112, 119), rather than three, compartments as previously postulated (2, 114). One is a basal compartment in which spermatogonia, preleptotene, and leptotene spermatocytes reside. The other is an adluminal compartment in which meiotic spermatocytes and spermatids in various stages of spermatogenesis and spermiogenesis exist.

a. Concept of the blood-testis barrier.
The concept of the blood-testis barrier was first developed in the 1970s based on two important findings (for reviews, see Refs.112 , 120 , and 121). First, there were drastic differences in the composition of fluids and proteins obtained from the rete testis and seminiferous tubule lumen, and the testicular lymph and blood plasma. For example, it was demonstrated that fluid collected from the rete testis was higher in potassium and chloride than that collected from the blood plasma (Ref.122 ; for review, see Ref.123). In addition, the total protein content of the rete testis fluid was only approximately 1/20 to 1/50 that of the plasma (124). Second, there were variations in the rate in which radioactive tracers or dyes could pass from the blood plasma into testicular fluids (114, 125, 126, 127, 128). Although these results suggested that a barrier existed, concrete evidence, not to mention the physiological significance of such a barrier, was for the most part lacking until the 1980s when cell biology and morphology studies confirmed earlier observations.

b. Functions of the blood-testis barrier.
Three main functions are ascribed to the blood-testis barrier. The blood-testis barrier: 1) creates a specialized environment; 2) regulates the passage of molecules; and 3) serves as an immunological barrier. First, the blood-testis barrier contributes directly to the complex structural organization of the testis by creating a specialized environment necessary for germ cell development and movement. As such, Sertoli cells are obliged to synthesize, secrete, and efficiently deliver products that are essential for the growth and differentiation of developing germ cells (Refs.129 and 130 ; for reviews, see Refs.131, 132, 133, 134, 135, 136). For instance, the synthesis of testicular transferrin, which was first reported by Thorbecke et al. (137) and later by Skinner and Griswold (138), is the classic example of this Sertoli cell characteristic (for reviews, see Refs.136 and 139). Because germ cells residing in the adluminal compartment do not have access to serum iron, a transport mechanism orchestrated by Sertoli cells must exist. Nevertheless, recent in vitro studies have demonstrated that germ cells can indeed stimulate Sertoli cell transferrin mRNA and protein levels, suggesting that germ cells govern their own iron requirements via their interactions with Sertoli cells (140, 141, 142). One must be cautioned, however, that some of the earlier reported effects of germ cells on Sertoli cell function may indeed be artifacts because residual trypsin, which was used to isolate germ cells from the testis, can mimic some of the reported effects on Sertoli cells (143).

Tight junctions that constitute the blood-testis barrier also regulate the movement of products, such as nutrients and wastes, both into and out of the seminiferous epithelium (for review, see Ref.144). Although studies that have specifically focused on this tight junction attribute in the testis are by far limited, the regulated movement of solutes across tight junctions continues to be well studied in other organs, such as the kidney and intestine in normal (e.g., food absorption in the small intestine) and pathological (e.g., migration of neutrophils across the tight junction barrier during inflammation) responses. In the testis, the best example of regulated movement of products lies in the biology of FSH, whose major site of action is on Sertoli cells. However, FSH cannot enter the seminiferous tubule fluid readily (for reviews, see Refs.145, 146, 147). Therefore, it is not unexpected that receptors for FSH are found in the basal compartment residing on the Sertoli cell membrane (146, 148, 149, 150, 151, 152).

The third main function of the blood-testis barrier is to create an immunological barrier, ensuring that the organism’s immune system does not recognize unique antigens present on the cell surfaces of haploid germ cells. This would result in the organism being immunized against its own spermatozoa. In addition, recent studies have shown that Sertoli and germ cells maintain a unique antiviral defense system via the production of interferons (IFNs), ILs, and cytokines (153, 154). The blood-testis barrier also prevents the entrance of Igs and lymphocytes into the adluminal compartment (for review, see Ref.155).

c. Regulation of the blood-testis barrier.
The blood-testis barrier is one of the tightest barriers in the mammalian body comparable to the blood-brain barrier, and tight junction barriers in the endothelium of blood vessels and the epidermis. However, the blood-testis barrier is different in that it must open periodically to accommodate the passage of germ cells during spermatogenesis. For instance, developing preleptotene/leptotene spermatocytes must traverse the blood-testis barrier, which is known to take place in late stage VIII–early IX of the epithelial cycle (2). This process requires that Sertoli-Sertoli and Sertoli-germ cell junctions be disassembled and reassembled. This also illustrates the unusual dynamic nature of the blood-testis barrier. However, the mechanism(s) by which germ cell movement takes place remains to be elucidated. Additionally, the factor(s) that regulates the formation and maintenance of the blood-testis barrier is currently not known. For instance, gonadotropins have been implicated, but this is largely a speculation that has remained relatively unexplored. Until recently, the lack of information on the biology of the blood-testis barrier has largely stemmed from the lack of suitable in vitro and in vivo models that could be used to study Sertoli cell tight junction dynamics. These will be discussed below.

   i. An in vitro model.
Sertoli cells cultured in vitro on Matrigel-coated dishes or bicameral units at a cell density ranging between 0.5 and 1.2 x 106 cells/cm2 are known to establish a functional tight junction barrier (24, 31, 32, 35, 36, 37). The assembly and maintenance of the tight junction barrier was assessed by transepithelial electrical resistance (TER); polarized secretion of Sertoli cell proteins; restricted diffusion of [3H]inulin, [125I]BSA, or fluorescein isothiocyanate (FITC)-dextran (Mr, 4.4 and 35.6 kDa); or maintenance of nonequilibrium of media across the Sertoli cell epithelium in bicameral units (24, 27, 31, 32, 35, 36, 37, 48). Using this system, several laboratories, including ours, have shown that Sertoli cell tight junction barrier function is regulated by an array of molecules, including intracellular calcium, cAMP, cytokines, protease inhibitors, protein kinases and phosphatases, and others (for reviews, see Refs.4 and 44). However, this in vitro system is not flawless. For instance, the Sertoli cell tight junction that constitutes the blood-testis barrier is one of the tightest barriers in the mammalian body (Section II.B.2). However, the tightness of the Sertoli cell tight junction barrier in vitro is only approximately 100 ohm·cm2 (22, 24, 27, 28, 29, 34, 57) vs. 1000–2000 ohm·cm2 in Madin-Darby canine kidney (MDCK) cells and keratinocytes (156, 157, 158) when barrier function was assessed by TER measurement. These results seemingly suggest that Sertoli cell tight junctions in vitro are only moderately tight when compared with other cell types. Recent studies have shown that the inclusion of androgens (27, 28), cAMP (34), and protease inhibitors (29) into Sertoli cell cultures during tight junction assembly can increase the tightness of the tight junction permeability barrier in vitro, illustrating that many biological factors present in vivo contribute to the tightness of this barrier in the testis. In short, these additional data demonstrate that this in vitro model is useful for studying tight junction dynamics.

Indeed, this in vitro model was used to verify some of the in vivo observations regarding Sertoli cell tight junction barrier function. For instance, recent studies have shown that extracellular matrix components, such as laminin and heparan sulfate, can promote the formation of the blood-testis barrier in vivo (Ref.159 ; for review, see Ref.160), whereas another report illustrated that laminin can also regulate the Sertoli cell tight junction barrier in vitro (161). To determine whether a relationship between extracellular matrix proteins and the assembly of the Sertoli cell tight junction permeability barrier does indeed exist (162, 163), this in vitro model was also used. Interestingly, the inclusion of an anticollagen {alpha}3(IV) antibody into Sertoli cells cultured at high density (1.2 x 106 cells/cm2) on Matrigel-coated bicameral units was able to perturb the assembly of the tight junction barrier, indicating that this protein is essential to tight junction functionality (163). This result also brings on a rare significance all on its own, because tight junctions in the testis are located in the basal third of the seminiferous epithelium closest to the basement membrane (21) [comprised of laminin, type I and IV collagen, heparan sulfate, and entactin (164)]. This is unlike other epithelia where tight junctions are located apically, farthest away from the extracellular matrix. What is not known, however, is whether this anticollagen-induced effect on Sertoli cell tight junction assembly is mediated via integrins or other yet-to-be identified molecules that constitute the focal adhesion or hemidesmosome. It has also been suggested that peritubular myoid and endothelial cells contribute, at least in part, to the functionality of the blood-testis barrier (97, 165), but the significance of this is presently unknown because there are no in vitro or in vivo studies examining the effects of these two cell types on the Sertoli cell tight junction barrier.

Other studies have demonstrated that the formation of the blood-testis barrier is not dependent upon germ cells because the disappearance of these cells from the seminiferous epithelium in vivo did not prevent the formation of the barrier (166, 167). Additional studies have demonstrated that the formation of the Sertoli cell tight junction permeability barrier is dependent on temperature and hormones (27, 33, 34, 168). For instance, the addition of testosterone (0.001–10 µM) into Sertoli cells cultured on bicameral units in vitro was able to enhance TER across the Sertoli cell epithelium (33, 34). This is not entirely unexpected because the testis is an androgen-dependent organ. On the other hand, treatment of rats with estradiol valerate did not affect the passive diffusion of [3H]inulin into the tubule lumen, although testicular weight and the serum testosterone level were shown to be altered (169), illustrating that estrogens do not regulate Sertoli cell tight junction barrier function.

There is also limited evidence to suggest that protease inhibitors can affect Sertoli cell tight junctions. A recent report by Okanlawon and Dym (29) demonstrated that chloroquine (an antimalarial drug and a protease inhibitor that has the property of increasing the pH within lysosomes and endocytic vesicles) was able to dose-dependently increase TER, making the Sertoli cell tight junction barrier tighter, when compared with Sertoli cells cultured in the absence of chloroquine. Unfortunately, the effects of protease inhibitors on Sertoli cell tight junction dynamics remain limited to this single report, and there is not a single study in which the effects of proteases are examined. In studies in which other cell types and cell lines such as MDCK cells were used, proteases were found to induce the aberrant formation of tight junctions. For example, the application of trypsin, a serine protease, together with calcium to the basolateral surface of confluent MDCK monolayers resulted in the formation of basally situated tight junction strands, which was accompanied by a transient increase in TER (170). These results seemingly suggest that this increase in tight junction barrier function is a normal physiological response of an epithelium to a potential cellular hazard. What is not known is whether the cellular distributions of occludin and claudin were altered in response to trypsin treatment. The participation of protease inhibitors was also studied in the human adenocarcinoma cell line, Caco-2, when these cells were cultured in the presence of nontoxic concentrations of either leupeptin or antipain (Ref.171 ; for review, see Ref.172). It was shown that these protease inhibitors could effectively block tight junction barrier assembly in vitro. These results, taken collectively, demonstrate the involvement of proteases and protease inhibitors in tight junction dynamics, yet similar studies in the testis await to be performed.

   ii. In vivo models.
Once formed, the blood-testis barrier cannot be easily disrupted, such as by heat or irradiation (166, 173). However, ip administration of cadmium salts (e.g., cadmium chloride) can cause the blood-testis barrier to break down, resulting in complete degeneration of the seminiferous epithelium (28, 37, 40, 41, 174). This in vivo model of blood-testis barrier disruption is irreversible, and an explanation that would help to understand the destructive effects of cadmium chloride in the testis is still lacking. In studies using cell lines, the effects of cadmium chloride were shown to be concentration- and time-dependent, decreasing the tight junction barrier by TER, increasing the permeability of mannitol, and altering the localizations of occludin, zonula occludens (ZO)-1, and E-cadherin (175). In another recent in vitro study from our laboratory, Sertoli cells were cultured in the presence of cadmium chloride (noncytotoxic concentrations), which induced a disruption of the tight junction permeability barrier as assessed by TER. As anticipated, the tight junction barrier failed to reseal upon removal of cadmium chloride (27). However, the addition of testosterone (1 x 10–9 M) allowed reassembly of the Sertoli cell tight junction permeability barrier after cadmium chloride was removed from cultures, and a 200-fold increase in testosterone even protected Sertoli cells from cadmium chloride-induced damage (27). This suggests that this androgen can protect Sertoli cell tight junctions from being damaged.

Another in vivo model of blood-testis barrier destruction is the glycerol model (Refs.176, 177, 178, 179, 180 ; for review, see Ref.181). Similar to cadmium chloride, intratesticular injection of glycerol irreversibly disrupts the blood-testis barrier and, consequently so, spermatogenesis. However, glycerol does not affect Leydig cell steroidogenesis or serum FSH and LH levels (176). In a recently published article by Wiebe et al. (42), the effects of glycerol on the testis were expanded when the localizations of cytoskeletal and tight junctional proteins such as F-actin, tubulin, and occludin were examined by immunofluorescence. It was shown that glycerol, in addition to upsetting the localization of occludin, was capable of perturbing microfilament and microtubule organization in the testis. Unfortunately, comparable studies on the effects of glycerol on Sertoli cells in vitro are lacking. Moreover, results obtained from the study of these two models suggest that a primary disruption of the blood-testis barrier can also lead to a loss of adherens junction function since the treatment of rats with cadmium chloride or glycerol results in the loss of germ cells from the seminiferous epithelium, causing aspermatogenesis and infertility (for review, see Ref.44).

A third in vivo model to study blood-testis barrier dynamics is based on a recent study from this laboratory. When a single dose of a synthetic occludin peptide (NH2-GSQIYTICSQFYTPGGTGLYVD-COOH, corresponding to amino acid residues 209–230 in the second extracellular loop of rat occludin) (Fig. 4Go) was administered intratesticularly at 1.5–10 mg/testis, it caused reversible germ cell loss from the seminiferous epithelium (43). Morphological analysis of treated testes revealed that more advanced germ cells, such as elongate spermatids, began to deplete from the epithelium 1–2 wk after administration of the peptide (43). By 4 wk post treatment, there was a massive depletion of germ cells from the seminiferous epithelium in virtually all of the tubules examined. This event also associated with a disruption of the integrity of the blood-testis barrier when barrier function was monitored by micropuncture technique, detecting leakage of [125I]BSA from the systemic circulation into the lumens of the rete testis and seminiferous tubules (43). Figure 5Go shows recent results using immunofluorescent microscopy to monitor the integrity of the blood-testis barrier by localizing occludin to this site. Damage of blood-testis barrier function was associated with an extensive disruption (Fig. 5Go, A—E) and loss of occludin immunostaining intensity (Fig. 5FGo) at the site of the blood-testis barrier. In addition, tubules in occludin peptide-treated testes shrunk significantly, with the tubule diameter reducing by as much as 20–30% when compared with control testes receiving either vehicle or a myotubularin synthetic peptide (43). Thereafter, germ cells began to repopulate the epithelium. By 7–8 wk, some spermatocytes were clearly visible in all of the tubules examined. By 10–16 wk (depending on the dose of occludin peptide used), the morphology of the seminiferous epithelium was indistinguishable from that of control rats, showing full recovery from occludin peptide-induced damage. The fact that testes recovered almost completely illustrates that spermatogonia were not destroyed. Occludin peptide-induced germ cell loss was also accompanied by a reversible disruption of the blood-testis barrier when assessed by micropuncture technique that quantified [125I]BSA in rete testis and seminiferous tubule fluids after administration of [125I]BSA through the jugular vein (43). Moreover, recovery of the blood-testis barrier coincided with the recovery of the seminiferous epithelium when examined histologically (43). It is likely that this peptide exerts its effects by interfering with the homotypic interactions that exist between two occludin molecules in apposing Sertoli cell membranes, thereby disrupting blood-testis barrier function. Once the peptide is metabolized and/or cleared, the blood-testis barrier reseals. Thus, these results illustrate that occludin peptide-induced reversible damage of the blood-testis barrier can be a useful in vivo model to study the dynamics of the blood-testis barrier if adequately characterized.



View larger version (18K):
[in this window]
[in a new window]
 
FIG. 4. Schematic drawing illustrating the architecture of occludin, a tight junction integral membrane protein. Each occludin molecule is composed of an N and a C terminus, four transmembrane domains, one intracellular loop, and two extracellular loops. The 22-amino acid peptide corresponding to the outermost region in loop 2 (amino acid residues 209–230) is shown. This figure was prepared based on the following original research articles and reviews: (Refs.43 , 285 , 370 371 372 373 , and 377 ).

 


View larger version (23K):
[in this window]
[in a new window]
 
FIG. 5. Immunofluorescent localization of occludin in the seminiferous epithelium in testes from a control rat (A) and rats on d 6 (B), d 30 (C), d 42 (D), and d 52 (E) after intratesticular injection of occludin peptide. Adult rats (n = 3; ~300 g body weight) received 2 mg HPLC-purified occludin peptide suspended in 0.1% dimethylsulfoxide on d 0 and 14 (a total of two doses with 2 mg peptide/dose) at three sites as described (43 ). Thereafter, rats were terminated at specified time points and processed for immunofluorescence microscopy. Occludin was found to localize to the basal compartment of the seminiferous epithelium (A and B), consistent with its localization at the site of the blood-testis barrier. From panels C–E, it is evident that disruption of the blood-testis barrier occurred by d 30 and persisted until d 52 after administration of occludin peptide (see arrowheads), which was confirmed in an earlier study using micropuncture technique (43 ). F, Results of image analysis performed using at least 100 different micrographs from each time point where the relative fluorescence intensity was integrated using ImageTool (version 3.0; ImageTool, Roswell, GA). *, Significantly different from control by Student’s t test, P < 0.01. Scale bars, 120 µm.

 
d. General discussion on the regulation of the blood-testis barrier based on recent in vitro and in vivo studies.
Countless reports have implicated cytokines and growth factors in regulating tight junction dynamics (Table 3Go) (for reviews, see Refs.182, 183, 184). In Sertoli cells cultured in vitro, for instance, the mRNA level of TGF-ß3 was found to decrease approximately 2-fold during the assembly of the tight junction barrier from d 1–3, which coincided with a transient but significant increase in the expression of occludin and ZO-1 (22). However, during the maintenance phase of the tight junction permeability barrier from d 5–8, the level of TGF-ß3 increased. The reason for this increase is not immediately known, but it is likely that TGF-ß3 is not needed for the maintenance of the Sertoli cell tight junction barrier.


View this table:
[in this window]
[in a new window]
 
TABLE 3. Effects of cytokines/growth factors on the tight junction permeability barrier in vitro

 
Nevertheless, in vitro and in vivo studies have shown that TGF-ß3 can exert its effects on the Sertoli cell tight junction (23) and blood-testis (38) barriers via the p38 MAPK signaling pathway (Fig. 6Go). These observations were verified when an in vivo model of blood-testis barrier disruption induced by cadmium chloride was used in which 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1H-imidazole (SB202109, a specific p38 MAPK inhibitor) could effectively block the cadmium chloride-mediated loss of occludin from the site of the blood-testis barrier (38). This illustrates that the dynamics of the blood-testis barrier are regulated, at least in part, by TGF-ß3 via the p38 MAPK pathway.



View larger version (52K):
[in this window]
[in a new window]
 
FIG. 6. Schematic drawing illustrating the molecular architecture of the three multiprotein complexes found at the Sertoli cell tight junction that constitute the blood-testis barrier. Shown are the three multiprotein complexes found at the Sertoli cell tight junction: 1) occludin–ZO-1/ZO-2; 2) claudin–ZO-1/ZO-2; and 3) JAM–ZO-1. Also shown are peripheral membrane proteins known to regulate Sertoli cell tight junction dynamics. This figure was prepared based on the following original research articles and reviews: (Refs.4 , 28 , 114 , 149 , 150 , 254 255 256 , and 341 ).

 
Another recent study from this laboratory has shown that TNF-{alpha} can also perturb Sertoli cell tight junction barrier function by affecting the production of occludin, collagen, matrix metalloprotease-9 (MMP-9), and tissue inhibitor of metalloproteases-1 (TIMP-1) (163). It was postulated that TNF-{alpha} induces the production of Sertoli cell collagen {alpha}3(IV), MMP-9, and TIMP-1, as well as promoting the activation of pro-MMP-9. Because activated MMP-9 cleaves the collagen network in the basement membrane, the Sertoli cell tight junction barrier is perturbed. This creates a negative feedback loop that causes TNF-{alpha} to induce the synthesis of collagen and TIMP-1, which are needed to reassemble the disrupted collagen network and tight junction barrier (163). TNF-{alpha} may also limit the activity of MMP-9. As such, this cytokine likely regulates collagen, MMP-9, and TIMP-1 which collectively maintain the integrity of the blood-testis barrier in vivo (163).

Many other cytokines and growth factors have also been investigated with regard to their effects on tight junction barrier assembly and disassembly. However, these studies were all performed in nongonadal cell types and cell lines. For instance, cytokines such as TGF-{alpha}, epidermal growth factor (EGF), and IL-1 have all been documented to affect tight junction barrier function in different epithelial cell types and cell lines in vitro (Table 3Go). Such a disturbance may be mediated via: 1) a redistribution and/or shut-down in the production of tight junction proteins, or 2) remodeling of the actin cytoskeleton (for reviews, see Refs.182 and 184). If adequately expanded, these studies should shed light on the regulation of tight junction dynamics in the testis.

Interestingly, a recent study has shown that nitric oxide (NO) also plays an important role in the regulation of Sertoli cell tight junction dynamics via its effects on soluble guanylate cyclase and protein kinase G (PKG). For instance, significant decreases in the expression of inducible (iNOS) and endothelial NO synthase (eNOS) were detected during the assembly of the Sertoli cell tight junction permeability barrier in vitro, seemingly suggesting that NO can down-regulate tight junction barrier function (30). Indeed, the inclusion of zinc II protoporphyrin-IX (ZnPP, a specific inhibitor of NOS that can also inhibit soluble guanylate cyclase) into Sertoli cell cultures facilitated tight junction barrier assembly, whereas the presence of 8-bromo-cyclic GMP (cGMP) perturbed tight junction barrier function (30). Furthermore, C29H25N3O5 (KT-5823, a specific inhibitor of PKG) could also facilitate Sertoli cell tight junction barrier assembly (30). Lastly, iNOS and eNOS were both shown to physically interact with occludin, but not with N-cadherin and nectin-3 as demonstrated by coimmunoprecipitation (30). Collectively, these data have demonstrated that NO regulates Sertoli cell tight junction dynamics via the NOS/soluble guanylate cyclase/PKG signaling pathway. Needless to say, these data also illustrate that blood-testis barrier dynamics are under the regulation of multiple variables, some operating independently and others cooperatively.

e. Additional comments.
After nearly three decades of study by reproductive biologists, a much finer physiological distinction has arisen between the blood-testis barrier (e.g., occluding zonule) and Sertoli cell tight junction (e.g., occluding macule) based on the fact that the assembly of the blood-testis barrier and Sertoli cell tight junction are not synchronous events in vivo (213, 214, 215). The occluding zonule, which separates the seminiferous epithelium into basal and adluminal compartments, is the basis of the blood-testis barrier. The fibrils that compose the occluding zonule, or blood-testis barrier, are continuous, encircling each Sertoli cell and forming an impermeable barrier. In the rat, the blood-testis barrier forms by approximately 15–18 d of age (for reviews, see Refs.16 and 116). The occluding macule, on the other hand, is constituted by a focal seal through which interstitial fluids or tracers can readily pass. Morphological studies have shown that the fibrils that constitute the occluding macule in the testis are discontinuous and situated immediately above and below the occluding zonule (213, 214, 215). It must be noted that in other epithelial cell types and cell lines, such as MDCK cells, the occluding zonule is synonymous with the tight junction.

3. Assisting in germ cell translocation.
Sertoli cells are directly involved in the movement of developing germ cells because these cells lack an architecture characteristic of migrating cells, such as fibroblasts (for review, see Ref.3). A possible mechanism underlying germ cell movement may involve members of the GTPase superfamily, as shown in a series of recent studies from our laboratory (45, 50). Moreover, other studies have shown that the translocation of elongating/elongate spermatids across the seminiferous epithelium is largely conferred by the ectoplasmic specialization (Section III.A.3) (for reviews, see Refs.20 , 61 , and 65). It has been shown that microtubules, together with several motor proteins such as dynein (216, 217) and myosin VIIa (218), ATPases, and GTPases (for review, see Ref.219) present at the site of the ectoplasmic specialization assist in the migration of elongating/elongate spermatids across the seminiferous epithelium. This is analogous to a train (e.g., elongating/elongate spermatid) on a railroad track (e.g., microtubule) whose motion is driven by an engine (e.g., dynein, myosin VIIa). Because this hypothesis has been recently reviewed (for reviews, see Refs.20 and 216), it will not be discussed any further. However, many questions still remain unanswered. For instance, if the movement of germ cells must coincide with their developmental status, then what signal(s) dictates the timely movement of spermatids across the epithelium during the epithelial cycle? What is the mechanism(s) that regulates the restructuring of the ectoplasmic specialization? Do germ cells signal to Sertoli cells when they need to be lifted upward? To answer these questions, the biochemical architecture of the ectoplasmic specialization must first be completely elucidated.

Sertoli cells also assist in the translocation of early meiotic spermatocytes from the basal to the adluminal compartment during the epithelial cycle in the seminiferous epithelium. This process, which likely requires the disassembly of Sertoli-Sertoli and Sertoli-germ cell adherens junctions, is a highly selective process. For instance, type A spermatogonia cannot be lifted but must remain attached to the basement membrane, suggesting that an intriguing mechanism must exist to determine which specific cell types can be lifted from the basement membrane to the basal compartment.

4. Spermiation.
Sertoli cells are indispensable to the release of mature spermatids from the seminiferous epithelium. This process involves a cascade of events, some of which include: 1) encapsulation of spermatid heads by Sertoli cell cytoplasmic processes; 2) expulsion of spermatids from Sertoli cell crypts; and 3) release of spermatid heads (for reviews, see Refs.3 and 6).

5. Phagocytosis.
After the release of mature spermatids from Sertoli cell cytoplasmic crypts, Sertoli cells phagocytose the residual bodies that were released from spermatids and any germ cells that may have degenerated during spermatogenesis (220, 221, 222, 223). In this respect, Sertoli cells function as macrophages by maintaining the integrity of the seminiferous epithelium.

6. Pinocytosis and receptor-mediated endocytosis.
In addition to phagocytosis, studies have shown that Sertoli cells undergo active pinocytosis and receptor-mediated endocytosis in the adluminal and basal compartments of the epithelium, respectively (222, 223, 224).

7. Secretory function.
Sertoli cells are secretory cells. This is backed by the observation that approximately 15% of the total proteins produced by Sertoli cells are glycoproteins that are destined to be secreted (for reviews, see Refs.9 , 35 , 62 , 63 , 132 , 133 , 225 , and 226). As part of an attempt by many investigators to understand the many functions of Sertoli cells, in particular the relationship between these cells and germ cells, numerous research articles were published that identified and characterized an array of proteins; these include 1) proteases, 2) protease inhibitors, 3) hormones, 4) energy substrates, 5) growth factors, 6) paracrine factors, and 7) extracellular matrix components, as Sertoli cell secretory products (for reviews, see Refs.9 , 11 , 62 , 63 , 132 , 133 , 134 , 225 , and 227, 228, 229, 230). Brief descriptions on some of these proteins as they relate to germ cell movement are found below.

a. Proteases and protease inhibitors.
Sertoli cells synthesize and secrete proteases and protease inhibitors, which participate in nearly all cellular processes involving tissue maintenance, repair, growth, and development. Proteases and their inhibitors have also been implicated in the events of germ cell movement (for reviews, see Refs.225 , 231 , and 232). For example, it was postulated that cathepsin L plays a role in spermiation because its expression was highest in stage VII before germ cell release when compared with other stages of the epithelial cycle (47, 233, 234). However, subsequent studies have shown that the mRNA levels of cathepsins D (an aspartic protease) and S (a cysteine protease) peaked in stages VII–IX and VII–VIII, respectively (47). Thus, if cathepsin L is indeed required to cleave Sertoli cell-elongate spermatid junctions at spermiation, then what are the roles of cathepsins D and S? Needless to say, each protease or protease inhibitor likely works with other molecules so that a unique physiological effect relating to spermatogenesis and germ cell movement can be executed. Parvinen’s group also showed enhanced secretion of plasminogen activator (PA, a serine protease) in stages VII–VIII of the epithelial cycle (235), suggesting that this protease may also be required to cleave Sertoli-germ cell junctions to permit for the release of elongate spermatids into the tubule lumen. In yet another study from our laboratory, it was demonstrated that there was a transient but significant increase in overall serine protease activity during the adhesion of germ cells to Sertoli cells in vitro, but preceding the formation of Sertoli-germ cell junctions (5). Taken collectively, these results suggest that proteases need to be activated before junction disassembly (47, 233, 234) and assembly (5).

Studies in which changes in protease inhibitors correlated with junction assembly and/or disassembly in the testis include cystatin C (236) and {alpha}2-macroglobulin [{alpha}2-MG (237)]. In both cases, the localizations of these protease inhibitors were reduced in stage VII when proteases such as urokinase-type PA (u-PA) and cathepsin L were highest (Refs.5 and 233 ; for review, see Ref.225), illustrating the existence of a ying-yang relationship between proteases and protease inhibitors. Furthermore, it was shown that {alpha}2-MG associated tightly with elongating spermatids in stages I–VI of the epithelial cycle, apparently protecting the epithelium from unwanted proteolysis (237). These results also illustrate the significance of protease inhibitors in germ cell movement in the seminiferous epithelium.

b. Growth, autocrine, and paracrine factors.
Growth, autocrine, and paracrine factors are secretory molecules that bind to cell surface receptors to induce a cascade of signal transduction events that affect cell growth, differentiation, and function (for reviews, see Refs.13 , 14 , 238 , and 239). In the testis, these factors play a crucial role in the maintenance of spermatogenesis and germ cell movement (for reviews, see Refs.240, 241, 242, 243, 244, 245, 246, 247). For instance, TGF-{alpha}, a member of the EGF family (for reviews, see Refs.248, 249, 250) and putative Sertoli, germ, and peritubular myoid cell product (251), stimulates the proliferation of prepubertal Sertoli cells (252). On the other hand, several different TGF-ß isoforms are known to exist (for reviews, see Refs.253, 254, 255, 256, 257), and the presence of TGF-ß1, -ß2, and -ß3 (23, 258, 259) and their receptors (260, 261, 262) have all been demonstrated in the testis. Interestingly, the TGF-ßIII receptor, also known as betaglycan (for reviews, see Refs.253 and 255), was recently shown by Vale and colleagues to bind inhibin (Refs.263 and 264 ; for review, see Ref.265). Moreover, it appears that TGF-{alpha} and -ß elicit opposite effects on cell division and differentiation in several different cell types, such as granulosa (266) and Leydig (267, 268) cells, suggesting that these cytokines may work synergistically but have opposite effects in regulating specific cellular events.

c. Extracellular matrix components.
It has been known for several decades that the extracellular matrix plays an extremely important role in cellular movement, such as in the invasion and metastasis of malignant cells. However, its participation in germ cell movement is less clear. In the testis, the extracellular matrix at the basal lamina surrounding seminiferous tubules constitutes the basement membrane, which ultimately associates with Sertoli cells and developing germ cells (Fig. 1Go). It is largely composed of laminin, type IV collagen, heparan sulfate proteoglycan, and entactin (for review, see Ref.21). Sertoli cells are known to secrete components of the extracellular matrix, such as collagen (269, 270, 271, 272) and laminin (270, 272), that contribute to the structural integrity of the seminiferous epithelium, whereas peritubular myoid cells produce fibronectin (269). Indeed, a previous study has shown that laminin is crucial in maintaining the integrity of the Sertoli cell tight junction and blood-testis barriers (161). Recently, collagen was also shown to play an important role in regulating the Sertoli cell tight junction barrier in vitro, possibly via an interaction with TNF-{alpha}, MMP-9, and TIMP-1 (163). Indeed, it has been shown that TNF-{alpha} can stimulate Sertoli cell collagen {alpha}3(IV) production by as much as 12-fold vs. controls without TNF-{alpha} (163) and that germ cells and testicular macrophages are the major source of TNF-{alpha} in the testis (273). Collectively, these data illustrate that Sertoli, germ, and peritubular myoid cells contribute to the making and maintenance of the extracellular matrix, which in turn affects junction dynamics.

8. Provision of nutrients.
Sertoli cell products, many of which are important for germ cell survival, need to be synthesized and efficiently delivered in sufficient quantities to spermatocytes and spermatids residing behind the blood-testis barrier. These products include amino acids, carbohydrates, lipids, vitamins, and metal ions. This transfer of nutritive products from Sertoli to germ cells is largely made possible because an intricate relationship exists between these two cell types (for review, see Ref.62). This is exemplified best when one isolates and then attempts to culture germ cells for an extended period of time because these cells are incapable of survival past 24 h (for review, see Ref.274). The finding that stem cell factor, a putative Sertoli cell product, can prevent germ cell apoptosis in vitro (275), suggests that germ cell survival is largely dependent on Sertoli cells. Indeed, earlier studies have shown that germ cells can survive up to approximately 8 d in vitro when cocultured with Sertoli cells (276). Other factors that can enhance the viability of germ cells both in vivo and in vitro include hormones [e.g., testosterone (277), dihydrotestosterone, and estradiol (278)] and cytokines [e.g., TNF-{alpha} (279)].

a. Sertoli cell metabolism.
The metabolism of Sertoli cells continues to be poorly understood because many of the investigations that were conducted thus far are in vitro studies, and they may not reflect the actual in vivo condition (for reviews, see Refs.62 , 227 , and 228). For instance, the hormonal environment of Sertoli cells cultured in vitro is drastically different from that of in vivo because these cells are cultured in serum-free, chemically defined media. If serum is added into Sertoli cell cultures, results obtained from these experiments become misleading because the presence of the blood-testis barrier in vivo restricts access of serum proteins into the adluminal compartment. As such, the interpretation of these results in the context of the testis in vivo is often difficult, if not impossible. Nevertheless, morphological studies of Sertoli cells have shown that these cells have a large surface area, which remains in close contact with developing germ cells in all stages of the epithelial cycle. This is of great importance to the biology of the testis when one considers that a single Sertoli cell can sustain approximately 50 developing germ cells (71, 73). As such, the net output of energy is enormous, which is important not only to spermatogenesis, but also to germ cell development and movement (for review, see Ref.133). This is best exemplified in the observation that Sertoli cells can efficiently metabolize glucose into lactate (the preferred energy source of germ cells) and pyruvate (280, 281), which is likely channeled via gap junctions to germ cells to maintain their survival.


    III. Sertoli-Sertoli and Sertoli-Germ Cell Interactions
 Top
 Abstract
 I. Introduction
 II. Sertoli Cells
 III. Sertoli-Sertoli and Sertoli...
 IV. Mechanism of Germ...
 V. Concluding Remarks
 References
 
The different types of junctions found in the testis have already been briefly described in Section I and summarized in Table 1Go. In this section, these junctions and their constituent proteins as they relate to junction dynamics and germ cell movement are discussed in greater detail.

A. Cell junctions present in the testis
1. Occluding junctions.
Tight junctions are the only known example of occluding junctions (for reviews, see Refs.282, 283, 284, 285) (Figs. 1Go and 6Go and Table 1Go). In the testis, the tight junction is an area of close contact between plasma membranes of neighboring cells composed of fibrils, usually 50–100 in number, that completely encircle the basal domain of each cell. This divides the Sertoli cell, forming a basal and an adluminal compartment. Although the biochemical composition of these strands is not entirely known, it is believed that each of these fibrils represents a row of tightly arranged transmembrane proteins, such as occludin and claudin, that seal the paracellular space (for reviews, see Refs.282, 283, 284, 285). Unlike tight junctions found in other epithelia, in the testis these junctions have a unique location in that they are closest to the basement membrane, which is a modified form of the extracellular matrix (for reviews, see Refs.13 , 14 , and 16). In addition, the blood-testis barrier as constituted by Sertoli cell tight junctions is not assembled until 15–18 d of age in the rat testis, at which time a specialized microenvironment is created. This microenvironment is essential for germ cell development and movement.

a. Functions of occluding junctions.
Tight junctions (for reviews, see Refs.13 and 14) have two main functions; they 1) create a barrier, and 2) form a boundary. First, tight junctions create a semipermeable barrier, which restricts the passage of molecules. This is known as the barrier function of tight junctions. However, the passage of molecules depends largely on their molecular weight and chemical nature (for reviews, see Refs.144 and 286, 287, 288). In fact, tight junction permeabilities are known to vary among tissues so as to adjust to the physiological needs and functions of different organs (for reviews, see Refs.118 , 184 , and 289, 290, 291). Studies have also shown that tight junction permeability can be regulated by different factors and physiological conditions. For instance, sodium orthovanadate, a protein tyrosine phosphatase inhibitor, was able to perturb tight junction permeability in MDCK cells when the diffusion of inulin across the epithelium was examined (292), suggesting that an increase in protein tyrosine phosphorylation can perturb tight junction barrier function. These results were corroborated and expanded in a recent report from our laboratory which illustrated that inhibitors of protein tyrosine and serine/threonine phosphatases could perturb the assembly and maintenance of the Sertoli cell tight junction barrier (293). However, these observations warrant further investigation to complement earlier in vivo studies (125, 126, 127, 128).

Second, tight junctions in the testis form a boundary, dividing the Sertoli cell into a basal and an adluminal compartment, which are different from each other. This is known as the fence function of tight junctions (for reviews, see Refs.287 , and 294, 295, 296). This function also confers cell polarity in epithelia. Basically, the fence function of tight junctions prevents the intermixing of molecules, such as proteins and lipids, between the two domains. This is also an important feature for Sertoli cell function because these cells secrete several of their products such as androgen binding protein, testin, and transferrin in a polarized fashion (for reviews, see Refs.62 , 133 , 136 , and 226).

b. Models explaining the chemical nature of occluding junction strands.
Presently, there are two models that explain the chemical nature of occluding junction strands. In the first model, known as the lipid model, tight junction fibrils are proposed to be formed by micelles with the polar groups of the lipids directed inward and the hydrophobic tails immersed in the lipid matrix of the two plasma membranes (297, 298, 299). However, the lipid model appears to be inconsistent with currently available data. For instance, when the total composition of phospholipids, sphingolipids, and cholesterol in epithelial cells was altered, the appearance of tight junctions did not change. The barrier and fence functions of tight junctions were also not changed (300). However, another study reported that a rapid reduction in total cell cholesterol by methyl-ß-cyclodextrin resulted in a decline in TER, an increase in the influx of mannitol, and an increase in the number of tight junction particles associating with the E face [in freeze-fracture technique, the cytoplasmic face of the membrane is known as the protoplasmic or P face, and the exoplasmic is the E face (301)]. The validity of the lipid model has not yet been a subject of investigation in the testis.

In the second model, known as the protein model, integral membrane proteins associate with other integral membrane proteins (e.g., occludin + occludin, claudin 1 + claudin 2, claudin 1 + claudin 3) in the apposing plasma membrane of the adjacent cell. It is also possible that microscopic pores are present in these strands to permit for the passage of molecules across the tight junction barrier (302). Collectively, these results suggest that tight junction fibrils are composed of integral membrane proteins, but that their structure and functions are sensitive to rapid changes in the lipidic environment.

c. Proteins of occluding junctions.
The membrane-associated guanylate kinase (MAGUK) homolog protein family is composed of several members, including: 1) ZO-1; 2) ZO-2; and 3) ZO-3 (Fig. 6Go). They are known to: 1) regulate cell proliferation and differentiation; 2) control membrane organization; 3) manage signal transduction pathways; and 4) regulate cell polarity (for reviews, see Refs.285 and 303). All members of the MAGUK family possess three distinct domains: 1) a yeast enzyme guanylate kinase; 2) a src-homology region 3 (SH3); and 3) one or more postsynaptic density-95/Discs-large/ZO-1 (PDZ) domains, which are all important for protein-protein interactions (for reviews, see Refs.285 and 304, 305, 306). Proteins containing PDZ domains 1) coordinate the assembly of multiprotein complexes, 2) cluster tight junction proteins, and 3) recruit signaling molecules. Non-PDZ domain-containing proteins, on the other hand, can be recruited to the site of the tight junction by PDZ domain-containing proteins or interact directly with tight junction integral membrane proteins. For example, the recently identified multi-PDZ domain protein 1 (MUPP1) is known to have 13 PDZ domains (307, 308). This protein, which binds to claudin-1 and junctional adhesion molecule (JAM, another tight junction molecule) and colocalizes with ZO-1 in MDCK cells, may function by recruiting molecules to the site of tight junctions (308). These studies did not determine whether MUPP1 is present in the testis, but this is possible given the fact that MUPP1’s interacting partners, namely claudin-1 (309), JAM-1, JAM-2 (310), and ZO-1 (311, 312), are all found in the testis. Moreover, the SH3 domain of MAGUK proteins is known to interact with actin (for review, see Ref.313), illustrating that a relationship exists between membrane-associated proteins belonging to the MAGUK homolog family and the actin cytoskeleton.

The most recently identified MAGUK proteins are the MAGUKs with inverted orientation (MAGI) proteins. Studies on the first MAGI protein, MAGI 1, have revealed that it interacts with K-Ras (314), whereas MAGI 2 and 3 both relate with a protein known as phosphatase and tensin homolog deleted on chromosome 10 (PTEN) [a phosphatase and tumor suppressor; PTEN 2, a homolog of PTEN, is found only in the testis (315, 316, 317, 318)]. Furthermore, the expression of MAGI 3 was recently detected in the testis by PCR (315), whereas a study to determine whether MAGI 1 and 2 are found in the testis has not yet been performed. The significance of this observation as it relates to germ cell movement is currently not known, but studies that investigated the interplay of MAGI 3 with PTEN in other systems suggest that these proteins work coordinately to inhibit cell movement (for reviews, see Refs.319, 320, 321). This postulate is not proposed without ground because deletion of PTEN in a mouse fibroblast cell line led to increased cell motility likely mediated by Rac1 and Cdc42 (322), two small GTPases that regulate the dynamics of the actin cytoskeleton. What is also known is that the PDZ domain of MAGI 1 interacts with ß-catenin (323), suggesting that there is cross-talk between constituents of the tight and adherens junction via MAGIs. Although MAGIs appear to be potentially important for the function of tight, and possibly adherens junctions, little is understood regarding their role in junction dynamics.

   i. ZO-1.
ZO-1, a 210- to 225-kDa peripheral membrane protein that associates with tight junctions in epithelial and endothelial cells, is believed to have scaffolding and signaling functions (for reviews, see Refs.285 and 324) (Fig. 6Go). ZO-1 is most notably known for its direct interaction with the C terminus of occludin at an occludin:ZO-1 stoichiometric ratio of 1:1 (325, 326). ZO-1 also associates with actin (326, 327) and {alpha}-catenin (328, 329) in epithelial and nonepithelial cells, illustrating that ZO-1 can associate with adherens junctions. In another recent report by Gonzalez-Mariscal’s group (330), ZO-1 shuttled away from the site of the tight junction and moved into the nucleus when the tight junction in epithelial cells was compromised. Not surprisingly, this was mediated via the actin cytoskeleton. Thus, it is possible that ZO-1 has other cell functions, possibly of a signaling nature (e.g., involved in transcriptional regulation). In the testis, ZO-1 is localized almost exclusively to Sertoli cell tight junctions at the site of the blood-testis barrier consistent with an earlier report (312) (Fig. 7Go). Immunoreactive ZO-1 was also reported to be found at the site of Sertoli cell ectoplasmic specializations adjacent to early, but not late, elongating spermatids just before spermiation (312), suggesting its involvement in germ cell movement.



View larger version (8K):
[in this window]
[in a new window]
 
FIG. 7. Immunofluorescent localization of ZO-1 in the seminiferous epithelium of the rat testis. A micrograph of a cross-section of an adult rat testis immunostained with a mouse anti-ZO-1 monoclonal antibody conjugated to FITC (cat. no. 33-9111F, lot no. 10665662, Zymed Laboratories, South San Francisco, CA). ZO-1 was found to localize to the basal compartment of the seminiferous epithelium at the site of the blood-testis barrier. This observation is consistent with earlier reports demonstrating the localization of ZO-1 in the rat and mouse testis (312 333 ). Scale bar, 100 µm.

 
Studies have illustrated that ZO-1 has two distinct isoforms: 1) {alpha}, and 2) {alpha}+, which are the result of alternative splicing of its mRNA (331, 332). These two isoforms play different roles in the assembly, maintenance, and regulation of tight junctions because they associate differently with tight junctions (331, 332, 333). For instance, in the testis ZO-1{alpha} and ZO-1{alpha}+ are expressed exclusively during adulthood and puberty, respectively, suggesting that these isoforms are crucial to junction disassembly (e.g., germ cell movement) and assembly (e.g., blood-testis barrier formation) (332, 333). [The homolog of ZO-1 in Drosophila, Polychaetoid, sometimes referred to as Tamou or Tam, is also alternatively spliced, generating two isoforms that differ in localization and function, similar to that seen for ZO-1 in the testis. When antibodies specific for each isoform were generated, it was found that one isoform localized to the adherens junction, whereas the other one had a much broader distribution (334).]

In addition to occludin, ZO-1 can also associate with other proteins (Fig. 6Go). ZO-1 was found to interact with ZO-2 (335, 336), ZO-3 (335), ZO-1 associated protein kinase [a serine protein kinase (337)], ZO-1-associated nucleic acid-binding protein [ZONAB, a nucleic-acid binding protein/transcription factor (338, 339)], and connexin43 [a gap junction protein (340)]. Other proteins interacting with ZO-1, which were largely determined by coimmunoprecipitation and/or immunolocalization experiments, include F-actin (336), JAM (341), claudin-1 (342), cingulin (343), spectrin (344), partitioning-defective-3 [PAR-3, a cell polarity protein (345)], ALL-1 fusion partner from chromosome 6 [AF-6 (346)], Rab8 [a Rab GTPase (50, 347)], Rab13 (348), 19B1 (349), atypical protein kinase C (PKC) isotype-specific interacting protein [ASIP (350)], G{alpha}o (351, 352), G{alpha}2 (351), G{alpha}i2 (351, 352), G{alpha}s (352), G{alpha}12 (353), absent, small, or homeotic 1 [ASH1 (354)], protein 4.1R (344), MAGI 1 (355), junction-enriched and -associated protein [JEAP; this protein was not found in the testis by immunoblotting (356)], peripheral myelin protein 22 (357), vasodilator-stimulated phosphoprotein (VASP) (358), proteins associated with Lin-7 [Pals; consists of two variants, Pals1 and Pals2, but thus far only Pals2 has been positively identified in the testis (359)], Crumbs homolog 1 [CRB1, which determines apical polarity (360)], Sec6, and Sec8 (361). It must be noted that the association of ZO-1 with many of these proteins in the testis has not yet been shown or may not even exist, but recent studies have shown that some of these proteins, such as Rab8B and Rab13, are likely to play a crucial role in regulating junction dynamics in the testis (50).

   ii. ZO-2.
ZO-2, a 160-kDa protein first identified as a ZO-1 binding partner in MDCK cells (Ref.362 ; for reviews, see Refs.285 and 324), is present in the testis (363) (Fig. 6Go), but has not been studied extensively in this organ. A detailed characterization of ZO-2 has demonstrated that it shares a 51% homology with ZO-1 in the three MAGUK domains (364, 365), but only a 25% homology in the C terminus, suggesting that the latter region participates in determining the functional uniqueness of these two molecules. ZO-2 can be phosphorylated by PKC-ß, -{epsilon}, -{lambda}, and -{zeta} isoforms (366), illustrating that it can be activated by protein kinases. Other in vitro and in vivo studies have demonstrated that ZO-2 binds to occludin (336) and claudin (342). Several reports have also described the association of ZO-2 with F-actin (336) and {alpha}-catenin (367), alluding to the fact that this signaling molecule may also participate in the regulation of the adherens junction, similar to ZO-1.

   iii. ZO-3.
ZO-3, first identified as a 130-kDa polypeptide in MDCK cells and designated as p130, was subsequently renamed as ZO-3 when it was found to share a high homology with both ZO-1 and ZO-2 (Ref.335 ; for reviews, see Refs.285 and 324). In MDCK cells it was shown that ZO-3, similar to ZO-1 and ZO-2, is a putative substrate of protein kinases and can be phosphorylated on serine and tyrosine residues (Refs.332 and 368 ; for review, see Ref.369). By immunofluorescence and immunoelectron microscopy, ZO-3 was shown to colocalize with ZO-1 at the site of tight junctions (335). It was also found to interact with occludin (335), claudin (342), actin (336), and Pals1 associated tight junction protein (360), but not with ZO-2 (335). Although its cDNA sequence has been available since 1998 (335), its presence in the testis has not yet been demonstrated.

   iv. Occludin.
To date, the best-studied tight junction transmembrane protein is occludin (for reviews, see Refs.285 and 370, 371, 372, 373) (Figs. 4Go, 6Go, and 8Go). Occludin is a 60- to 65-kDa protein [often migrates on SDS-polyacrylamide gels as multiple bands as a result of its different phosphorylation states (374)] containing four transmembrane domains, two extracellular loops, and one intracellular loop. Both N and C termini exit into the cell cytoplasm (Figs. 4Go and 6Go). The first extracellular loop of occludin is comprised of approximately 60% tyrosine and glycine residues, and it participates in cell-cell adhesion (375). On the other hand, the second extracellular loop participates in the formation of the paracellular barrier because the tight junction permeability barrier was shown to be altered when a synthetic peptide corresponding to the second extracellular domain was added into epithelial (376, 377) or Sertoli (43) cell cultures. Peptides corresponding to the first extracellular loop exhibited no effects on the tight junction barrier in epithelial cells (376, 377). Moreover, when a truncated form of occludin lacking the second extracellular loop was generated and expressed in occludin-null Rat-1 fibroblasts and MDCK cells, it failed to localize to the site of tight junctions (378), illustrating the significance of the second extracellular loop in targeting occludin to tight junctions. In line with the above functional studies, when chicken occludin was overexpressed in MDCK cells, the number of tight junction strands increased (379). This occurred concomitantly with a surge in TER (379), whereas in another important study, the depletion of occludin from tight junctions did not significantly affect cell morphology (380), suggesting that other tight junction proteins can substitute its structural role. In a follow-up study by the same group, occludin–/– male mice failed to produce litters with wild-type females, indicating that males were sterile (381). This observation is consistent with a recently published report from our laboratory which demonstrated that the intratesticular injection of a 22-amino acid synthetic peptide corresponding to the second extracellular loop of occludin resulted in reversible infertility (43). This is not entirely unexpected because this peptide induced aspermatogenesis via a disruption of the blood-testis barrier (Fig. 5Go) by interfering with the homotypic interactions between two occludins in apposing Sertoli cell membranes. This subsequently resulted in germ cell loss from the seminiferous epithelium because it is possible that Sertoli-germ cell adherens junctions were also perturbed. When the peptide was metabolized or cleared, the blood-testis barrier reassembled and spermatogenesis resumed (43). Taken collectively, these results illustrate that occludin is required for testis function, namely spermatogenesis and germ cell movement.



View larger version (11K):
[in this window]
[in a new window]
 
FIG. 8. Immunofluorescent localization of occludin in the seminiferous epithelium of the rat testis. A micrograph of a cross-section of an adult rat testis immunostained with a rabbit antioccludin polyclonal antibody (cat. no. 71-1500, lot no. 11067632, Zymed), followed by a goat antirabbit IgG-FITC secondary antibody. Occludin was found to localize exclusively to the basal compartment of the seminiferous epithelium, consistent with its localization at the site of the blood-testis barrier (390 ). Scale bar, 120 µm.

 
To some extent, an adhesive role, although weak, can also be attributed to occludin since it has been shown to mediate the aggregation of fibroblasts (382). Just recently, the stretch of amino acids responsible for conferring cell adhesive properties to occludin, namely Leu-Tyr-His-Tyr found in the second extracellular loop, has been identified (383). This finding will definitely help investigators better understand the role of occludin in the tight junction. Occludin has also been implicated in the migration of leukocytes across epithelial cells (for review, see Ref.384)]. For instance, modifying the N-terminal cytosolic domain of occludin increased neutrophil migration (384). In addition to the associations described above, occludin also interacts with F-actin (336), JEAP (356), peripheral myelin protein 22 (357), and VAMP associated protein of 33 kDa [VAP-33, a protein of unknown function that was previously shown to be involved in vesicular transport mediated by GTPases (385)]. In a study using MDCK cells, it was demonstrated that occludin can be phosphorylated (phosphorylated occludin is found at the site of tight junctions) on tyrosine and serine/threonine residues (374, 386, 387) and that phosphorylation on Ser338 was mediated by PKC (387). A minor pool of less- and nonphosphorylated occludin was also present at the basolateral membrane of MDCK and T-84 cells (374, 388), but it is not known whether this reservoir of occludin molecules actually participates in the assembly of tight junctions. In the adult testis, the occludin mRNA level was found to be quite high (389, 390). By immunohistochemistry, the localization of occludin coincided precisely with the assembly of the blood-testis barrier in the mouse testis (390). In the adult rat testis, occludin was found in the seminiferous epithelium consistent with its localization at the level of the blood-testis barrier (Fig. 8Go) (390). Interestingly, its localization in either species was not stage-specific (390), suggesting the importance of this protein throughout the entire epithelial cycle during spermatogenesis. On the other hand, an irregular staining pattern of occludin in Sertoli cells in 1-wk-old testes when the blood-testis barrier had not yet been formed was demonstrated by Cyr et al. (390). This is consistent with our results when immunofluorescence was performed using approximately 2-wk-old testes (our unpublished observations). Recently, a variant of occludin, occludin 1B, with an apparent Mr of 70 kDa was identified and found to be present in several mouse tissues, including the testis (391). Occludin 1B is different from occludin in at least three respects. Occludin 1B has a unique N-terminal sequence of 56 amino acids, and a 193-bp insertion that codes for a larger occludin molecule (391). Moreover, occludin 1B does not appear to be phosphorylated (391), suggesting that phosphorylation, although important, is not the only mechanism regulating tight junction dynamics. The precise roles of occludin and occludin 1B in germ cell movement are not yet known.

   v. Claudins.
Presently, the claudin superfamily of tight junction transmembrane proteins of Mr 20–24 kDa consists of at least 24 members (for reviews, see Refs.58 , 370 , 371 , and 392, 393, 394, 395, 396). Claudins have been shown to localize precisely to the site of tight junctions (Fig. 6Go) as demonstrated by conventional freeze-fracture technique (397). This observation, together with the fact that tight junction strands could be reconstituted when the expression of a single claudin was induced in cultured fibroblasts (398), illustrates that claudins are one of the main building blocks of tight junctions. Although the topology of claudin has been shown to be similar to that of occludin, except that the cytoplasmic domain and second extracellular loop of claudin are significantly smaller, different claudin proteins do not exhibit any significant sequence homologies with occludin (for reviews, see Refs.370 and 393). In addition, the expression pattern of each claudin varies considerably among different tissues (for reviews, see Refs.58 , 392 , and 394). For example, claudin 11 is restricted largely to the testis and brain (397, 399). A 2.3-kb claudin 11 transcript was also barely detectable in the kidney (399). In addition, it is not known whether claudins are phosphorylated, yet the C termini of claudins are known to contain putative phosphorylation sites for PKC, casein kinase 2, and cAMP-dependent protein kinase (for review, see Ref.394). In fact, the greatest differences between the various claudins lie in their C termini, suggesting that their participation in tight junction dynamics in different organs may be related to their association with different cytoplasmic proteins (for reviews, see Refs.58 , 370 , 371 , and 392, 393, 394, 395). However, the last two amino acid residues at the C terminus, namely Tyr-Val, present in most claudin species are needed for their interaction with PDZ domains (342). Tsukita and Furuse (393) have also put forth a hypothesis stating that aqueous pores (or paracellular channels) that control ion selectivity exist within paired tight junction strands as was shown in transfection experiments using MDCK cells (400, 401). These studies illustrated not only that at any one time a cell can express more than two claudins, but also that the combination of different claudins between two cells determines the nature and possibly the physical size of the aqueous pores (for review, see Ref.58). This assigns unique properties to tight junctions in different cells and tissues. However, this model cannot explain how cells, such as preleptotene/leptotene spermatocytes, can pass through the Sertoli cell tight junction barrier.

In the testis, seven different claudins have been positively identified, namely claudins 1, 3, 4, 5, 7, 8, and 11 (for reviews, see Refs.58 , 392 , and 394). Claudin 11, the only claudin in the testis that has been studied in some detail, was shown to be restricted to the Sertoli cell at the site of the blood-testis barrier (399, 402). In the mouse testis, its expression coincided with the assembly of the blood-testis barrier at 6–16 d after birth (402), and its expression in Sertoli cells in vitro could be inhibited by FSH and TNF-{alpha} (402). More importantly, gene knock-out experiments demonstrated that mice lacking claudin 11 are sterile (403), illustrating that the integrity of the blood-testis barrier is crucial for normal spermatogenesis.

   vi. JAMs.
JAM, a member of the newly described Ig superfamily, was found to localize at the site of the tight junction in epithelial and endothelial cells (404). Unfortunately, it is not yet known whether JAM is an actual component of the tight junction. To date, three JAMs, namely JAM 1, 2, and 3, have been identified, and the expression of JAM 1 and 2 in the testis has been demonstrated by Northern blots (310). Studies have shown that JAM colocalizes with occludin (341, 405), ZO-1 (341, 406), and cingulin (341) (Fig. 6Go). Other reports have demonstrated that JAM associates with AF-6 (407), ASIP/PAR-3 (406, 408), MUPP1 (308), and calcium/calmodulin-dependent serine protein kinase (409). When an anti-JAM antibody was used in a functional study, the migration of leukocytes across endothelial cells was inhibited (404), whereas in another report, the inclusion of TNF-{alpha} and IFN-{gamma} resulted in the redistribution of JAM (410). This enhanced the migration of leukocytes across umbilical vein endothelial cells (410). JAM may also participate in homotypic cell adhesion (404), but a detailed investigation examining this characteristic has not yet been performed. Taken collectively, these results assign JAM a crucial role in cell movement, but it remains to be determined whether JAM facilitates or retards the movement of developing germ cells in the seminiferous epithelium. In view of recent findings that implicate JAM in cell movement, this family of tight junction integral membrane proteins should be vigorously studied in the testis.

   vii. Coxsackievirus and adenovirus receptor (CAR).
Another recently identified tight junction protein (Table 1Go) is CAR, a 46-kDa integral membrane protein possessing a transmembrane, long cytoplasmic, and extracellular domain with two Ig-like regions. Although it is too premature to speculate on the function of CAR in tight junction dynamics, it is known that CAR mediates viral attachment and infection (411, 412). For instance, coxsackievirus and adenovirus are two enteroviruses that traverse the tight junction in epithelia (either the gastrointestinal or respiratory tract) during the course of infection, resulting in the loss of tight junction integrity, before disseminating to target organs such as the heart and brain. It is likely that these viruses gain entry into cells via CAR, which is similar to JAM [recently identified as a receptor for mammalian reoviruses (413)] and some claudins [can also function as receptors for Clostridium perfringens enterotoxin (414, 415)]. In nonpolarized cells, CAR localized to intercellular contacts and recruited ZO-1 to these sites, illustrating that CAR can promote cell adhesion (416). This observation was supported by additional results from the same group that illustrated the colocalization of CAR with N-cadherin in intercalated discs in cardiac myocytes (416), where ZO-1 was also found to be present (417). In polarized epithelial cells, CAR and ZO-1 colocalized at the site of the tight junction. This association was subsequently verified in coimmunoprecipitation experiments (416). The overexpression of CAR was even shown to increase barrier function (416). Surprisingly, CAR has been found to be expressed in germ cells in the mouse (418), but its presence in Sertoli cells remains to be determined.

   viii. Others.
Several other tight junction-associated proteins have also been identified at the site of tight junctions, including those in the testis (Fig. 6Go and Table 1Go). These include cingulin (343, 419), symplekin (420), spectrin/fodrin (344), 7H6 [also known as barmotin (421, 422, 423)], AF-6 (346, 424), PAR-6 (425), atypical PKC (350, 426), Sec 6, Sec 8 (361), Rab13 (348), Rab3B (427), ZONAB (338, 339), ASH1 [a transcription factor colocalizing with ZO-1 and cingulin (354)], Tax [a viral oncoprotein and transcription factor (428)], protein 4.1R (344), BG9.1 antigen (429), 220-kDa protein (430), 19B1 (349), ASIP (350, 431), MAGI 1 (314, 323), and WNK1 kinase (432). It must be mentioned that ZO-1 (433), symplekin (420), and cingulin (434) have all been localized to the nucleus as well. The presence of many of these proteins in the testis has not yet been determined.

Cingulin is a well-characterized, peripheral membrane protein that has two molecular variants of 108 and 140 kDa (419, 434, 435, 436). Studies have shown the 108-kDa protein to be a coiled dimer, sharing a high homology with cytoskeletal proteins and belonging to the myosin family. Indeed, cingulin was shown to interact with myosin II in pull-down assays (343). Cingulin is phosphorylated on serine residues in MDCK cells (437), and it is present in the testis (for review, see Ref.16). Symplekin is another tight junction-associated protein found in the testis at the site of Sertoli cell tight junctions (420). However, its expression, was also detected in other tissues, some of which do not even possess functional tight junctions. As such, it was labeled as a housekeeping gene in tissues lacking tight junctions (420). Both cingulin and symplekin are non-PDZ domain-containing proteins (for review, see Ref.324).

Another well-studied tight junction-associated protein is 7H6. The localization of this protein was found to be related to its phosphorylation status because the depletion of cellular ATP resulted in the dissociation of 7H6 from the tight junction (422). Moreover, hepatocyte growth factor (HGF)/scatter factor (SF), which induced the migration of MDCK cells, reduced the expression of 7H6, illustrating once again the participation of cytokines/growth factors in tight junction dynamics via their effects on tight junction-associated proteins (423).

Reports dealing with the role of AF-6 at the tight junction have thus far been arguable. A previous investigation has shown AF-6 to be a Ras effector protein, as determined by a study that characterized mutants of the Caenorhabditis elegans homolog Ce-AF-6 (438), yet AF-6 was also shown to associate with actin, occludin, and ZO-1 (346, 439). Furthermore, when a null mutation in the murine AF-6 locus was generated, homozygous mutant embryos died at 10 d post coitum, resulting from a loss of epithelial cell polarity and junctions (440). In addition, AF-6 interacts with nectin, a homophilic cell adhesion molecule belonging to the Ig superfamily (441). Preliminary observations from our laboratory have demonstrated the presence of AF-6 in the testis (83). Collectively, these results illustrate the potential significance of AF-6 in the function of the blood-testis barrier.

   ix. Additional comments.
Less studied (at least, in mammals), but equally important, is cell polarity as it relates to the dynamics of tight junctions (for review, see Ref.442). It was recently shown that the polarity of a typical epithelial cell is initiated when that cell becomes integrated into an epithelium and that these events are largely mediated by cell adhesion. In the Drosophila embryo, removal of E-cadherin or ß-catenin resulted in not only the loss of cell adhesion but also cell polarity (443, 444, 445), suggesting that an intimate relationship between tight and adherens junctions exists. It must also be noted that cell polarity is not only a manifestation of the tight junction, but of the cytoskeleton as well, because forces that are responsible for cell shape must be transduced throughout the entire cell (for review, see Ref.442). Thus, the cytoskeleton also participates in the formation of spatially and functionally distinct domains within cells, which is an area of research receiving much attention lately through the study of GTPases, in particular Rabs and ADP-ribosylation factors (for reviews, see Refs.446, 447, 448, 449).

Investigators studying tight junction dynamics, in particular epithelial cell polarity, in the Drosophila are all familiar with the recently identified Crumbs, Stardust, Discs Lost, Scribble, Bazooka/Par-3, and DmPar-6 proteins (for reviews, see Refs.442 and 450). We will not discuss these in detail because they are outside the scope of this review, but will briefly comment because it is possible that counterparts of these tight junction proteins are likely to be found in mammalian tight junctions. This is based on a recent study that reported the existence of a human homolog of Drosophila Crumbs, designated CRB1, a tight junction integral membrane protein found in many vertebrate epithelia and proposed to function in the maintenance of cell polarity (Ref.451 ; for review, see Ref.452). By Northern blots, CRB1 was detected in the brain, but not in the testis (453). The human homolog of Drosophila Scribble (a member of the leucine-rich repeats and PDZ domains protein family functioning in the maintenance of cell polarity) has also been identified and designated Vartul (454). In MDCK cells, Vartul was found to colocalize with ZO-1 at the site of tight junctions (454), yet it is not known whether Vartul is present in mammalian tight junctions, such as those found in the brain, mammary gland, intestine, testis, and epididymis. Needless to say, if some of these tight junction polarity-conferring proteins are present at the site of the blood-testis barrier, which is likely the case, this area of research should be vigorously expanded in future studies.

   x. Future perspectives.
The study of junction dynamics has matured in the sense that investigators in the field are interested in determining how the junctional complex is assembled into functional tight and adherens junctions. Several questions relating to the interrelationship between tight junctions and germ cell movement have arisen for which answers are needed. For instance, how does a typical epithelial cell perceive polarity/orientation so that tight and adherens junctions can be assembled properly? Is there a link between cell junction assembly/disassembly and endocytic machinery? To what extent is the underlying actin cytoskeleton involved? For the most part, cell junctions assemble in such a way that they can inherently differentiate between the apical and basolateral domain of an epithelial cell. Stated simply but eloquently by Lecuit and Wieschaus, "junctions can organize polarity" (for review, see Ref.455). The assembly of tight junctions in vitro also requires a drastic increase in membrane surface area, which ultimately results in a tall columnar epithelium (for review, see Ref.455). Moreover, it is known that functional adherens junctions must be assembled first before tight junctions can be assembled. This conclusion is supported based on an analysis of the spatial and temporal patterns of expression of tight junction proteins in early mouse embryonic development. For instance, in the compacting eight-cell stage embryo, immature apicolateral junctions contain ZO-1 and catenins (456). However, from the 32-cell stage and onward, ZO-1 is found in association with occludin and cingulin at tight junctions, separated from the adjacent cadherin-catenin adherens junction complex (456). This illustrates that adherens junctions are formed before tight junctions. How this sorting of proteins occurs remains unclear, but it is postulated that the recruitment of proteins into different complexes depends on the different binding affinities of each component protein.

2. Anchoring junctions.
There are four types of anchoring junctions: 1) adherens junctions (also known as zonula adherens); 2) focal contacts or adhesions; 3) desmosomes; and 4) hemidesmosomes (for reviews, see Refs.13 and 14), all of which are structurally and biochemically different from each other (Fig. 1Go and Table 1Go). The major difference among these four junction types is that the adherens junction and focal adhesion use actin filaments as their attachment sites, whereas the desmosome and hemidesmosome utilize intermediate filaments. In the testis, two modified adherens junction types are also present, namely the ectoplasmic specialization and tubulobulbar complex, which are also discussed below.

a. Functions of anchoring junctions.
Although anchoring junctions differ from each other, they all have one main function. They link a cell’s internal machinery or cytoskeleton either to another cell or to the extracellular matrix, creating a network that maintains tissue integrity. Additional reports have suggested that anchoring junctions may also function in signal transduction events because some of the component proteins of these junctions are signal transducers that relay bidirectional signals to regulate basic cellular processes, such as cell proliferation, differentiation, and movement (for reviews, see Refs.457, 458, 459).

b. Proteins of adherens junctions.
Presently, four adherens junction functional units have been identified conferring actin-based cell adhesion. These are: 1) cadherin-catenin, 2) nectin-afadin-ponsin, 3) integrin-laminin, and 4) vezatin-myosin cell adhesion units (for review, see Ref.460) (Fig. 9Go). Only 1) to 3) have been positively identified in the testis, because it is not known whether vezatin is present in this organ.



View larger version (50K):
[in this window]
[in a new window]
 
FIG. 9. Schematic drawing illustrating the molecular architecture of the four multiprotein complexes found at the Sertoli-germ cell adherens junction. Shown are the four multiprotein complexes found at the Sertoli-germ cell adherens junction: 1) cadherin–catenin, 2) nectin–afadin–ponsin, 3) integrin–laminin, and 4) vezatin-myosin (?). It is not yet known whether vezatin, the binding partner of myosin, is present in the testis. Also shown are signaling proteins known to regulate Sertoli-germ cell adherens junction dynamics. This figure was prepared based on the following original research articles and reviews: Refs.4 , 49 , 53 , 60 , and 459 ).

 
   i. Cadherin-catenin.
Cadherins, the best-studied adherens junction proteins, are transmembrane proteins of 115–140 kDa belonging to the family of calcium-dependent cell adhesion molecules known to regulate cell architecture, morphology, and function (for reviews, see Refs.461, 462, 463, 464, 465, 466, 467) (Fig. 9Go). More than six dozen cadherin family members have been identified thus far. Most cadherins are glycoproteins composed of several domains: 1) two cytoplasmic, 2) one transmembrane, and 3) five calcium-binding domains (designated EC1–5). The most highly conserved region found in classical cadherins, the cell adhesion recognition sequence, namely His-Ala-Val (468), is harbored within the EC1 domain. This sequence is important to adherens junction function because synthetic peptides of His-Ala-Val or antibodies against this tripeptide could perturb cell adhesion in a variety of cell types, including Sertoli and germ cells in the testis (468, 469, 470). Specifically, adhesion conferred by cadherins is via calcium-dependent [calcium is known to rigidify the multidomain structure of cadherins (471, 472)], homotypic interactions with cadherins residing in the adjacent cell membrane. In the absence of calcium, cadherins are inactive and susceptible to proteolysis (473, 474). On the other hand, the importance of the cadherin cytoplasmic domain lies in its interaction with intracellular proteins. These proteins participate in the clustering of cadherins to form functional adherens junctions, as well as to relay information from the cell surface to the nucleus, in turn activating specific gene(s) so that the integrity of the epithelium can be maintained. Moreover, several studies have demonstrated that E-cadherin can mediate the assembly of desmosomes, tight and gap junctions (475, 476, 477), but the mechanism by which this is accomplished remains to be elucidated.

The function of cadherin also depends on the binding of its cytoplasmic domain to either ß- or {gamma}-catenin (Ref.478 ; for reviews, see Refs.462 , 467 , and 479). {gamma}-Catenin, a close relative of ß-catenin, is also known as plakoglobin (480, 481, 482) (Fig. 9Go). ß-Catenin has an additional function in that it can also behave as a transcriptional cofactor when stimulated by the Wnt signal transduction pathway (for reviews, see Refs.483, 484, 485). The cadherin-catenin complex is linked indirectly to the actin cytoskeleton by {alpha}-catenin, illustrating that this catenin specifically recruits molecules that participate in actin dynamics to the site of the adherens junction (for review, see Ref.486). {alpha}-Catenin, which is related to vinculin (487, 488, 489), also interacts with spectrin (490). Moreover, ß-catenin was able to colocalize with ezrin, a protein linking the cell membrane with the actin cytoskeleton (491) and TGF-ß type II receptor (TGF-ß1 RII) (492). The latter interaction was demonstrated in a recent study which showed that TGF-ß1 RII dissociated from ß-catenin when HK-2 cells were stimulated by TGF-ß1 (492), suggesting a possible link between TGF-ß1 and adherens junction dynamics.

Another recently identified catenin, p120ctn [formerly known as p120cas (cadherin-associated Src substrate); for review, see Ref.493 ], is a putative Src-substrate associating with cadherins (494) but not with {alpha}-catenin (494), suggesting that p120ctn has a unique function in the cadherin-catenin cell adhesion unit. Another study has shown that p120ctn can induce the clustering of E-cadherin (495). p120ctn can be phosphorylated on both tyrosine and serine residues in response to a variety of growth factors such as EGF and platelet-derived growth factor (PDGF) (496, 497). It can also enter the nucleus, where it interacts with a newly identified transcription factor, Kaiso (498). Recent studies have shown that an initial interaction between E-cadherin and ß-catenin is required for eliciting the cascade of events leading to cell adhesion, but that an interaction between E-cadherin and p120ctn is necessary for the formation of stable adherens junctions (for review, see Ref.499). Moreover, changes in the phosphorylation status of p120ctn can affect cell adhesion (500). In general, a decrease in phosphorylation is associated with tighter cell adhesion, whereas an increase results in the loss of adhesiveness (for reviews, see Refs.500 and 501). Lastly, p120ctn also interacts with Fujinami poultry sarcoma/feline sarcoma kinase [a tyrosine kinase (54, 502)], BP180 [type XVII collagen (503)], and connexin43{alpha}1 (504).

Other proteins that have been shown to localize to the adherens junction include VASP [a protein that regulates actin polymerization and directly binds to vinculin (358, 505)] and mammalian Lin-7 [also known as Veli; a PDZ domain-containing protein that binds directly to ß-catenin (506) and localizes at the nectin-afadin-ponsin-based adherens junction (507)]. Mammalian Lin-7, which was shown to associate with several other proteins such as Pals1 and Pals2 (359), is also found at the tight junction in MDCK cells (508).

The key to cadherin and catenin regulation may be found in the study of GTPases. For example, the overexpression of p120ctn increased cell motility via its action on Rho GTPases (for reviews, see Refs.509 and 510). Several members of this family such as RhoA, Rac1, and Cdc42 have recently been shown to localize to the cadherin-catenin-based cell adhesion unit (for reviews, see Refs.511 and 512). Other studies have shown that during junction disassembly E-cadherin and ß-catenin are first internalized and then recycled back to the plasma membrane by Rab5 (513, 514), another member of the GTPase superfamily. Phosphorylation also appears to play a significant role in adherens junction dynamics as was shown in experiments in which tyrosine phosphorylation of ß- and/or {gamma}-catenin resulted in the loss of cadherin-mediated cell adhesion (Refs.515, 516, 517 ; for review, see Ref.500).

In the testis, at least two dozen cadherins are known to be present, and all exhibit unique expression patterns (518, 519). For example, N-cadherin associated with the heads of elongating spermatids in a stage-specific manner (111) (Fig. 10Go), suggesting its involvement in germ cell movement. However, most of the N-cadherin was confined to the basal compartment of the seminiferous epithelium (50, 53, 111). In addition, the inclusion of an anti-N-cadherin antibody perturbed the adhesion of germ cells to Sertoli cells in vitro (469, 520). Moreover, a series of coimmunoprecipitation and chemical cross-linking experiments demonstrated that Sertoli cell N-cadherin interacts with actin and vimentin (to a lesser extent) (Ref.53 and our unpublished observations), indicating that the testis utilizes the cadherin-catenin actin-based cell adhesion unit. Other studies have shown that Sertoli-germ cell adherens junctions are also comprised of E-cadherin, {alpha}-, ß-, and {gamma}-catenins, p120ctn, Src [a protein tyrosine kinase (53)], Rho (45) and Rab GTPases (50). Taken collectively, these results suggest that the germ cell is equipped with similar adhesion and signaling proteins as its cellular counterpart, the Sertoli cell, in the seminiferous epithelium.



View larger version (17K):
[in this window]
[in a new window]
 
FIG. 10. Immunofluorescent localization of N-cadherin in the seminiferous epithelium of the rat testis. A micrograph of a cross-section of an adult rat testis immunostained with a mouse anti-N-cadherin monoclonal antibody (cat. no. 33-3900, lot no. 20671409, Zymed Laboratories). N-Cadherin was found to localize to both the basal and adluminal compartments. This observation is consistent with earlier reports that illustrated N-cadherin to be an ectoplasmic specialization-associated protein (83 111 519 ). Scale bar, 120 µm.

 
   ii. Nectin-afadin-ponsin.
The second system conferring actin-based cell adhesion is comprised of nectin, afadin, and ponsin (also known as the NAP cell adhesion unit) (Fig. 9Go). It is important to recognize that the nectin-afadin-ponsin cell adhesion unit does associate with the cadherin-catenin system and that the two units function cooperatively to form functional adherens junctions, such as those found in the testis (Ref.521 ; for review, see Ref.460). Nectin [originally known as poliovirus receptor-related protein, but later renamed as nectin (441)] is a calcium-independent cell adhesion protein of the Ig superfamily consisting of three domains: 1) a transmembrane, 2) cytoplasmic, and 3) three extracellular Ig-like domains (522, 523). Thus far, at least five nectins, namely nectins-1, -2, -3, -4, and poliovirus receptor (some nectins such as nectin-1 can also act as poliovirus or {alpha}-herpesvirus receptors) have been identified (460, 524, 525). Assembly of the nectin-afadin-ponsin cell adhesion unit is mediated in part by each nectin family member interacting homo- or heterotypically with another nectin molecule on the apposing cell membrane (441, 524, 526, 527, 528). In fact, the heterotypic interaction of nectin-3 (e.g., nectin-3 + nectin-1) was shown to be stronger than its homotypic interaction (524).

In the testis, the presence of nectin-1 (weak expression), -2 (moderate expression), -3 (strong expression), and -4 (weak expression) has been demonstrated by Northern blots (524, 528). Specifically, nectin-2 was found in Sertoli, germ, and Leydig cells, whereas nectin-3 was restricted to spermatids (529). In the mouse testis, nectin-2{delta} associated with Sertoli cells and elongate spermatids colocalizing with F-actin, which was consistent with its localization at the site of apical ectoplasmic specializations. Its level was also highest in stages VI–VIII of the epithelial cycle (530), suggesting a role in germ cell movement. More importantly, nectin-2–/– mice displayed a defective sperm morphology and were infertile (530).

Afadin has two variants: 1) l-afadin (large splicing variant of AF-6 protein localized at adherens junctions), and 2) s-afadin (small splicing variant of l-afadin). The expression of l-afadin is ubiquitous, whereas s-afadin is found only in neural tissues (439). l-Afadin is an F-actin binding protein whose PDZ domain binds to the cytoplasmic domain of nectin (439, 441). In another recent report, {alpha}-catenin was shown to contain the entire binding site for l-afadin, illustrating that there is cross-talk between the cadherin-catenin and nectin-afadin-ponsin cell adhesion units (for review, see Ref.525). In fact, {alpha}-catenin is required for the nectin-afadin-ponsin complex to localize to the adherens junction (531). Moreover, when MDCK cells were cultured in calcium-depleted media, E-cadherin, but not l-afadin, was rapidly endocytosed possibly via Rab GTPases (532). Mouse embryos that lack l-afadin die at approximately 10 d post coitum, resulting from a disruption of tight and adherens junctions in neuroectodermal cells (440, 533), suggesting that this protein is important in tight and adherens junction dynamics. l-Afadin is also known to associate with the cytoplasmic protein ponsin (534). On the other hand, s-afadin lacks the actin binding domain that is characteristic of l-afadin (439, 441). Human s-afadin has also been shown to be identical to AF-6 (535). Presently, there is not a single report in the literature examining the function of afadin in the testis.

Ponsin, the third member of the nectin-afadin-ponsin cell adhesion unit, interacts with either l-afadin or vinculin (489, 536, 537, 538, 539) to form a complex. It has even been proposed that vinculin is the protein linking the cadherin-catenin and nectin-afadin-ponsin cell adhesion units together (534). Ponsin has remained relatively uncharacterized since being identified in 1999, but it has been found to be present in the testis by Northern blots (534). However, the significance of the nectin-afadin-ponsin cell adhesion unit as it relates to germ cell movement in the testis remains to be determined.

   iii. Vezatin-myosin VII.
The vezatin-myosin VII complex also confers actin-based cell adhesion. Vezatin is a novel transmembrane protein that bridges either myosin VIIA or the cadherin-catenin complex to the actin cytoskeleton (540, 541). Vezatin has three domains: 1) a short extracellular, 2) transmembrane, and 3) long intracellular domain that binds to myosin VIIA. Myosin VIIA, a 250-kDa motor protein, was shown to be present in a variety of organs such as the brain, intestine, liver, kidney, and testis (542, 543). In the testis, myosin VIIA is highly expressed, associating with Sertoli-germ cell ectoplasmic specializations (544). Additional reports have implicated motor proteins in other processes, such as in vesicle motility and signal transduction (for reviews, see Refs.545, 546, 547). Due to the inherent property of myosin VIIA in regulating actin dynamics, it is likely that this protein participates in the turnover of actin filaments at the site of the ectoplasmic specialization. Myosin VIIA also associates with protein kinase A (PKA) (540), suggesting that it may be regulated by protein kinases. Furthermore, vezatin and myosin VIIA were both recruited to the adherens junction during its assembly in MDCK cells (540, 541). Vezatin was also shown to coimmunoprecipitate with {alpha}- and ß-catenin (540, 541). Thus, it was postulated that vezatin is recruited to adherens junctions via its interaction with {alpha}-catenin, which is followed by the enlisting of myosin VIIA to these sites. The presence of vezatin in the testis has not yet been determined.

   iv. Integrin-laminin.
Two studies by Salanova et al. (548, 549) have linked {alpha}6ß1 integrin to ectoplasmic specializations between Sertoli cells and between Sertoli cells-elongate spermatids, illustrating the existence of yet another actin-based adherens junction functional unit (Fig. 9Go). However, these findings presented a biological dilemma in that integrins, traditionally known to be cell adhesion molecules between cells and the extracellular matrix, interact with collagens and laminins (for reviews, see Refs.463 and 550) in the extracellular matrix at the site of the focal adhesion and hemidesmosome. If {alpha}6ß1 integrin is found in Sertoli cells, then what is the binding partner of this adhesion molecule in germ cells? Interestingly, a recent study has shown the presence of the {gamma}3 laminin chain of laminin 12 [laminins are glycoproteins composed of an {alpha}-, ß-, and {gamma}-chain (551, 552)] in the testis, localized to the adluminal compartment of the seminiferous epithelium, but not to the basement membrane (553). This observation represents the first nonbasement membrane laminin chain found in any epithelium. Taken collectively, these results suggest that the {gamma}3 laminin chain may be the binding partner of {alpha}6ß1 integrin in the ectoplasmic specialization. However, this is largely a speculation that requires further investigation. Moreover, the identities of the other {alpha}- and ß-chains needed to contribute to a functional laminin receptor that can interact with {alpha}6ß1 integrin are still not known.

3. Ectoplasmic specializations.
Specifically, the ectoplasmic specialization is a modified adherens junction type found only in the testis. It uses actin filaments as its attachment site (for reviews, see Refs.3 , 18 , 20 , 61 , and 87) (Fig. 9Go). The ectoplasmic specialization is important to spermiation, the translocation of spermatids, and possibly in the stabilization of other junction types present between Sertoli and Sertoli-germ cells, such as tight and desmosome-like junctions (for reviews, see Refs.3 , 7 , 16 , 18 , and 20). In the rat testis, the ectoplasmic specialization is first seen facing spermatids when they begin to elongate [step 8 of spermiogenesis (554)], and they disappear from the seminiferous epithelium at spermiation. It must also be noted that this junction type confers adhesion not only between Sertoli cells and elongating/elongate spermatids, but also between Sertoli cells (3, 20, 554, 555). In addition, the separation of elongating/elongate spermatids (step 8 and beyond of spermiogenesis in the rat) from Sertoli cells requires the use of trypsin (554) or cytochalasin D (18), illustrating the stability of this testis-specific anchoring junction. Basically, ectoplasmic specializations prevent the premature release of elongating/ elongate spermatids into the tubule lumen because desmosome-like junctions are no longer present between Sertoli cells and spermatids during this time (18). It has even been suggested that the ectoplasmic specialization replaces the desmosome-like junction as the anchoring junction type between Sertoli cells and elongate spermatids (18), yet it is not physiologically known why one junction type would be replaced by another with essentially the same function. It is possible that ectoplasmic specializations also participate in positioning elongating/elongate spermatids with an identical orientation in the epithelium because elongating/elongate, but not round, spermatids are highly polarized cells. Moreover, when elongate spermatids are embedded within Sertoli cell crypts, which is accompanied by drastic changes in the position and shape of spermatid heads, ectoplasmic specializations constantly remodel themselves to adapt to these morphological changes (Refs.2 , 556 , and 557 ; for reviews, see Refs.6 , 15 , and 16).

Although the precise biochemical constituents of the ectoplasmic specialization are not entirely known, recent studies have shown that there are two types of ectoplasmic specializations, designated apical and basal. The best-studied apical ectoplasmic specialization protein is {alpha}6ß1 integrin (548, 558, 559). Another recent study has shown that {alpha}4ß1 integrin (560) is another likely molecule present at the apical ectoplasmic specialization, but it must be noted that {alpha}4 integrin is also found at various sites in the seminiferous epithelium including the basal ectoplasmic specialization (560). Although {alpha}6ß4 integrin has been postulated to be a constituent protein of hemidesmosome junctions between Sertoli cells and the basement membrane (559), the constituent proteins at basal ectoplasmic specializations between Sertoli cells at the blood-testis barrier in the seminiferous epithelium of the rat testis are not characterized as well as those of apical ectoplasmic specializations. In addition, the nectin-afadin-ponsin complex is apparently restricted to apical ectoplasmic specializations (529), whereas the cadherin-catenin complex is more predominant in basal ectoplasmic specializations (53, 560, 561). Indeed, recent studies using both semiquantitative RT-PCR and immunoblotting have confirmed the presence of E-cadherin and ß-catenin in highly purified germ cells at a 1:1 equimolar ratio (53), whereas N-cadherin was shown to be more predominant in Sertoli cells (53). This was followed by studies that used immunofluorescent microscopy to confirm the presence of the cadherin-catenin complex in the seminiferous epithelium at the site of the apical ectoplasmic specialization (83, 561). This is also consistent with an earlier report that demonstrated the presence of N-cadherin at sites of Sertoli-Sertoli and Sertoli cell-spermatid contact in the rat seminiferous epithelium (561). Moreover, the N-cadherin-catenin complex likely associates with desmosome-like junctions because N-cadherin was shown by immunofluorescent microscopy to colocalize with plectin, an intermediate filament protein (561). This also strengthens another earlier morphological study which illustrated that there is cross talk between ectoplasmic specializations and desmosome-like junctions (559), since studies by coimmunoprecipitation have repeatedly demonstrated that the cadherin-catenin complex in the seminiferous epithelium is similar to cadherin-catenin complexes found in other tissues in that it uses actin filaments as its attachment site (53, 83). However, approximately 5% of cadherin associated with vimentin-based intermediate filaments (83).

Germ cells were also shown to express specific forms of nectin, such as nectin-3, which heterotypically associate with nectin-2 in the apposing germ or Sertoli cell plasma membrane (529). Collectively, these data illustrate that germ cells contribute to the protein complexes that confer cell adhesion to the ectoplasmic specialization. This is not entirely unexpected because ectoplasmic specializations between Sertoli and germ cells are constantly changing during spermatogenesis and spermiogenesis because of the continuous movement of germ cells across the seminiferous epithelium. As such, ectoplasmic specializations are probably using additional cell adhesion proteins to regulate their restructuring, which may not be found in adherens junctions. For instance, integrins are restricted to cell-matrix anchoring junctions in other epithelia, yet {alpha}6ß1 integrin is a putative structural protein at the site of apical ectoplasmic specializations. More recent studies have identified proteins, such as focal adhesion kinase (FAK), at the site of the ectoplasmic specialization (49, 559). However FAK regulates cell movement and is usually restricted to the focal contact (562, 563, 564). These results illustrate that the proteins that constitute apical and basal ectoplasmic specializations are different.

Other proteins that confer functionality to the ectoplasmic specialization include actin (for review, see Ref.7), {alpha}-actinin (for review, see Ref.565), myosin VIIA (544), fimbrin (555), espin (566), vinculin (567, 568), paxillin (559), gelsolin (569), integrin-linked kinase [ILK (559 ], nectin (530), testin (Ref.57 ; for review, see Ref.4), and Kelch-like neurofilament (NF)-E2-related molecule (ECH)-associating protein 1 [Keap1, a negative regulator of the NF-E2-related factor 2 transcription factor (218, 570)] (Fig. 9Go). Keap1, an interacting partner of myosin VIIA (544) was found to be targeted to ectoplasmic specializations even in the absence of myosin VIIA, suggesting that Keap1 can associate with other molecules at the site of the ectoplasmic specialization (218). On the other hand, nectin was restricted to sites of contact between Sertoli cells and elongating/elongate spermatids in stages VII–VIII, consistent with its localization at the ectoplasmic specialization (530). In this context, it is also important to note that other junction types, such as tight and desmosome-like junctions, are present within the vicinity of basal ectoplasmic specializations (for reviews, see Refs.7 , 16 , and 18). Moreover, "free" ectoplasmic specialization structures (ectoplasmic specializations that are found within Sertoli cell plasma membranes but not in contact with another cell) are often found in the seminiferous epithelium (3). Although the significance of "free" ectoplasmic specialization structures is not immediately known, it is tempting to speculate that they are participating in the recycling ectoplasmic specialization protein complexes. Alternatively, they may be attachment sites that were leftover after germ movement. This illustrates not only the dynamic nature, but also the multifunctional role of the ectoplasmic specialization in the seminiferous epithelium. However, much research is needed to define the biochemical architecture of ectoplasmic specializations found between Sertoli-Sertoli and between Sertoli cell-elongating/elongate spermatids, as well as to understand their regulation.

Espin, consisting of a single polypeptide chain of Mr 110 kDa, is present in many organs including the brain, heart, liver, kidney, small intestine, spleen, thymus, and others, but it is found most abundantly in the testis, restricted to basal and apical ectoplasmic specializations (566, 571) (Fig. 11Go). Each espin molecule consists of three putative actin binding sites with an espin:actin stoichiometric ratio of approximately 1:20 (566, 572). Furthermore, it was estimated that each ectoplasmic specialization is composed of approximately 4.5 x 106 molecules of espin (572). By immunofluorescence microscopy, espin was found to localize to both basal and apical ectoplasmic specializations in the seminiferous epithelium, but in stages VI—VII, espin was found primarily at the site of the apical ectoplasmic specialization (Fig. 11Go), illustrating that it is a stage-specific protein. This is also consistent with earlier published reports (566, 571) that demonstrated espin to be an apical and basal ectoplasmic specialization-associated protein.



View larger version (8K):
[in this window]
[in a new window]
 
FIG. 11. Immunofluorescent localization of espin in the seminiferous epithelium of the rat testis. A micrograph of a cross-section of an adult rat testis immunostained with a mouse antiespin monoclonal antibody (cat. no. E17520, lot no. 1, Transduction Lab, Lexington, KY), followed by a goat antimouse IgG-Cy3 secondary antibody. Espin was found to localize to both the basal (see stage VI–VII and IX tubules) and adluminal compartments (see stage VI–VII tubule) at the site of the basal and apical ectoplasmic specialization. This is consistent with earlier reports that illustrated espin to be an ectoplasmic specialization-associated protein (566 572 ). Scale bar, 50 µm.

 
4. Tubulobulbar complexes.
Another testis-specific structure, which is a modified type of the adherens junction, is the tubulobulbar complex found between Sertoli cells at the level of the tight junction and between Sertoli cells and elongate spermatids that are ready for release into the tubule lumen (Refs.557 , 573 , and 574 ; for review, see Ref.7). The tubulobulbar complex exists as a pair of tubular structures surrounded by actin. It extends from the concave surface of the spermatid head (575). A unique characteristic of apical tubulobulbar complexes is that they are not visible in the epithelium until a few days before spermiation at stage VII. After spermiation at the end of stage VIII, tubulobulbar complexes are quickly internalized and degraded by Sertoli cell lysosomes (556, 575). On the other hand, basal tubulobulbar complexes form in stages II–V, being most and least numerous in stages IV–V and VI–VIII of the epithelial cycle, respectively (7). Another difference is that the apical tubulobulbar complex is slightly longer than its counterpart in the basal compartment. Studies have shown that each mature spermatid can contain from 4–24 tubulobulbar complexes, suggesting the importance of these structures in germ cell movement (573, 574).

It is believed that the function of the tubulobulbar complex is to prevent the premature release of elongate spermatids into the tubule lumen (556). It is also possible that these structures facilitate the removal of cytoplasm from spermatids (573) because the volume of cytoplasm was reduced by as much as 70% when tubulobulbar complexes were present in the epithelium (573). Indeed, a recent study has shown that MN7, an acrosomal glycoprotein having periodic acid-Schiff reactivity, is incorporated into the tubulobulbar complex, supporting the notion that this junction type facilitates the removal of excessive acrosomal contents at spermiation (576). Furthermore, tubulobulbar complexes may internalize junctions [basal tubulobulbar complexes are intermingled between tight and gap junctions (574)] during germ cell movement (574, 577, 578).

5. Focal contacts.
Focal contacts, also known as focal adhesions or adhesion plaques, are actin-based cell-extracellular matrix anchoring junctions (Table 1Go).

a. Functions of focal adhesions.
Focal adhesions, comprised largely of integrins, connect a cell’s actin filaments to the extracellular matrix. They are found in virtually all epithelia. Focal adhesions are dynamic structures that regulate cell movement, such as in fibroblasts and macrophages, and are also known to function in signal transduction events (for reviews, see Refs.510 and 579, 580, 581, 582, 583). Although this junction type has yet to be investigated in the testis, a review of the focal adhesion is included here. This is because proteins that are usually found at the focal contact in other epithelia have now been shown to be present at the site of the ectoplasmic specialization. This suggests that these proteins may participate in cell adhesive function at the ectoplasmic specialization. As such, the following sections will serve as a guide for future investigators in the field.

b. Proteins of focal adhesions.
Integrins belong to a large family of {alpha}ß heterodimeric transmembrane proteins (for reviews, see Refs.550 , 584 , and 585). Thus far, 18 {alpha}-subunits and eight ß-subunits have been identified, and they can combine to form 24 different functional integrin receptor proteins, which fall into three basic categories: 1) ß1, 2) ß2, and 3) {alpha}v. Some integrins only bind to one ligand (components of the extracellular matrix such as collagen, laminin, fibronectin, or vitronectin), whereas others bind to more than one ligand. In addition to providing a physical link between the cytoskeleton of a cell and the extracellular matrix, integrins also transduce bidirectional signals across the plasma membrane to regulate many aspects of cell behavior such as differentiation, proliferation, migration, and death. For instance, integrin cytoplasmic-domain-associated protein-1, which associates exclusively with ß1 integrin, was shown to act as a negative regulator of cell adhesion and migration (586, 587, 588). Moreover, integrin cytoplasmic-domain-associated protein-1 contains phosphorylation sites for PKC, cAMP-/cGMP-dependent kinases, and calcium/calmodulin-dependent protein kinase II and can be phosphorylated in response to cell adhesion (for review, see Ref.589).

   i. Vinculin.
Vinculin, an adaptor protein localized to the focal adhesion in other epithelia, is functionally related to {alpha}-catenin (Ref.590 ; for reviews, see Refs.591 and 592). Although {alpha}-catenin is a constituent of the cell-cell adherens junction, vinculin can be found in both cell-cell and cell-extracellular matrix anchoring junctions. For instance, vinculin is localized largely to the E-cadherin-catenin complex, but not the N-cadherin-catenin complex in multiple epithelia (593). Vinculin and {alpha}-catenin also function as tumor suppressors. More importantly, when the expression of vinculin was suppressed in 3T3 cells, adhesion was perturbed and motility increased (594). On the other hand, the overexpression of vinculin decreased cell movement (595, 596). Furthermore, vinculin appears to be important in the early phases of focal adhesion assembly because it was found within this structure 15 min after the binding of cells to the extracellular matrix (597, 598). It is also a substrate for tyrosine and serine/threonine protein kinases (599, 600). Vinculin has been shown to interact with {alpha}-/ß-catenin (in cell-cell adherens junctions only; for review, see Ref.592), actin (537, 601), talin (537, 602), {alpha}-actinin (603), paxillin (604), vinexin (605), and VASP (505, 606). Vinculin can also substitute {alpha}-catenin to form functional adherens junctions (593). In the testis, vinculin is found in both apical and basal ectoplasmic specializations (567, 568) (Fig. 9Go). It is also detected in the cytoplasm of Sertoli cells (111, 571) (Fig. 3AGo).

   ii. Talin.
Talin (Mr, 235 kDa) is another major structural component of the focal adhesion (for review, see Ref.589). Talin contains binding sites for actin [both G- and F-actin (607, 608)], vinculin (602), FAK (609), phospholipids (610), TES [shares a high homology with zyxin (611, 612, 613)], and layilin [a hyaluronan receptor (614)]. In addition, talin binds to the cytoplasmic tails of ß1, ß2, ß3, and ß7 (weakly) integrins (Refs.615, 616, 617, 618 ; for review, see Ref.589). Both talin and ß integrin are required for focal adhesion assembly (619). Moreover, microinjection of an antitalin antibody or talin antisense RNA perturbed adhesion, spreading, and migration of fibroblasts and HeLa cells (Ref.620 ; for review, see Ref.591), suggesting that talin and integrins facilitate cell movement. Talin has been found in the testis (621).

   iii. Paxillin.
Paxillin (Mr, 68 kDa), an adaptor protein, associates exclusively with the cytoplasmic domain of {alpha}4 integrin (Ref.622 ; for reviews, see Refs.623 and 624). (Adaptor proteins recruit proteins to form a multiprotein complex at the site of the tight or adherens junction). Likewise, paxillin participates in cell spreading and movement (Ref.622 ; for reviews, see Refs.625 and 626). It can be tyrosine and serine/threonine phosphorylated in response to cell adhesion or growth factor stimulation (627, 628, 629, 630). Paxillin has been shown to interact with other proteins, such as FAK (631, 632, 633, 634), Src (635, 636), Crk (636, 637), C-terminal Src-kinase (Csk) (636), actopaxin [a newly identified focal adhesion protein that also interacts with actin (638)], paxillin kinase-linker with a Mr of 95 kDa (639, 640), p21 GTPase-activated kinase-interacting exchange factor [a guanine nucleotide exchange factor (639)], p21 GTPase-activated kinase (639, 641), protein-tyrosine phosphatase-Pro-Glu-Ser-Thr [a nonreceptor protein tyrosine phosphatase that dephosphorylates p130 Cas (Crk- and Src-associated substrate having a Mr of 130 kDa, Ref.639)], proline-rich tyrosine kinase-2 [a nonreceptor tyrosine kinase related to FAK and found in Sertoli and germ cells (642)], E6 oncoprotein of bovine papillomavirus type 1 (643), and E6 protein of the cancer-associated HPV-16 (644). In the testis, paxillin is an adaptor protein (49, 111, 559, 560) localized to the site of the ectoplasmic specialization (111). It associates with actin, p120ctn, cortactin, FAK, {alpha}6ß1 integrin, tubulin, and vinculin (559, 560).

   iv. Others.
The transmembrane 4 (also known as TM4, TM4SF, or tetraspanins because they span the plasma membrane four times) superfamily is a group of ubiquitously expressed proteins associating with selected integrins (e.g., {alpha}3ß1, {alpha}4ß1, {alpha}5ß1, {alpha}6ß1, and {alpha}6ß4 integrins) (for reviews, see Refs.584 , 645 , and 646). At least 25 members have been identified to date. Tetraspanins have been implicated in the regulation of diverse cellular functions, such as cell proliferation and movement (for reviews, see Refs.584 and 645). For instance, tetraspanins have been localized to the periphery (e.g., lamellipodia) of migrating cells (647, 648), suggesting that this superfamily of proteins participates in cell movement. It is not yet known whether members of this protein family are present in the testis.

Other proteins that participate in the function of focal adhesions include VASP, which was found at the site of lamellipodia (Refs.505 and 649 ; for reviews, see Refs.650 and 651). VASP interacts with profilin [G-actin binding protein (652)] and zyxin (653). Zyxin (Mr, 82 kDa) is a phosphoprotein that localized not only to the adherens junction (Fig. 3BGo) [interacts with {alpha}-actinin (486, 654, 655, 656)], but also to the nucleus [interacts with Vav, a nucleotide exchange factor (657)], illustrating that zyxin has other functions in addition to its role as an adaptor protein. Lastly, calpain, a calcium-dependent cysteine protease has been shown to localize to focal adhesions (658), where it can cleave integrins, talin, and FAK (659, 660). Studies using calpain inhibitors have suggested that this protein participates in the assembly (661) and disassembly of focal adhesions during cell migration (662).

   v. Additional comments.
It is now well established that integrins transmit bidirectional signals that trigger events such as tyrosine phosphorylation (for reviews, see Refs.663, 664, 665). This activates downstream signal transducers (e.g., Rho GTPase, FAK), triggering a cascade of events to affect Sertoli-germ cell adherens junction dynamics (45, 49). For instance, it is known that Sertoli-germ cell adherens junction dynamics at the site of apical ectoplasmic specializations are likely regulated, at least in part, via the integrin/Rho-associated protein kinase (ROCK)/Lin-11, Isl-1, and Mec-3 (LIM) kinase/cofilin signaling pathway (45) because these signaling molecules were shown to be induced concomitantly with changes in their phosphorylation status when cell adhesion in the seminiferous epithelium was perturbed by AF-2364 (666, 667). This conclusion is further strengthened by the fact that pretreatment of rats with (R)-(+)-trans-N-(4-pyridyl)-4-(1-aminoethyl)cyclohexane-carboxamide, 2HCl (Y-27632, a specific ROCK inhibitor) could delay AF-2364-induced germ cell loss from the epithelium (45). Furthermore, AF-2364 was also shown to perturb Sertoli-germ cell adhesion at the site of the apical ectoplasmic specialization via the integrin/FAK/phosphatidylinositol 3 (PI 3)-kinase/p130 Cas/ERK signaling pathway (49), downstream of which is likely MAPK. Taken collectively, these results suggest that the integrin/ROCK/LIM kinase/cofilin and integrin/FAK/PI 3-kinase/p130 Cas/ERK signaling pathways are two putative pathways that regulate ectoplasmic specialization restructuring. Work is now in progress to investigate whether these two pathways merge via one of the crucial signaling molecules, such as PI 3-kinase, a specific GTPase, or an adaptor, such as p130 Cas.

Additionally, integrins mediate signaling events that induce mechanical forces across the plasma membrane, enabling cells to generate traction during movement and exert tension during extracellular matrix remodeling (668). As such, cell movement involves cycles of adhesion and de-adhesion (for reviews, see Refs.669 and 670). Several kinases, many of which have been shown to associate with ectoplasmic specializations, in particular FAK (49, 559), Src (49, 111), Csk (111), and ILK (559), have been shown to participate in integrin-mediated signaling. For instance, fibroblasts obtained from FAK–/– embryos migrate more slowly than those from FAK+/+ embryos. FAK–/– fibroblasts also had an increased number of focal adhesions (671). These results were corroborated in another study which demonstrated that the dephosphorylation of FAK by PTEN inhibited the assembly of focal adhesions and cell migration (672). Other proteins that were also shown to be required for the turnover of focal adhesions were vinculin, talin, and {alpha}-actinin (562, 673, 674).

On the other hand, several extracellular factors such as thrombospondin, tenascin, and secreted protein, acidic and rich in cysteine (SPARC, participates in cell adhesion) have been described for their antiadhesive properties (for reviews, see Refs.675 and 676). These proteins promote the disassembly of focal adhesions, in turn stimulating cell migration (677, 678). Many of these proteins, such as SPARC (679, 680) and sertolin [sertolin is related to thrombospondin (26)] have been positively identified in the testis and implicated in the regulation of junction dynamics in the seminiferous epithelium. Growth factors have also been demonstrated to induce de-adhesion. For example, EGF promotes cell rounding, resulting in a decrease in adhesive strength and the disassembly of focal adhesions (681, 682, 683). This was apparently mediated via the MAPK pathway because a mitogen-activated protein/extracellular signal-regulated kinase kinase (MEKK) inhibitor decreased EGF-induced de-adhesion (683). HGF/SF and PDGF have also been demonstrated to negatively regulate adhesive strength (684, 685).

   vi. Future perspectives.
As reviewed herein, studies on the biology of adherens junction dynamics in the testis lag far behind those investigating the blood-testis barrier, largely because of the lack of suitable in vitro and in vivo models that can be used to study adherens junction dynamics. For instance, in vivo models that investigate the dynamics of the blood-testis barrier, such as the cadmium chloride (40, 41, 174) and glycerol (176, 177, 179, 180) models, have illustrated that a loss of blood-testis barrier function can also compromise cell adhesion. This postulate is further supported by another recently developed in vivo model of blood-testis barrier dynamics using an occludin peptide (43). Moreover, the biochemical constituents of the adherens junction have not been known until recently (Fig. 9Go). Thus, it was virtually impossible to study adherens junction dynamics as they relate to germ cell movement. Moreover, the biochemical composition of desmosome-like junctions, hemidesmosomes, and focal adhesions in the testis remain largely uncharacterized.

Nonetheless, other laboratories, including ours, have established an in vitro model to study Sertoli-germ cell adherens junction dynamics with some success (for reviews, see Refs.4 , 5 , 48 , and 50, 51, 52). In two earlier studies by electron microscopy, both desmosome-like junctions and ectoplasmic specializations were shown to form by 24–48 h after the addition of germ cells to the Sertoli cell epithelium (51, 52). In brief, Sertoli cells were cultured alone for 5 d on Matrigel-coated dishes at a density of 0.5 x 106 cells/cm2. This allowed cells to form an epithelium with intact tight and adherens junctions. On d 6, total germ cells were isolated from adult rat testes and added to the Sertoli cell epithelium to initiate Sertoli-germ cell adherens junction assembly (Fig. 12Go). In Fig. 12AGo, a germ cell [still connected to another germ cell by cytoplasmic intercellular bridges (arrowheads in Fig. 12AGo) has assembled functional adherens junctions with a Sertoli cell (arrows in Fig. 12AGo). A microvillus, commonly found in Sertoli cells cultured in vitro, was also detected (asterisk in Fig. 12AGo). Figure 12BGo is the boxed area shown in Fig. 12AGo that shows an ectoplasmic specialization, a testis-specific adherens junction type, formed between a Sertoli and germ cell in vitro, which is typified by the presence of packed actin filaments sandwiched in between cisternae of endoplasmic reticulum and the plasma membranes of two opposing Sertoli and germ cells (arrowheads in Fig. 12BGo). Figure 12CGo shows the presence of desmosome-like junctions between a Sertoli and germ cell. This is typified by the presence of electron-dense patches (arrowheads in Fig. 12DGo), similar to those present in other epithelia. Figure 12Go, E and F, shows the corresponding magnified views of an ectoplasmic specialization and desmosome-like junctions between Sertoli and germ cell cultured in vitro (also see Fig. 12Go, B and D). These results illustrate that functional anchoring junctions are present between Sertoli and germ cells in vitro, consistent with two previously published reports (51, 52). Using this in vitro model, we have demonstrated that the assembly of Sertoli-germ cell adherens junctions requires the participation of numerous biological factors, including structural and signaling proteins, proteases, protease inhibitors, and GTPases (5, 45, 47, 48, 49, 50).



View larger version (114K):
[in this window]
[in a new window]
 
FIG. 12. Characterization of functional anchoring junctions between Sertoli and germ cells cocultured in vitro. Sertoli cells were isolated from 20-d-old Sprague Dawley rats and cultured at high density (0.5 x 106 cells/cm2) on Matrigel-coated dishes for 5 d in F12/DMEM as described (5 48 ). Thereafter, germ cells isolated from adult rats were added to the Sertoli cell epithelium (5 48 ) and processed for electron microscopy (30 ). A, An electron micrograph of germ cells cocultured with Sertoli cells for 2 d in vitro. Notice that the two germ cells are still connected via intercellular bridges (arrowheads). A microvillus, typical of Sertoli cells cultured in vitro, was also detected (asterisk). Functional anchoring junctions formed between Sertoli and germ cells (boxed; also see arrows). B, A magnified view of the boxed area shown in A, in which an ectoplasmic specialization was detected. The opposing arrowheads correspond to the plasma membranes of a Sertoli and germ cell. ES, Ectoplasmic specialization; er, endoplasmic reticulum; SC, Sertoli cell; GC, germ cell; Nu, Sertoli cell nucleus. C, An electron micrograph of a germ cell attached to a Sertoli cell via desmosome-like junctions (boxed). D, A magnified view of the boxed area shown in C, depicting electron-dense patches typical of Sertoli-germ cell desmosome-like junctions (arrowheads). E and F, Electron micrographs at higher magnifications showing an ectoplasmic specialization (E) and desmosome-like junctions (F) between a Sertoli and germ cell in vitro. The ectoplasmic specialization (E) is typified by the presence of the endoplasmic reticulum adjacent to the Sertoli cell plasma membrane. The opposing arrowheads (E) correspond to the plasma membranes of a Sertoli and germ cell. Actin filament bundles were also detected (asterisk). Desmosome-like junctions (F) are typified by the presence of electron-dense patches at sites of Sertoli-germ cell contact (arrowheads). Scale bars, A, 10 µm; B, 2 µm; C, 8 µm; D, 1 µm; E, 0.5 µm; and F, 0.25 µm.

 
Needless to say, recent developments in the field have shed light on the regulation of adherens junctions, in particular ectoplasmic specializations. For instance, it has become increasingly clear that ectoplasmic specializations use some of the same proteins that are found in focal adhesions in other epithelia. These include integrins, laminin, ILK, FAK, PI 3-kinase, p130 Cas, and others (45, 49). In addition, two signaling pathways that are used to regulate adherens junction dynamics in the testis have now been identified (45, 49). These are discussed herein. Most important of all, when an in vivo model of adherens junction disruption was used where rats were treated with AF-2364, a potential male contraceptive, Sertoli-germ cell adhesion, particularly at the site of the ectoplasmic specialization, was compromised. This conclusion was reached based on several recently published studies. First, the half-time of disappearance of elongating/elongate spermatids was 6.5 h vs. 3 and 6.5 d for round spermatids and spermatocytes, respectively, when the kinetics of germ cell loss from the seminiferous epithelium in adult rats was estimated after AF-2364 treatment (50 mg/kg body weight by gavage) (54). This suggests that apical ectoplasmic specializations are most susceptible to AF-2364. Second, the loss of germ cells from the epithelium was preceded by an activation of ß1 integrin, phosphorylated FAK (pFAK), and PI 3-kinase (49), suggesting that signaling proteins, such as FAK, are the upstream targets of AF-2364. This increase in pFAK was confirmed when an intense accumulation of pFAK at the site of the ectoplasmic specialization was detected during AF-2364-induced adherens junction disassembly by immunofluorescence microscopy (49). Third, integrins residing at the site of apical ectoplasmic specializations are apparently the target proteins of AF-2364 because their activation can lead to a disruption of the signaling function of ROCK. By using a specific ROCK inhibitor [Y-27632 (686)] to block this signaling pathway, AF-2364-induced germ cell loss from the epithelium was effectively delayed (45). Taken collectively, these studies illustrate that the proteins which constitute the apical ectoplasmic specialization are the initial targets of AF-2364 (53, 54).

More importantly, cadherins and integrins are cell adhesion molecules present in other epithelia. Why wouldn’t AF-2364 damage anchoring junctions in other organs? First, adult male rats treated with AF-2364 at doses effective in inducing transient infertility did not display any damage in the kidney, liver, and epididymis when these organs were examined morphologically. This was in contrast to the testis (667). AF-2364 also failed to affect liver and kidney function based on serum microchemistry analysis (666, 667). Although AF-2364 induced germ cell loss via an initial activation of RhoB, this GTPase was not induced in the liver and kidney (45). This was also true for cadherin and catenin; both proteins were activated by AF-2364 in the testis (53, 54) but not in the liver and kidney (our unpublished observations). Taken collectively, these data suggest that cadherin/catenin and integrin/laminin complexes at the site of the ectoplasmic specialization require unique, testis-specific proteins such as testin (for review, see Ref.4) and other yet-to-be identified molecules to act as a receptor protein complex for AF-2364. In summary, these data suggest that the primary targets of AF-2364 are Sertoli cell-germ cell adherens junctions, such as the apical ectoplasmic specialization.

There is yet another question that remains to be addressed. Does AF-2364 limit its action only on the adherens junction or does it also affect the integrity of the blood-testis barrier? Shown in Fig. 13Go are results of a recent study using immunofluorescent microscopy to monitor the integrity of the blood-testis barrier after treatment with AF-2364 (50 mg/kg body weight by gavage) (Fig. 13Go, D–F) vs. control rat testes (Fig. 13Go, A–C). Routine histological analysis has shown that virtually all of the tubules were devoid of elongating/elongate and round spermatids, and more than 70% of spermatocytes (Fig. 13Go, H vs. G) on d 12 after AF-2364 treatment, consistent with three earlier reports (54, 666, 667). However, the immunostaining intensity of occludin and ZO-1 at the site of the blood-testis barrier remained unaltered (Fig. 13Go, D–F vs. A–C). By d 120, germ cells repopulated the seminiferous epithelium, and more than 40% of the tubules were indistinguishable from control rats (Fig. 13Go, I vs. G and H). These observations are consistent with our postulate that AF-2364 exerts its effects on the cadherin/catenin/testin/integrin multiprotein complex at the site of the apical ectoplasmic specialization (for review, see Ref.4). Taken collectively, these results illustrate that a disruption of adherens junctions in the seminiferous epithelium by AF-2364 does not compromise the integrity of the blood-testis barrier. In light of these findings, we have named AF-2364 as Adjudin (an inducer of adherens junction disruption). Recently completed acute toxicity (in both mice and rats) and genotoxicity studies (micronucleus test in CHO cells and mutation test in bacteria) performed by licensed toxicologists have shown that AF-2364 is not toxic and mutagenic at doses effective to induce infertility in male rats and up to 10 times higher than the effective antifertility dose (our unpublished observations). The results discussed in this section have also permitted us to identify two putative signaling pathways that regulate cell adhesion in the testis.



View larger version (47K):
[in this window]
[in a new window]
 
FIG. 13. A study illustrating that AF-2364 (Adjudin) induces germ cell loss from the seminiferous epithelium by perturbing Sertoli-germ cell adherens junctions without affecting the integrity of the blood-testis barrier. A–F, Immunofluorescence microscopy was performed using cross-sections of testes from control rats (A–B) and rats killed on d 12 after administration of a single dose of AF-2364 (50 mg/kg body weight) by gavage (D–E). Sections were immunostained simultaneously with rabbit antioccludin polyclonal (A, D) and mouse anti-ZO-1 monoclonal (conjugated to FITC) antibodies (B, E). To visualize occludin, goat antirabbit IgG-Cy3 was used. C and F, Corresponding merged images. Both occludin and ZO-1 colocalized to the basal compartment of the seminiferous epithelium. Also notice that the blood-testis barrier was not perturbed by AF-2364 because the distribution of both occludin and ZO-1 was unchanged when virtually all of the spermatids (elongating/elongate and round spermatids) and most of the spermatocytes (>70%) were not found in the epithelium by d 12 after treatment (53 54 666 667 ). Scale bar, 25 µm. G–I, Micrographs of cross-sections of testes from a control rat (G) and rats killed on d 12 (H) and d 120 (I) after administration of AF-2364 as described above but stained with hematoxylin and eosin. Notice that by d 12, virtually all of the tubules were devoid of germ cells (H vs. G). By d 120, germ cells had repopulated most of the tubules (I), except for a few (see asterisks). Scale bar, 150 µm.

 
This work is now being expanded to include another in vivo model in which cell adhesive function is perturbed. This model involves the use of androgen/estrogen implants to induce germ cell loss from the seminiferous epithelium (for review, see Ref.55). The rationale for conducting this series of experiments is to determine whether results published earlier using AF-2364 (45, 49) can be reproduced when another model is used. For instance, the loss of spermatids (step 8 and beyond of spermiogenesis in the rat) from the seminiferous epithelium induced by androgen suppression is a novel in vivo model to study adherens junction dynamics (for review, see Ref.55). Indeed, several studies have demonstrated that the ectoplasmic specialization is perturbed as a result of androgen suppression (571, 687). Unfortunately, the signaling pathways that regulate these events are not all known. Thus, it would be interesting to examine whether the integrin/RhoB GTPase/ROCK and/or the integrin/FAK/PI 3-kinase pathways are being activated during disruption of the ectoplasmic specialization when this in vivo model is used. Once this information is available, the signaling molecules that regulate ectoplasmic specialization dynamics can be targeted in the hopes that novel male contraceptives can be developed. For instance, if cell adhesion is perturbed, germ cells will detach prematurely from the seminiferous epithelium, rendering males infertile. Because the hypothalamic-pituitary-testicular axis is not disrupted, side effects, if any, will be minimal. In other words, AF-2364 did not affect serum FSH, LH, and testosterone levels (666, 667), illustrating that perturbing cell adhesion to induce reversible male infertility is a novel approach for the development of male contraceptives.

6. Desmosomes.
Desmosomes, cell-cell anchoring junctions that use intermediate filaments as their attachment sites (Fig. 1Go; Fig. 12Go, C, D, and F; and Table 1Go), have been studied most extensively in the epidermis, where they have important functions in the maintenance of tissue integrity. Although the presence of this type of junction in the testis has been known for almost three decades, its biochemical architecture remains unexplored (for reviews, see Refs.18 and 87) (Table 1Go).

a. Functions of desmosomes.
Studies have demonstrated that desmosomes are highly organized spots between adjacent cells sandwiched in between two plaques (for reviews, see Refs.688, 689, 690, 691, 692, 693). They consist of two principal domains: 1) the extracellular core or desmoglea; and 2) symmetrical dense cytoplasmic plaques that lie parallel to the plasma membrane. Intermediate filaments attach to the cytoplasmic plaques to form a continuous network throughout the entire cell.

b. Proteins of desmosomes.
Desmosomes are composed of members from three protein families: 1) the cadherins, 2) armadillo proteins, and 3) plakins (for review, see Ref.690). Desmosomal cadherins can be further categorized into the desmocollins and desmogleins. Desmocollin and desmoglein each have three isoforms, namely desmocollins 1, 2, and 3 and desmogleins 1, 2, and 3. Each is the product of a different gene, having distinct patterns of expression among different tissues. These major desmosomal cadherins are connected to the cytoskeleton via cytoplasmic proteins, such as plakoglobin (also known as {gamma}-catenin), desmoplakin, and plakophilin. It must be noted that plakoglobin is the only protein that is common to both desmosomes and adherens junctions (694). Minor components of desmosomes, such as IFAP 300 (695), pinin (696), desmocalmin (697), plectin (698), envoplakin (691), and periplakin (691) may also contribute to plaque structure. Except for plakoglobin (53), it is not known whether any of these proteins are found in the testis.

7. Hemidesmosomes.
Hemidesmosomes differ from desmosomes both structurally and functionally (for reviews, see Refs.13 , 14 , 699 , and 700) (Table 1Go). In the testis, hemidesmosomes are restricted to the basal lamina between the basal portion of the Sertoli cell and the underlying basement membrane (701, 702) (Fig. 1Go).

a. Functions of hemidesmosomes.
Hemidesmosomes are cell junctions that connect a cell’s cytoskeleton to the underlying basement membrane. In essence, their role is similar to that of focal adhesions, except that hemidesmosomal constituent proteins are linked to the cytoskeleton via intermediate filaments, not via actin.

b. Proteins of hemidesmosomes.
Except for integrins, the proteins that constitute the hemidesmosome have not been extensively characterized. It is known, however, that ß4 integrin confers hemidesmosome function by linking to intermediate filaments (for review, see Ref.703). Moreover, Imamura and colleagues (704) demonstrated that a monoclonal antibody designated 1-2B7B, which was obtained by immunizing mice with human prostate epithelial tissue, reacted with a protein that localized to the basement membrane of the testis. However, the identity and function of this protein have yet to be determined. In light of the closeness of the hemidesmosome to the blood-testis barrier, it is important that this junction type be investigated in the testis.

8. Communicating junctions.
There are two types of communicating junctions: 1) gap, and 2) chemical synapses (for reviews, see Refs.13 , 14 , and 705, 706, 707, 708, 709). Our discussion on communicating junctions will be limited only to gap junctions as they relate to germ cell movement in the testis (Fig. 1Go and Table 1Go). Readers are encouraged to refer to relevant review articles cited in this section for more information.

a. Functions of gap junctions.
Gap junctions are the means by which ions and small molecules are exchanged between two adjacent cells. They are intercellular channels formed by the noncovalent interaction of two hemichannels, or connexons, with each cell contributing a connexon. Each connexon (~1.6–2.0 nm in diameter with the two connexons separated by a space of 2–4 nm) is commonly found clustered together with other connexons to form a gap junctional plaque. Each connexon is further broken down into six integral membrane subunits, or connexins, surrounding a central hydrophilic pore (for reviews, see Refs.13 , 14 , and 710). Because gap junctions mediate signals between Sertoli and germ cells, they likely play a crucial role in coordinating events pertinent to germ cell movement in the seminiferous epithelium.

b. Proteins of gap junctions.
Gap junctions are comprised of connexin proteins. Each connexin traverses the plasma membrane four times, and both the N and C termini exit into the cytoplasm. The transmembrane and extracellular domains of different connexins are highly conserved, but regions located between the transmembrane domains and C termini are divergent. At least 20 connexins have been identified in mammalian tissues (for reviews, see Refs.710 and 711).

Morphological evidence for the presence of gap junctions between Sertoli cells has been known since the 1970s (112). More recent in vivo studies have demonstrated that dye coupling between Sertoli cells took place coordinately and associated with defined stages of the epithelial cycle (712). For instance, connexin43, the best-studied connexin, was found to be present at the site of Sertoli cell gap junctions, with the most intense staining detected in stages I–VIII (713). It was also shown that Sertoli cell connexin43 increased during testicular development (713). Other studies illustrated that gap junctions formed between Sertoli cells and pachytene spermatocytes in vitro as well (52, 714). Moreover, connexin33 is testis-specific and expressed largely by germ cells (25). To date, at least 13 connexins have been found to be present in the testis, namely connexins26, 31, 31.1, 32, 33, 36, 37, 40, 43, 45, 46, 50, and 57 (715).

Presently, it is not known how gap junctions contribute to germ cell movement in the testis. In a recent report, treatment of Novikoff hepatoma cells with cytochalasin B (disrupts actin filaments), colchicine (blocks microtubule assembly), or nocodazole (disrupts microtubules) did not appear to interfere with gap junction assembly (716). However, transfectants of 3T3 fibroblasts, which expressed a connexin43 mutant protein lacking the C-terminal cytoplasmic domain, were able to exhibit decreased cell motility as determined in Boyden chamber wounding assays (717). These results provide a link between gap junctions and cell movement, yet similar studies in the testis wait to be performed.


    IV. Mechanism of Germ Cell Movement
 Top
 Abstract
 I. Introduction
 II. Sertoli Cells
 III. Sertoli-Sertoli and Sertoli...
 IV. Mechanism of Germ...
 V. Concluding Remarks
 References
 
A. Theories of germ cell movement
1. Background.
In addition to the biochemical, molecular, and cellular events that take place during spermatogenesis, preleptotene/leptotene spermatocytes must traverse the blood-testis barrier in late stage VIII–early stage IX of the epithelial cycle, migrating from the basal to the adluminal compartment while differentiating into haploid spermatids (2). Likewise, round spermatids must migrate to the lumenal edge of the seminiferous epithelium to permit spermiation. It is envisioned that these events involve the participation of an array of molecules. Although many proteins via their effects on junction dynamics have been implicated in germ cell movement (Table 4Go), how they coordinate these events requires further investigation. Nevertheless, several possible theories have advanced in recent years based largely on morphological studies. These theories are elaborated on below.


View this table:
[in this window]
[in a new window]
 
TABLE 4. mRNAs and/or proteins synthesized by Sertoli and/or germ cells with possible roles in junction dynamics during germ cell movement

 
2. Zipper theory.
The "zipper theory" proposes that occluding zonules, consisting of fibrils that are positioned over preleptotene/leptotene spermatocytes in the epithelium, break down while new occluding zonules reform under the developing germ cell (74, 87, 113). Up until now, it has been quite difficult to substantiate this hypothesis, given the fact that there is not a single in vivo study demonstrating actual leakage of a vascularly infused tracer across the tight junction barrier into the tubule lumen even for a short period of time. The factor(s) responsible for triggering the breakdown of occluding zonules, if any, is presently not known.

3. Intermediate cellular compartment theory.
The intermediate cellular compartment theory, which asserts the existence of a unique compartment inhabited by germ cells in transit from the basal to the adluminal compartment (2), also falls short. This is because studies by two different groups, Pelletier and Friend (213) and Cavicchia and Sacerdote (119), have unquestionably demonstrated the existence of only one occluding zonule per Sertoli cell. Thus, the existence of a compartment in which a developing germ cell is trapped in between two occluding zonules is arguable.

4. Repetitive removal of membrane segments theory.
Lastly, the repetitive removal of membrane segments theory contends that the continuous, upward migration of a large number of germ cells creates a massive amount of stress on the Sertoli cell junctional complex (for review, see Ref.118). As a consequence, junctions proliferate to form numerous loops in which developing germ cells, except elongate spermatids, are lodged. Each intercellular pocket, sealed at both ends by tight, adherens, and gap junctions, progressively traverses the seminiferous epithelium until it is internalized in autophagic vesicles (for review, see Ref.118). Once again, this hypothesis is intriguing, but studies have failed to demonstrate the localization of tight junction proteins, such as occludin, throughout the epithelium. Needless to say, other yet-to-be identified tight and adherens junction integral membrane proteins may exist to substantiate this hypothesis. As such, it is important that future resources be allocated to the identification and characterization of novel proteins that constitute the various junction types in the testis.

5. Junction restructuring theory.
On this note, we hereby propose the junction restructuring theory (Fig. 14Go). This hypothesis, which is based on recently published and ongoing biochemical and molecular studies from this and other laboratories (for review, see Ref.4 and references cited therein), is not an attempt to discredit the aforementioned theories. On the contrary, this postulate complements the existing pool of knowledge on germ cell movement in the testis.



View larger version (42K):
[in this window]
[in a new window]
 
FIG. 14. Schematic drawing illustrating the junction restructuring theory of germ cell movement in the seminiferous epithelium. Shown is the cascade of events leading to the movement of germ cells from the basal to the adluminal compartment of the seminiferous epithelium (see phases 1–6). We hypothesize that germ cell movement, which involves cycles of Sertoli-Sertoli and Sertoli-germ cell junction disassembly and reassembly, requires the participation of an array of factors such as cytokines, proteases, protease inhibitors, protein kinases, protein phosphatases, junctional complex and extracellular matrix proteins, and GTPases.

 
We propose that germ cell movement consists of intermittent phases of cell junction disassembly and assembly (Fig. 14Go), which allow for the timely passage of germ cells from one site to another in the epithelium (for review, see Ref.11). For example, tight junctions comprised of transmembrane proteins, such as occludin and claudin (371, 718) (Tables 1Go and 4Go), must gradually disassemble (Fig. 14Go) one fibril at a time to allow for the passage of preleptotene/leptotene spermatocytes across the blood-testis barrier. Adherens and gap junctions also need to be disassembled in due course. It is envisioned that cytokines such as IL-1{alpha} and -1ß; basic fibroblast growth factor (bFGF); TNF-{alpha}; and TGF-{alpha} and -ß produced by Sertoli and/or germ cells (Table 4Go) trigger the cascade of events leading to the activation of proteases (719, 720, 721), which in turn cleave cell junctions (Fig. 14Go). Cytokines can also stimulate or inhibit the production of junctional component proteins (for reviews, see Refs.183 and 722) (Fig. 14Go). Indeed, a recent study from our laboratory has shown that TGF-ß3 can perturb the Sertoli cell tight junction barrier in vitro by blocking the transient induction of occludin and ZO-1 (22), which are needed for tight junction assembly (24, 25, 27, 43). Likewise, TNF-{alpha} was shown to inhibit the production of occludin, but not ZO-1, by Sertoli cells and to modulate tight junction dynamics by affecting collagen {alpha}3(IV), MMP-9, and TIMP-1 (49). However, disassembled junctions must be quickly reassembled to maintain the integrity of the seminiferous epithelium. The second phase of germ cell movement, cell junction assembly, requires that cytokines activate protease inhibitors (48, 723, 724, 725). This triggers the synthesis of proteins required for assembling disrupted junctions (Fig. 14Go). This is supported by recent studies which demonstrated that cytokines, such as TGF-ß3, can also affect the production of adherens junction-associated proteins [e.g., E-cadherin, ß-catenin, p120ctn, and Src (39)] and protease inhibitors [e.g., {alpha}2-MG (39)], besides their effects on tight junction proteins (22, 23, 38). It is also our belief that cytokines, proteases, and proteases inhibitors are involved in the restructuring of the ectoplasmic specialization in light of several reports which illustrated that these molecules are activated during the assembly of functional anchoring junctions between Sertoli and germ cells (5, 48). Additionally, one must remember that the mechanical force that lifts germ cells upward during the epithelial cycle is not entirely generated by Sertoli cells. This driving force may also be produced by the continuous mitotic divisions of spermatogonia in the basal compartment adjacent to the basement membrane (Figs. 2Go and 14Go). As such, junction disassembly and reassembly during spermatogenesis may be the result of the upward movement of germ cells and possibly not the cause of it (for review, see Ref.16). To reduce the complexity of this model, we have not included information on the use of motor proteins, ATPases, and GTPases by the ectoplasmic specialization for the translocation of elongating/elongate spermatids across the epithelium (for reviews, see Refs.20 and 87). All in all, this model will continue to be updated as advances in cell and molecular biology help us to better understand this cellular phenomenon in the seminiferous epithelium.

B. Additional comments
1. Cell movement in other cell types.
This hypothesis (Fig. 14Go) attempts to bring together the biochemical and molecular events of germ cell movement. However, it fails to take into account that germ cells cannot move from one site to another because they lack the cytoskeletal machinery necessary to do so. Numerous studies using other cell types, such as fibroblasts, have shown that cell movement involves cell adhesion via cycles of detachment and attachment (for reviews, see Refs.773 and 774). This is similar to the translocation of germ cells across the epithelium, which requires phases of Sertoli-germ cell junction disassembly (detachment) and assembly (attachment). It is possible that the polymerization and depolymerization of actin in Sertoli cells can generate the needed mechanical force to lift germ cells from one site to another similar to the mechanical force generated by structures known as filopodia and lamellipodia at the leading edge of migrating fibroblasts (for reviews, see Refs.773 and 774). These processes are mediated, at least in part, by members of the GTPase superfamily. However, germ cells are dissimilar to migrating fibroblasts in at least two aspects. First, germ cells do not possess an extensive cytoskeletal network, such as that found in fibroblasts. Second, germ cells in different stages of their development do not assume amoeboid cell shapes. Thus, it is believed that the cytoplasmic processes of Sertoli cells generate the protrusive force that is required for the movement of germ cells from one site to another in the seminiferous epithelium.

C. Regulation of cell junction dynamics in the testis by cytokines
1. Cytokines in the testis.
Sertoli and germ cells produce cytokines in the seminiferous epithelium. It is known that these two cell types synthesize several cytokines such as TGF-{alpha} and -ß; TNF-{alpha}; nerve growth factor; FGF; and IFN-{alpha}, -ß, and -{gamma}, which regulate cell growth, differentiation, and function (for reviews, see Refs.9 , 11 , 229 , 230 , and 244). For instance, EGF stimulates meiosis in spermatocytes but has no reported effects on spermatogonia and spermatids (for reviews, see Refs.8 , 9 , 775 , and 776). Specific cytokines, such as IFN-{gamma}, can even participate in the defense mechanism of cells in the testis (Refs.154 , 733 , and 734 ; for review, see Ref.777).

2. Effects of cytokines on tight junction dynamics.
A thorough literature search on the effects of cytokines on tight junctions in different epithelia has demonstrated that these effects are mediated by: 1) affecting the expression and/or synthesis; 2) redistribution; or 3) phosphorylation status of tight junction proteins (for review, see Ref.183). For example, TNF-{alpha} and IFN-{gamma}, used either alone or together in cultures of human intestinal HT-29/B6 cells, diminished occludin promoter activity (778). IL-4 and -13 were also shown to perturb the tight junction barrier by inhibiting the expression of occludin and ZO-1 in Calu-1 cells (196), which is similar to the way TGF-ß3 perturbs the Sertoli cell tight junction barrier in vitro (22). On the other hand, HGF affects the tight junction barrier by moving ZO-1 away from the site of tight junctions (187, 188, 779). Lastly, other studies have shown that IFN-{alpha} and EGF can perturb tight junction functionality by inducing the phosphorylation of occludin and ZO-1 in LLC-PK1 and A431 cells, respectively (185, 191). In the testis, TGF-ß2 and -ß3, and TNF-{alpha} participate in Sertoli cell tight junction dynamics by affecting occludin and/or ZO-1 expression (22, 163). The effect of TGF-ß3 on Sertoli cell tight junctions in vitro and in vivo is mediated via the mitogen-activated protein/MEKK/p38 MAPK pathway (23, 38), whereas TNF-{alpha} likely affects tight junction dynamics via the ILK/p130 Cas/JNK (c-Jun N-terminal kinase) signaling pathway (163).

3. Effects of cytokines on adherens junction dynamics.
In contrast to tight junctions, the effects of cytokines on adherens junction dynamics have not been studied extensively. What is known is that cytokines can either alter the phosphorylation status of adherens junction proteins or perturb the interactions that exist between adherens junction proteins and actin filaments. For example, EGF, HGF, and vascular endothelial growth factor can all stimulate tyrosine phosphorylation of {alpha}-catenin, ß-catenin, and p120ctn in different cell lines in vitro (517, 780, 781). Other cytokines, such as FGF, induced dissociation of the cadherin-ß-catenin complex and recruited ß-catenin to the nucleus (782). This is similar to TGF-ß1, which caused {alpha}- and ß-catenin, cadherin-5, and plakoglobin to move away from the site of adherens junctions in endothelial cells (783). Treatment of a proximal tubular cell line, HK-2, with TGF-ß1 also elicited similar effects (492). In a rat carcinoma cell line, EGF was shown to activate Src, resulting in cell motility (784). In summary, cytokines play an important role in the regulation of Sertoli cell tight junction dynamics. Although the role of cytokines on adherens junctions in the testis remains to be investigated, studies from other epithelia have clearly implicated them in the regulation of this junction type.

D. Regulation of cell junction dynamics in the testis by proteases and protease inhibitors
In this section, we review some of the recent studies on proteases and protease inhibitors as they relate to the events of germ cell movement in the seminiferous epithelium.

1. Proteases.
Proteases, enzymes that hydrolyze peptide bonds at specific sites, are categorized into one of two groups: 1) exopeptidases, and 2) endopeptidases (for reviews, see Refs.785, 786, 787, 788, 789, 790). Exopeptidases (also known as peptidases) cleave peptide bonds exclusively near the N or C terminus of a polypeptide, usually one or two amino acid residues from its end. On the other hand, endopeptidases (also known as proteinases) cleave peptide bonds internally and are classified into one of four types: 1) serine, 2) cysteine, 3) aspartic, and 4) metalloproteases, depending on the amino acid residue at its catalytic site (e.g., 1, 2, and 3) or if its activity requires divalent cations (e.g., 4).

a. Serine proteases.
Serine proteases have been studied extensively because they are active at a neutral pH and present nearly everywhere in the body. In addition, they are synthesized as inactive precursors, known as zymogens, and require limited proteolysis for activation. Serine proteases do not require any cofactors to exert their proteolytic activity (for review, see Ref.14).

To date, the best-studied serine proteases are trypsin, PA, and plasmin. PA is present in several tissues and cells (for reviews, see Refs.791 and 792). In the testis, Sertoli cells synthesize and secrete both u-PA and tissue-type PA, but not trypsin (143, 719, 793, 794). In fact, most of the PA activity detected in testicular extracts is derived from Sertoli cells, suggesting that this protease plays an important role in the biology of the Sertoli cell (744, 793). Moreover, studies have demonstrated that Sertoli cells secrete PA preferentially into the basal compartment when cultured on bicameral units (795). When staged seminiferous tubules were cultured in vitro, this serine protease was synthesized and secreted in a cyclic manner (794, 796). For example, studies have shown that PA secretion was at its highest level in stages VII–VIII of the epithelial cycle coinciding with the event of spermiation (796, 797). Although u-PA is the predominant type of PA secreted by Sertoli cells in vitro (796), tissue-type PA becomes the predominant type secreted when FSH or cAMP derivatives are added into Sertoli cell cultures (796, 798). In addition, coculture of residual bodies obtained by elutriation from adult rat testes with Sertoli cells was able to significantly increase PA activity (721, 799). Subsequently, the phagocytosis of these residual bodies by Sertoli cells resulted in an increase in IL-1{alpha} activity, suggesting that cytokines may regulate protease activity (721, 799). Insulin, cGMP derivatives, prostaglandins, EGF, estrogens, androgens, LH, and human chorionic gonadotropin all failed to affect Sertoli cell PA activity (800, 801). However, a previously published report demonstrated that TGF-ß affected Sertoli cell PA expression (719). Low levels of secreted PA in the form of two molecular variants, which differed in Mr from those previously reported, have also been detected in concentrated peritubular myoid cell-conditioned media (for review, see Ref.225). Germ cells consisting largely of spermatocytes, spermatids, and residual bodies secrete PA, but this may be the result of Sertoli cell contamination (745, 793).

A unique 41-kDa protein from germ cell-conditioned media has been identified (740). Studies have demonstrated that this molecule, in addition to being a serine protease, was also able to affect Sertoli cell secretion in vitro. For instance, this protein inhibited Sertoli cell clusterin and testin secretion at doses between 0.5 and 5 ng/ml, whereas at doses greater than 500 ng/ml it cleaved [125I]collagen and [125I]testin (740). It remains to be determined whether Sertoli cells can synthesize this serine protease. These findings illustrate that germ cells contribute to the pool of protease activity in the testis that is required for spermatogenesis and germ cell movement.

b. Cysteine proteases.
The best-studied acid lysosomal cysteine proteases, the cathepsins, are synthesized by many cell types (for reviews, see Refs.787 , 802 , and 803). They possess a highly reactive cysteine residue at their active site and require a pH 4.0 for maximal activity. To date, several cathepsins have been identified such as cathepsins B, H, K, L, N, O, S, and T (788).

Cathepsin L, also known as cyclic protein-2, is a 39-kDa Sertoli cell secretory product (47, 233, 804, 805, 806, 807). Germ cells can also synthesize cathepsin L (47, 741, 808). Studies have reported that cyclic protein-2 is the proenzyme of cathepsin L (807). More importantly, Sertoli cell cathepsin L was highest in stages VI–VII before spermiation, suggesting that it participates in the movement of elongate spermatids toward the tubule lumen (47). Indeed, studies by immunohistochemistry have localized cathepsin L to the site of the apical ectoplasmic specialization in late stage VII–early stage VIII of the epithelial cycle in the rat, consistent with its involvement in spermiation (233). Cathepsin L also increased in Sertoli cells isolated from aging testes with highest levels of cathepsin L detected in 38- to 45-d-old rats (809). In addition, this enzyme can: 1) activate u-PA; 2) degrade proteins; 3) initiate a cascade of events involving proteases; and 4) promote cell proliferation (for review, see Ref.225). However, before cathepsin L can participate in these processes, it must first be activated. Additional studies have shown that cathepsin L can be stimulated by oncogenes and tumor promoters. Thus, it has been implicated in the metabolism and invasion of tumor cells (for review, see Ref.810). The proenzyme, but not the mature protein, apparently participates in the regulation of Leydig cell steroidogenesis by forming a complex with TIMP-1 (811).

c. Aspartic proteases.
To date, few aspartic proteases (for reviews, see Refs.812 and 813) have been identified in the testis. For instance, pepsin is the best-studied aspartic protease, yet it is not present in the testis. Conversely, cathepsin D, the only known aspartic protease present exclusively in lysosomes (for reviews, see Refs.814 and 815), is found in the testis, rete testis, epididymis, and efferent ducts (816). Specifically, studies have demonstrated the presence of cathepsin D in primary spermatocytes, as well as in Sertoli and Leydig cells (816). In addition, cathepsin D mRNA was found to be highest in stages VII–IX of the epithelial cycle, suggesting that it participates in the release of mature spermatids into the tubule lumen (47). Similar to cathepsin L, it is also secreted as a proenzyme. Second, this protease requires a pH 3.0–4.0 for maximum activity and is inactive at or above pH 7.0. This illustrates that cathepsin D may be an important lysosomal enzyme required for the scavenger function of Sertoli cells, such as in the reabsorption of apoptotic germ cells or the proteolysis of cytoplasmic droplets during spermatogenesis.

In addition to cathepsin D, other aspartic proteases that are found in the testis include angiotensin-converting enzyme (ACE) and renin (for review, see Ref.817). Developing germ cells can synthesize a specific ACE that is different from somatic ACE found in tissues such as the epididymis, lung, and kidney (818, 819). More importantly, ACE plays an important role in male fertility because mice lacking the ACE gene were sterile (820, 821).

d. Metalloproteases.
Recent studies have demonstrated the presence of metalloproteases in the testis. These include: 1) the matrix metalloproteases, 2) neutral metalloendopeptidase, and 3) N-arginine dibasic convertase.

N-arginine dibasic (NRD) convertases, zinc-dependent metalloendopeptidases, cleave basic amino acids at the N terminus of arginine residues (for review, see Ref.822). A characterization of the first NRD (NRD1) convertase cDNA from the rat testis (743, 823) illustrated that it contains a long stretch of acidic amino acids (824). Recently, a second NRD (NRD2) convertase was identified, differing from NRD1 by an insertion of 68-amino acid residues close to the active site (825). NRD convertase was found to be highest in the testis, restricted to elongate spermatids (743). To date, the function of NRD convertase remains to be known, but it possibly relates to the event of spermiation.

Members of another emerging family of metalloproteases, the M13 family (for review, see Ref.826), which is comprised of six members, namely neprilysin [NEP (742, 827)], Kell blood group protein (828), phosphate regulating gene with homologies to endopeptidases on the X chromosome (829), endothelin-converting enzyme-2 (830), and X-converting enzyme are also found in the testis. The membrane metalloendopeptidase (MME) family has also been shown to play a significant role in the homeostasis of NEP, which can regulate other biological molecules by lowering their extracellular concentration via proteolysis, thereby affecting receptor binding and signaling function (for review, see Ref.831). In fact, overexpression of cell-surface NEP inhibited the phosphorylation of FAK (832). FAK can be activated by phosphorylation at Tyr397, which in turn affects ectoplasmic specialization dynamics in the testis. However, it remains to be shown whether proteases such as MMP-9 colocalize with pFAK. Studies have demonstrated the presence of NEP in several tissues such as the kidney, intestine, adrenal glands, lung, brain, epididymis, and prostate gland (833). Specifically, NEP is present in Sertoli cell membranes (834). Recently, a new member of the MME family, MME-like 2, was cloned, and its mRNA level was found to be highest in the testis (835). However, the significance of this finding remains to be determined.

2. Protease inhibitors
a. Serine protease inhibitors.
Serine protease inhibitors, also known as serpins, are large molecules consisting of approximately 400 amino acid residues (for review, see Ref.836). In the testis, PA inhibitor (PAI) is the best-studied serpin (792). To date, three PAIs are known to exist: 1) PAI-1, 2) PAI-2, and 3) PAI-3 (837). Sertoli and peritubular myoid cells are known to synthesize PAI-1, which specifically inhibits u-PA (719, 748, 800, 837, 838, 839), but not plasmin or trypsin. Interestingly, a recent study failed to detect PAI-1 mRNA in germ cells (748), yet in other studies it was detected in spermatids and residual bodies (838, 840). The reason for such a discrepancy may be the result of cell contamination. In addition, the level of PAI-1 increased in peritubular myoid cells after they were treated with TGF-{alpha}, TGF-ß, or bFGF (841), once again implicating cytokines in the homeostasis of proteases and protease inhibitors. Moreover, TGF-ß, bFGF, EGF, FSH, GnRH, and forskolin can also affect Sertoli cell PAI-1 mRNA in vitro, suggesting that PAI-1 can be regulated by various factors (724, 748, 801, 841).

A recently completed gene knockout experiment has demonstrated the significance of protease inhibitors in cell junction dynamics as they relate to germ cell movement. For instance, protein C inhibitor-1–/– (a nonspecific serine protease inhibitor) male mice are infertile with impaired spermatogenesis (842). Histological analysis of testes from protein C inhibitor-1–/– mice revealed that the seminiferous tubule lumen was filled with immature germ cells, possibly resulting from a loss of cell adhesion between Sertoli and germ cells (842). Furthermore, the Sertoli cell tight junction barrier was damaged (842). This is in concert with findings from our laboratory which demonstrated that the assembly of tight and adherens junctions in the testis is regulated by the interplay of proteases and protease inhibitors (5, 24, 27, 47). Although trypsin, the major serine protease found in the systemic circulation, is absent in the testis (143), recent studies have demonstrated the presence of tryptase in the testis (5). More importantly, the expression of tryptase, similar to u-PA, was induced by as much as 4-fold during the adhesion of germ cells to the Sertoli cell epithelium (5). Furthermore, there was a transient but significant induction of serine protease activity during Sertoli-germ cell adherens junction assembly, strengthening the notion that proteases are important in adherens junction dynamics (5). Indeed, a more recent study using an in vitro adhesion assay with fluorescently labeled germ cells has demonstrated that the interplay of proteases and protease inhibitors can affect Sertoli-germ cell adherens junction dynamics (48).

b. Cysteine protease inhibitors.
Cystatins, cysteine protease inhibitors, are important regulatory proteins (for reviews, see Refs.843, 844, 845). There are three types of cystatins: 1) cystatins, 2) stefins, and 3) kininogens, all of which are functionally related.

The cystatins are present in body fluids. They consist of cystatins C, D, E, M, and S. Specifically, cystatin C can be detected in blood plasma, and cerebrospinal and seminal vesicle fluids. It can also inhibit cathepsin B, H, and L activity. In the testis, Sertoli and Leydig, but not germ cells synthesize cystatin C (236, 747). Studies have demonstrated that in addition to the testis and seminal vesicles, the epididymis and prostate also contain cystatin C mRNA (846). Interestingly, the highest level of cystatin C was detected in seminal vesicle fluid. In addition, the synthesis of cystatin C was highest in Sertoli cells 2 and 3 d after these cells were plated on plastic or Matrigel-coated dishes, respectively (747). However, the inclusion of FSH into cell cultures failed to elicit any changes in cystatin C synthesis (747). To date, it is not known whether cystatins D and S are present in the testis.

Stefins are 11-kDa intracellular proteins (for review, see Ref.847). Cystatin A, a member of this protease inhibitor family, can inhibit cathepsin B, C, H, L, and S activity (Ref.843 ; for reviews, see Refs.844, 845). On the other hand, kininogens are large, multifunctional proteins present exclusively in the systemic circulation. They participate in the acute phase response, inflammatory reaction, and blood coagulation (for reviews, see Refs.848 and 849).

c. Aspartic protease inhibitors.
Although several aspartic proteases (for reviews, see Refs.812 and 850) such as cathepsin D, ACE, and renin are present in the testis, specific inhibitors against this protease class have not yet been identified. It must be noted, however, that {alpha}2-MG, a nonspecific protease inhibitor secreted by Sertoli cells, can inhibit aspartic proteases (746, 851, 852, 853).

d. Metalloprotease inhibitors.
TIMPs are proteins that inhibit MMP activity. To date, four members of the TIMP family have been characterized: 1) TIMP-1, 2) TIMP-2, 3) TIMP-3, and 4) TIMP-4 (for reviews, see Refs.854, 855, 856).

Both TIMP-1 and -2 inhibit MMP activity so that a balance between extracellular matrix deposition and degradation can be maintained (for reviews, see Refs.855, 856, 857, 858). Specifically, TIMP-1 and TIMP-2 can: 1) inhibit tumor cell growth, invasion, and metastasis; 2) modulate cell morphology in vitro; and 3) participate in gonadal steroidogenesis. As such, they are multifunctional proteins (for review, see Ref.855). Studies have shown that Sertoli cells synthesize TIMP-1 (749) and TIMP-2 (750, 859). Further investigation demonstrated that TIMP-2 mRNA increased during testicular development from 3–60 d of age (750). This increase in TIMP-2 expression was not due to an increase in germ cell number during testicular maturation because coculture of germ cells with Sertoli cells failed to elicit changes in TIMP-2 expression (750). Additionally, a recent study has shown that TIMP-1 was significantly induced during the assembly of Sertoli-germ cell anchoring and Sertoli cell tight junctions (48), implicating its significance in junction dynamics. A recent study from this laboratory showed that TIMP-1/MMP-9 interactions are important in determining the amount of collagen that eventually will be under the influence of TNF-{alpha} in the basement membrane (163). Also, it was shown that an antibody against collagen IV or recombinant TNF-{alpha} could perturb the functionality of the Sertoli cell tight junction barrier (163). Based on these observations, it was postulated that the activation of MMP-9 by TNF-{alpha} leads to the cleavage of collagen, releasing biologically active collagen fragments. This, in turn, perturbs Sertoli cell tight junctions, whereas TIMP-1 limits the action of MMP-9 on collagen (163). This suggests that cytokines regulate the homeostasis of the extracellular matrix via their effects on TIMPs and MMPs, which in turn affect tight junction functionality.

On the other hand, TIMP-3 (Mr, 21 kDa) participates in morphological changes that take place during cell transformation (856). Lastly, TIMP-4 has recently been cloned, and its expression was shown to be the highest in the heart (860). Both are also present in the testis (861). These results, taken collectively, illustrate that TIMPs are important regulatory molecules.

{alpha}2-MG, a nonspecific protease inhibitor, is secreted by Sertoli cells (746, 851, 852, 853). Although testicular {alpha}2-MG has the same characteristics as serum {alpha}2-MG (746), their regulation is drastically different (851, 852, 853). For instance, {alpha}2-MG is an acute-phase protein in the liver but not in the testis. It was shown that the concentration of {alpha}2-MG in the systemic circulation increased by approximately 100-fold in response to experimentally induced inflammation, but not in the testis (851, 852), possibly because the blood-testis barrier prohibited the inflammatory stimulus from entering the seminiferous epithelium. Studies have reported the presence of {alpha}2-MG in stages I–VI of the epithelial cycle adjacent to elongating/elongate spermatid heads (237), implicating it in the movement of germ cells across the epithelium. Interestingly, the incubation of germ cell-conditioned media-derived proteins with Sertoli cells increased {alpha}2-MG expression dose-dependently (852, 853), illustrating the significance of Sertoli-germ cell interactions in the regulation of cell movement. Moreover, other studies have suggested that low-density lipoprotein receptor-related protein-1, a Sertoli and Leydig cell protein that mediates the endocytosis of a variety of ligands, is the receptor for {alpha}2-MG (862). {alpha}2-MG is also found in the extracellular matrix where it binds to growth factors and cytokines such as TGF-ß, bFGF, TNF-{alpha}, PDGF, and IL-1 and -6 (863, 864). This provides a pool of cytokines to be used for the regulation of cellular events, such as junction disassembly and assembly. Indeed, a recent study using coimmunoprecipitation has shown that {alpha}2-MG associates with TGF-ß3, as well as with N-cadherin and ß-catenin, but not with ß1 integrin, clearly demonstrating the pivotal role of protease inhibitors in adherens junction dynamics. Collectively, these data illustrate that {alpha}2-MG participates in the movement of germ cells from the basal to the adluminal compartment by regulating paracrine factors in the testis (for review, see Ref.225).

3. Additional comments.
Several studies have shown that the synthesis of proteases and protease inhibitors by cultured Sertoli cells is under paracrine regulation (for review, see Ref.225). This is exemplified best with {alpha}2-MG, a nonspecific protease inhibitor and putative Sertoli cell product (746, 851), whose expression in Sertoli cells was not affected by pituitary hormones, testosterone, or glucocorticoids. However, its expression could be stimulated by coculturing Sertoli cells with either peritubular myoid (865) or germ cells (5, 852, 853). Also, the assembly of adherens junctions between peritubular myoid or germ cells and Sertoli cells may be responsible for this up-regulation. The activity of another protease inhibitor, PAI-1, was also enhanced when Sertoli cells were treated with TGF-ß1, which in turn inhibited PA activity in vitro (719). It would be ideal if the effects of cytokines on proteases and protease inhibitors could be confirmed by using an in vitro model of germ cell movement. However, such a model is presently unavailable. Furthermore, although coculturing germ cells with Sertoli cells can lengthen the viability of germ cells in vitro, permitting for the study of adherens junction assembly (4), the movement of germ cells across the Sertoli cell epithelium has yet to be shown.

E. Regulation of cell junction dynamics in the testis by protein kinases and phosphatases
Protein kinases and phosphatases are known regulators of junction dynamics in both epithelia and endothelia. For instance, it is known that approximately 30% of all cellular proteins are phosphorylated (866) and that phosphorylation of junction-associated proteins is important in the regulation of junction dynamics (for reviews, see Refs.467 , 664 , 867 , and 868). Indeed, proteins such as occludin, cadherin, nectin, catenin, and ß1 integrin are putative substrates of protein tyrosine and/or serine/threonine kinases, and their functions are regulated by phosphorylation at specific sites (for reviews, see Refs.4 , 467 , and 664). For instance, tyrosine phosphorylation of the cadherin-catenin complex has been implicated in the regulation of adherens junctions (for review, see Ref.500). On the other hand, Src (for reviews, see Refs.869 and 870), a putative protein tyrosine kinase, is a signaling molecule that is found in the seminiferous epithelium, including the ectoplasmic specialization (53, 111, 560). In fact, its phosphorylation causes it to become concentrated at the site of adherens junctions (871), specifically at ectoplasmic specializations between elongated spermatids and Sertoli cells before spermiation (111, 560). However, because this junction type is lost at spermiation (Ref.687 ; for reviews, see Refs.3 , 87 , and 554), the localization of Src at the ectoplasmic specialization is not necessarily indicative of its presence within the ectoplasmic specialization structure. Thus, additional studies are needed to confirm whether Src is indeed a constituent of the ectoplasmic specialization.

ß-Catenin, a signaling molecule that regulates adherens junction function, is also a putative substrate of protein tyrosine kinase (516). Apparently, tyrosine phosphorylation of ß-catenin correlates with a loss of cadherin-mediated cell adhesion (515, 516, 517). Moreover, both receptor tyrosine kinases and phosphatases coimmunoprecipitate with components of the cadherin-catenin functional unit, illustrating the participation of protein phosphorylation in the regulation of adherens junction dynamics (872, 873).

Several recent studies have reported that some myotubularins, which belong to a family of putative protein tyrosine and lipid phosphatases, can regulate the events of membrane trafficking (874) by down-regulating and degrading PI 3kinase (875). Interestingly, the expression of myotubularin related protein 2 was shown to be induced when adherens junctions in the seminiferous epithelium were perturbed by treating rats with AF-2364 (C. Y. Cheng, unpublished observations), illustrating once again the importance of protein and lipid phosphorylation in the regulation of cell adhesion in the testis (phosphoinositides are important cellular messengers). It is also known that cell adhesion depends on the phosphorylation status of the cadherin-catenin complex, which is regulated by a number of intracellular signaling molecules such as casein kinase 2 (a serine/threonine protein kinase; for review, see Ref.876), Csk (for review, see Ref.877), Src (for review, see Ref.870), and paxillin (for reviews, see Refs.625 and 878), all of which are found at the site of apical ectoplasmic specializations. Recently, Chapin and colleagues (111, 560) used immunohistochemistry to demonstrate changes in the levels of phosphorylated proteins in the seminiferous epithelium during spermiation. Other studies from our laboratory using inhibitors of protein kinases and phosphatases have shown that the Sertoli cell tight junction barrier is regulated by PKA and PKC (293, 879). Taken collectively, these data demonstrate the significance of kinases and phosphatases in junction dynamics.

Additional reports from our laboratory have clearly defined the physiological significance of kinases and phosphatases in the regulation of both adherens (45, 49) and tight (23, 38) junction dynamics in the testis. For instance, it was shown that Sertoli and/or germ cells are equipped with different kinases such as ILK (559), FAK (49), glycogen synthase kinase-3ß, c-Src, PI 3-kinase (49, 163, 559, 880), and MAPKs (49), some of which regulate Sertoli-germ cell adherens junctions by phosphorylating ß1 integrin. This leads to the activation of the pFAK/glycogen synthase kinase-3ß/p130 Cas/PI 3-kinase signaling pathway (163). Sertoli-germ cell adherens junction dynamics can also be regulated by RhoB via the ROCK/LIM kinase [both are putative protein kinases produced by Sertoli and/or germ cells (45)] signaling pathway.

Although the precise molecular mechanism(s) used by kinases and phosphatases in the seminiferous epithelium remains unclear, these studies have opened up an unprecedented opportunity to investigate how these proteins regulate junction dynamics, as well as cell movement, in the testis. For instance, specific inhibitors can be used to block key molecules in these pathways to determine whether there are any phenotypic changes at the level of cell adhesion. Indeed, the use of a specific ROCK inhibitor, Y-27632, could effectively block AF-2364-induced adherens junction disruption and the subsequent loss of germ cells from the epithelium (45). As such, this area of research needs to be expanded in future studies so that junction dynamics and germ cell movement can be better understood.

F. Regulation of cell junction dynamics in the testis by cAMP and cGMP
Although there are only a few studies that examine the roles of cAMP and cGMP on adherens junction dynamics in the testis, cAMP (the product of adenylate cyclase) has been known to regulate the Sertoli cell tight junction barrier since the 1990s (34). However, it is not known whether cGMP (the product of guanylate cyclase) also has a similar role in the testis. Once studies using protein kinase inhibitors illustrated that PKA and PKC are involved in the regulation of Sertoli cell tight junctions (293), there was some interest to explore the functional significance of these cyclic nucleotides in junction dynamics. Moreover, the role of cAMP in the regulation of epithelial and endothelial tight junction barriers, such as the blood-brain barrier, has been known for decades (for reviews, see Refs.868 and 881). Using Sertoli cells cultured in vitro, dibutyryl cAMP, a cAMP analog that is noncleavable by cAMP phosphodiesterase, was shown to have a biphasic effect on the functionality of the Sertoli cell tight junction barrier. At 4–20 µM or 100–500 µM, dibutyryl cAMP either facilitated or perturbed the tight junction barrier, respectively, suggesting that the effects of cAMP on Sertoli cell tight junctions are concentration dependent (34). Another study demonstrated a transient but significant increase in intracellular cAMP and cGMP levels in Sertoli cells during assembly of the tight junction barrier in vitro (30). Once the tight junction barrier assembled, intracellular cAMP and cGMP levels reduced to their basal levels (30). These results illustrate that whereas cAMP and cGMP may not be required for the maintenance of the Sertoli cell tight junction barrier, they are needed to assemble it. Interestingly, the presence of ZnPP (882), which significantly inhibited intracellular cGMP and NO levels, could also facilitate the assembly of the Sertoli cell tight junction barrier (30), illustrating for the first time the participation of cGMP in tight junction dynamics. Moreover, when Sertoli cells were exposed to 8-bromo-cGMP, a cell membrane-permeable cGMP analog, tight junction functionality was perturbed dose-dependently. Taken collectively, these data illustrate that cAMP and cGMP are important regulators of tight junction barrier function. These results also seemingly suggest that the upstream signaling molecule regulating intracellular cGMP, at least in part, is NO (30). Its effect is likely mediated via changes in tight junction integral membrane proteins because the presence of ZnPP was shown to induce the production of occludin in Sertoli cells (30). These results are supported by an observation from another cell culture system which demonstrated that NO can induce the removal of occludin and ZO-1 from the site of the tight junction, perturbing the functionality of the intestinal tight junction barrier (883). NO-induced disruption of tight junctions in cultured human cervical epithelial cells has also been shown to be mediated via changes in cGMP and PKG (884), which in turn disrupt the homeostasis of intracellular F- and G-actin (884). This leads to destabilization of the epithelium and increased cell permeability. Although these studies need to be expanded, these data have demonstrated that cyclic nucleotides under the regulation of NO play an important role in regulating tight junction dynamics in the testis, which is required for the movement of preleptotene/leptotene spermatocytes across the blood-testis barrier.

G. Regulation of cell junction dynamics in the testis by GTPases
1. Rho GTPases.
Rho GTPases are important regulators of the actin cytoskeleton and, thereby, the morphology and motility of eukaryotic cells (for reviews, see Refs.885, 886, 887, 888). The first report in the literature that implicated GTPases in germ cell movement appeared a decade ago. It demonstrated that the inactivation of Rho GTPases in bovine sperm tail by C3 exoenzyme could significantly inhibit sperm motility (889). More recent immunohistochemistry studies have localized Rac1 to the basal compartment of the seminiferous epithelium predominantly in stage VIII of the epithelial cycle (560), whereas Cdc42 was largely restricted to Sertoli cells, spermatocytes, and elongate spermatids. Another report has shown that RhoB is stage-specific in the rat testis, restricted to the site of basal and apical ectoplasmic specializations and associating largely with Sertoli cells, spermatocytes, and elongating but not elongate spermatids in the epithelium (45). Moreover, a novel protein kinase designated TESK1, found to be restricted almost exclusively to round spermatids (890), was shown to share an approximately 50% homology with LIM kinase (3), a downstream signaling molecule of the Rho GTPase signal transduction pathway (for review, see Ref.448). Subsequent studies have illustrated that TESK1 can stimulate the assembly of actin stress fibers and focal adhesions via phosphorylation of cofilin [an actin-severing protein (891)], another Rho GTPase downstream signal transducer (for review, see Ref.448). It is possible that the movement of germ cells across the seminiferous epithelium may utilize a similar mechanism.

Other Rho effectors (proteins that can activate Rho GTPases), such as citron kinase and protein kinase N, are also found in the testis (892, 893). Just as important, several testis-specific GTPase-activating proteins (GAPs, proteins that stimulate the intrinsic rate of GTP hydrolysis by converting a GTPase from its GTP- to GDP-bound state, thereby inactivating it; for review, see Ref.448), have now been identified. These are {alpha} 2-chimaerin (894), ß-chimaerin (895), and MgcRacGAP (896). Although the precise physiological roles of these GTPase regulatory proteins in germ cell movement remain to be established, these GAPs are restricted largely to germ cells and known to be involved in the reorganization of the cytoskeleton (for review, see Ref.448). Interestingly, another report has shown that Rho GDI–/– mice (guanosine nucleotide dissociation inhibitor, proteins that sequester a GDP-bound GTPase in the cytoplasm and inhibit the dissociation of GDP from it; for review, see Ref.448) were infertile (897). Taken collectively, these studies illustrate the crucial roles of GTPases in the testis and their possible involvement in germ cell movement because the downstream signaling endpoint of these GTPases is the cytoskeleton.

2. Rab GTPases.
Unfortunately, the study of Rab GTPases in the testis continues to be a largely unexplored area of research. Although the presence of several Rab GTPases, such as Rab8B (898), has been demonstrated in the testis, not a single in-depth study exists in which Rab GTPase function is explored in this organ. Several reports have demonstrated the participation of Rab8 in vesicular traffic from the trans-Golgi network to the basolateral plasma membrane (347, 899), whereas other studies have implicated this GTPase in the events of cell movement. For example, the expression of wild-type enhanced green fluorescent protein-Rab8B promoted the reorganization of actin (899, 900). Other published results have shown Rab8 to promote cell polarization, a phenomenon that is essential for the assembly and maintenance of tight (for review, see Ref.294), and possibly adherens junctions in epithelial cells (521, 901). We are currently examining the roles of Rab GTPases in the events of junction assembly and disassembly (50) and propose that selected GTPases function as a "traffic light" (GTP-bound form, green-GO; GDP-bound form, red-STOP) by participating in the delivery of proteins, such as cadherin, to Sertoli-Sertoli and Sertoli-germ cell adherens junctions during their assembly. During disassembly, on the other hand, GTPases move proteins away from tight and adherens junctions. Such a mechanism of protein trafficking is basic to cells when junctions need to be briefly but quickly disassembled and assembled. Indeed, a mechanism responsible for regulating adherens junctions in MDCK cells, which involves the participation of Rab GTPases (for review, see Ref.902), has recently been proposed. Using cell surface biotinylation and recycling assays, Stow and colleagues (514) have shown that the internalization of E-cadherin and ß-catenin after cell adhesion was disrupted by depletion of extracellular calcium. This was followed by their recycling back to the plasma membrane after calcium was repleted in the medium. They also demonstrated that E-cadherin colocalized with Rab5 in early endosomes (514). Other reports have shown that integrins are also recycled via vesicles during cell movement (Refs.903 and 904 ; for reviews, see Refs.905, 906, 907). Moreover, a recent report has placed Rab8B in the forefront of our current research. By coimmunoprecipitation, Rab8B was shown to associate with E-cadherin and {gamma}-catenin but not with ß1 integrin and paxillin (50). Rab8B was also found to localize to the site of basal and apical ectoplasmic specializations by immunohistochemistry (50), confirming results obtained from coimmunoprecipitation experiments. In addition, Rab8B increased during the assembly of Sertoli-germ cell adherens junctions (50). These observations implicate GTPases in the dynamics of adherens junctions. Future studies should address whether a disruption of adherens junctions during the movement of germ cells involves a similar mechanism.

H. Regulation of cell junction dynamics in the testis by calcium
Calcium plays an important role in junction dynamics (for reviews, see Refs.908, 909, 910). However, virtually all of the studies investigating the physiological significance of calcium in junction dynamics were performed using nontesticular cell types. For instance, depletion of calcium from the media of MDCK cultures was shown to perturb the tight junction barrier within minutes. Once calcium was replaced, the disrupted tight junction barrier rapidly resealed, illustrating the importance of calcium in tight junction dynamics (for review, see Ref.911). A similar study from our laboratory has shown that depletion of calcium from Sertoli cells cultured in vitro can also disrupt tight junction barrier function within 15 min, which was followed by its resealing within 90 min after the replacement of calcium (57). In this context, it is also of interest to note that the inclusion of an anti-E-cadherin antibody into the media of MDCK cultures prevented resealing of the disrupted tight junction barrier (156, 912). In the absence of calcium, cadherins also became susceptible to proteolysis (for reviews, see Refs.458 , 908 , and 913). These data demonstrate that calcium is an important regulator of junction dynamics, functioning with molecules that confer cell adhesion (for review, see Ref.4).


    V. Concluding Remarks
 Top
 Abstract
 I. Introduction
 II. Sertoli Cells
 III. Sertoli-Sertoli and Sertoli...
 IV. Mechanism of Germ...
 V. Concluding Remarks
 References
 
The study of Sertoli-germ cell interactions during the 1980s and 1990s focused largely on proteins produced by either Sertoli or germ cells using approaches such as testicular cell or seminiferous tubule cultures, two-dimensional gel electrophoresis, SDS-PAGE, and HPLC (for reviews, see Refs.4 , 8 , 10, 11, 12 , 131 , and 134). Because Sertoli-germ cell interactions affect spermatogenesis at the molecular, cellular, and biochemical levels, this continues to be an important area of research. However, in the past decade attention has largely shifted to the study of cell junction dynamics. This stems from the fact that communication between these cells takes place at the level of cell-cell contact, which in turn affects Sertoli and germ cell function. With recent advances in cell biology, a new protein having an important structural, signaling, or trafficking role in tight or anchoring junctions is identified almost weekly. Unfortunately, studies that examine junction regulation as it relates to spermatogenesis and germ cell movement lag far behind similar investigations conducted in other epithelia. In other words, almost all of the research conducted in the testis thus far has only replicated studies performed in other epithelia (e.g., MDCK cells, keratinocytes, and fibroblasts), some of which were published over a decade ago (for review, see Ref.4).

As reviewed in this article, junctions are platforms for signal transduction events (for reviews, see Refs.4 , 458 , 467 , and 914, 915, 916). Signaling events not only can alter the integrity of tight and adherens junctions, but can also be relayed to the nucleus to change transcriptional activity. More importantly, most of these studies have significantly impacted our understanding of junction restructuring during germ cell movement, in that they have provided innovative concepts for the development of safe and effective male contraceptives. AF-2364 is an example of such an effort (for review, see Ref.4). Currently, it is known that AF-2364 exerts its effects by compromising cell adhesion in the testis by targeting the multiprotein complex that comprises the ectoplasmic specialization (45, 49, 50, 54, 666, 667). Taken collectively, these results demonstrate that a thorough understanding of the biochemical architecture of tight and anchoring junctions and the signaling pathways that regulate them is crucial to the development of new male contraceptives, in addition to those that are currently being investigated (for reviews, see Refs.917 and 918).

In this review, we have discussed the biology of tight (e.g., blood-testis barrier) and adherens (e.g., ectoplasmic specialization) junctions in the testis, highlighting specific areas that deserve future investigation. We have also described several key observations that were obtained when different in vitro and in vivo models of junction disassembly and assembly were used. Lastly, we have proposed a new model of germ cell movement in the seminiferous epithelium based on recent research from other laboratories, as well as ours, which takes into account the roles of tight and adherens junction-associated proteins, cytokines, proteases and their inhibitors, GTPases, kinases and phosphatases, and other autocrine and paracrine factors. This model will likely serve as a framework for future investigators whose aim will be to delineate the biology and regulation of germ cell movement during spermatogenesis. Thus, it will be continuously updated as more information becomes available in the years to come.


    Acknowledgments
 
The authors sincerely thank Miss Anne M. Conway (Population Council) for her expertise in performing the immunofluorescence microscopy experiments. We also thank Ms. Eleana Sphicas at the Bio-Imaging Resource Center, The Rockefeller University (New York, NY), for her assistance in electron microscopy studies.


    Footnotes
 
This work from the authors’ laboratory was supported in part by grants from the National Institutes of Health (National Institute of Child Health & Human Development, U01 HD45908, U54 HD29990, and U54 HD13541), the CONRAD Program (Consortium for Industrial Collaboration in Contraceptive Research, CIG-01–72, CIG-96–05-A/-B, and CIG-01–74), and the Noopolis Foundation.

Abbreviations: ACE, Angiotensin-converting enzyme; AF-2364, 1-(2,4-dichlorobenzyl)-indazole-3-carbohydrazide (also known as Adjudin); AF-6, ALL-1 fusion partner from chromosome 6; ASH1, absent, small, or homeotic 1; ASIP, atypical PKC isotype-specific interacting protein; bFGF, basic FGF; CAR, coxsackievirus and adenovirus receptor; cGMP, cyclic GMP; CRB1, Crumbs homolog 1; Csk, C-terminal Src-kinase; ECH, NF-E2 (also known as p45)-related molecule, alternative names for ECH are Nrf2 or NF-B2 related factor-2; EGF, epidermal growth factor; eNOS, endothelial NOS; FAK, focal adhesion kinase; FGF, fibroblast growth factor; FITC, fluorescein isothiocyanate; GAP, GTPase-activating protein; HGF, hepatocyte growth factor; IFN, interferon; ILK, integrin-linked kinase; iNOS, inducible NOS; JAM, junctional adhesion molecule; JEAP, junction-enriched and -associated protein; Keap1, kelch-like ECH-associating protein 1; LIM, Lin-11, Isl-1, and Mec-3; MAGI, MAGUKs with inverted orientation; MAGUK, membrane-associated guanylate kinase; MDCK, Madin-Darby canine kidney; {alpha}2-MG, {alpha}2-macroglobulin; MME, membrane metalloendopeptidase; MMP-9, matrix metalloprotease-9; Mr, molecular mass; MUPP1, multi-PDZ domain protein 1; NEP, neprilysin; NF, neurofilament; NO, nitric oxide; NOS, NO synthase; NRD, N-arginine dibasic; PA, plasminogen activator; PAI, PA inhibitor; Pals, proteins associated with Lin-7; PAR, partitioning-defective; PDGF, platelet-derived growth factor; PDZ, postsynaptic density-95/Discs-large/ZO-1; pFAK, phosphorylated FAK; PI 3-kinase, phosphoinositide 3-kinase (also known as phosphatidylinositol 3 kinase); PKA, protein kinase A; PKC, protein kinase C; PKG, protein kinase G; PTEN, phosphatase and tensin homolog deleted on chromosome 10; ROCK, Rho-associated protein kinase; SF, scatter factor; SH3, src-homology region 3; TER, transepithelial electrical resistance; TIMP-1, tissue inhibitor of metalloproteases-1; u-PA, urokinase-type PA; VASP, vasodilator-stimulated phosphoprotein; Y-27632, (R)-(+)-trans-N-(4-pyridyl)-4-(1-aminoethyl) cyclohexane-carboxamide, 2HCl; ZnPP, zinc II protoporphyrin-IX; ZO, zonula occludens.


    References
 Top
 Abstract
 I. Introduction
 II. Sertoli Cells
 III. Sertoli-Sertoli and Sertoli...
 IV. Mechanism of Germ...
 V. Concluding Remarks
 References
 

  1. Setchell BP, Waites GMB 1975 The blood-testis barrier. In: Hamilton DW, Greep RO, eds. The handbook of physiology. Baltimore: Williams and Wilkens; 143–172
  2. Russell LD 1977 Movement of spermatocytes from the basal to the adluminal compartment of the rat testis. Am J Anat 148:313–328[CrossRef][Medline]
  3. de Kretser DM, Kerr JB1988 The cytology of the testis. In: Knobil E, Neill JB, Ewing LL, Greenwald GS, Markert CL, Pfaff DW, eds. The physiology of reproduction. New York: Raven Press; 837–932
  4. Cheng CY, Mruk DD 2002 Cell junction dynamics in the testis: Sertoli-germ cell interactions and male contraceptive development. Physiol Rev 82:825–874[Abstract/Free Full Text]
  5. Mruk D, Zhu LJ, Silvestrini B, Lee WM, Cheng CY 1997 Interactions of proteases and protease inhibitors in Sertoli-germ cell cocultures preceding the formation of specialized Sertoli-germ cell junctions in vitro. J Androl 18:612–622[Abstract/Free Full Text]
  6. Russell LD 1993 Role in spermiation. In: Russell LD, Griswold MD, eds. The Sertoli cell. Clearwater, FL: Cache River Press; 269–303
  7. Vogl AW, Pfeiffer DC, Redenbach DM, Grove BD 1993 Sertoli cell cytoskeleton. In: Russell LD, Griswold MD, eds. The Sertoli cell. Clearwater, FL: Cache River Press; 39–86
  8. Skinner MK 1991 Cell-cell interactions in the testis. Endocr Rev 12:45–77[Abstract/Free Full Text]
  9. Skinner MK 1993 Secretion of growth factors and other regulatory factors. In: Russell LD, Griswold MD, eds. The Sertoli cell. Clearwater, FL: Cache River Press; 237–247
  10. Jegou B 1993 The Sertoli-germ cell communication network in mammals. Int Rev Cytol 147:25–96[Medline]
  11. Mruk D, Cheng CY 2000 Sertoli cell proteins in testicular paracriny. In: Jegou B, Pineau C, Saez J, eds. Testis, epididymis, and technologies in the year 2000. Berlin: Springer-Verlag; 197–228
  12. Skinner MK, Norton JN, Mullaney BP, Rosselli M, Whaley PD, Anthony CT 1991 Cell-cell interactions and the regulation of testis function. Ann NY Acad Sci 637:354–363[Medline]
  13. Lodish H, Berk A, Zipursky SL, Matsudaira P, Baltimore D, Darnell J 1999 Molecular cell biology. 4th ed. New York: WH Freeman and Co.
  14. Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P 2002 Molecular biology of the cell. 4th ed. New York: Garland Science
  15. Byers S, Jegou B, MacCalman C, Blaschuk O 1993 Sertoli cell adhesion molecules and the collective organization of the testis. In: Russell LD, Griswold MD, eds. The Sertoli cell. Clearwater, FL: Cache River Press; 461–476
  16. Byers S, Pelletier RM, Suarez-Quain C 1993 Sertoli cell junctions and the seminiferous epithelium barrier. In: Russell LD, Griswold MD, eds. The Sertoli cell. Clearwater, FL: Cache River Press; 431–446
  17. Enders GC 1993 Sertoli-Sertoli and Sertoli-germ cell communications. In: Russell LD, Griswold MD, eds. The Sertoli cell. Clearwater, FL: Cache River Press; 447–460
  18. Russell LD 1993 Morphological and functional evidence for Sertoli-germ cell relationships. In: Russell LD, Griswold MD, eds. The Sertoli cell. Clearwater, FL: Cache River Press; 365–390
  19. Vogl A, Pfeiffer D, Redenbach D 1991 Ectoplasmic ("junctional") specializations in mammalian Sertoli cells: influence on spermatogenic cells. Ann NY Acad Sci 637:175–202[Medline]
  20. Vogl AW, Pfeiffer DC, Mulholland D, Kimel G, Guttman J 2000 Unique and multifunctional adhesion junctions in the testis: ectoplasmic specializations. Arch Histol Cytol 63:1–15[CrossRef][Medline]
  21. Dym M 1994 Basement membrane regulation of Sertoli cells. Endocr Rev 15:102–115[Abstract/Free Full Text]
  22. Lui WY, Lee WM, Cheng CY 2001 Transforming growth factor-ß3 perturbs the inter-Sertoli tight junction permeability barrier in vitro possibly mediated via its effects on occludin, zonula occludens-1, and claudin-11. Endocrinology 142:1865–1877[Abstract/Free Full Text]
  23. Lui WY, Lee WM, Cheng CY 2003 Transforming growth factor-ß3 regulates the dynamics of Sertoli cell tight junctions via the p38 mitogen-activated protein kinase pathway. Biol Reprod 68:1597–1612[Abstract/Free Full Text]
  24. Wong CCS, Chung SSW, Grima J, Zhu LJ, Mruk D, Lee WM, Cheng CY 2000 Changes in the expression of junctional and nonjunctional complex component genes when inter-Sertoli tight junctions are formed in vitro. J Androl 21:227–237[Abstract]
  25. Chung SS, Lee WM, Cheng CY 1999 Study on the formation of specialized inter-Sertoli cell junctions in vitro. J Cell Physiol 181:258–272[CrossRef][Medline]
  26. Mruk D, Cheng CY 1999 Sertolin is a novel gene marker of cell-cell interactions in the rat testis. J Biol Chem 274:27056–27068[Abstract/Free Full Text]
  27. Chung NPY, Cheng CY 2001 Is cadmium chloride-induced inter-Sertoli tight junction permeability barrier disruption a suitable in vitro model to study the events of junction disassembly during spermatogenesis in the rat testis? Endocrinology 142:1878–1888[Abstract/Free Full Text]
  28. Janecki A, Jakubowiak A, Steinberger A 1992 Effect of cadmium chloride on transepithelial electrical resistance of Sertoli cell monolayers in two-compartment cultures: a new model for toxicological investigations of the "blood-testis" barrier in vitro. Toxicol Appl Pharmacol 112:51–57[CrossRef][Medline]
  29. Okanlawon A, Dym M 1996 Effect of chloroquine on the formation of tight junctions in cultured immature rat Sertoli cells. J Androl 17:249–255[Abstract/Free Full Text]
  30. Lee NPY, Cheng CY 2003 Regulation of Sertoli cell tight junction dynamics in the rat testis via the nitric oxide synthase/soluble guanylate cyclase/3',5'-cyclic guanosine monophosphate/protein kinase G signaling pathway: an in vitro study. Endocrinology 144:3114–3129[Abstract/Free Full Text]
  31. Byers S, Hadley MA, Djakiew D, Dym M 1986 Growth and characterization of epididymal epithelial cells and Sertoli cells in dual environment culture chambers. J Androl 7:59–68[Abstract/Free Full Text]
  32. Janecki A, Steinberger A 1986 Polarized Sertoli cell functions in a new two-compartment culture system. J Androl 7:69–71[Abstract/Free Full Text]
  33. Janecki A, Jakubowiak A, Steinberger A 1991 Regulation of transepithelial electrical resistance in two-compartment Sertoli cell cultures: in vitro model of the blood-testis barrier. Endocrinology 129:1489–1496[Abstract/Free Full Text]
  34. Janecki A, Jakubowiak A, Steinberger A 1991 Effects of cyclic AMP and phorbol ester on transepithelial electrical resistance of Sertoli cell monolayers in two-compartment culture. Mol Cell Endocrinol 82:61–69[CrossRef][Medline]
  35. Djakiew D, Onoda M 1993 Multichamber cell culture and directional secretion. In: Russell LD, Griswold MD, eds. The Sertoli cell. Clearwater, FL: Cache River Press; 181–194
  36. Grima J, Pineau C, Bardin CW, Cheng CY 1992 Rat Sertoli cell clusterin, {alpha}2-macroglobulin, and testins: biosynthesis and differential regulation by germ cells. Mol Cell Endocrinol 89:127–140[CrossRef][Medline]
  37. Grima J, Cheng CY 2000 Testin induction: the role of cyclic 3',5'-adenosine monophosphate/protein kinase A signaling in the regulation of basal and lonidamine-induced testin expression by rat Sertoli cells. Biol Reprod 63:1648–1660[Abstract/Free Full Text]
  38. Lui WY, Wong CH, Mruk DD, Cheng CY 2003 TGF-ß3 regulates the blood-testis barrier dynamics via the p38 mitogen activated protein (MAP) kinase pathway: an in vivo study. Endocrinology 144:1139–1142[Abstract/Free Full Text]
  39. Wong CH, Mruk DD, Lui WY, Cheng CY 2004 Regulation of blood-testis barrier dynamics: an in vivo study. J Cell Sci 117:783–798[Abstract/Free Full Text]
  40. Hew KW, Heath GL, Jiwa AH, Welsh MJ 1993 Cadmium in vivo causes disruption of tight junction-associated microfilaments in rat Sertoli cells. Biol Reprod 49:840–849[Abstract]
  41. Hew KW, Ericson WA, Welsh MJ 1993 A single low cadmium dose causes failure of spermiation in the rat. Toxicol Appl Pharmacol 121:15–21[CrossRef][Medline]
  42. Wiebe JP, Kowalik A, Gallardi RL, Egeler O, Clubb BH 2000 Glycerol disrupts tight junction-associated actin microfilaments, occludin, and microtubules in Sertoli cells. J Androl 21:625–635[Abstract]
  43. Chung NP, Mruk D, Mo MY, Lee WM, Cheng CY 2001 A 22-amino acid synthetic peptide corresponding to the second extracellular loop of rat occludin perturbs the blood-testis barrier and disrupts spermatogenesis reversibly in vivo. Biol Reprod 65:1340–1351[Abstract/Free Full Text]
  44. Lui WY, Mruk D, Lee WM, Cheng CY 2003 Sertoli cell tight junction dynamics: their regulation during spermatogenesis. Biol Reprod 68:1087–1097[Abstract/Free Full Text]
  45. Lui WY, Lee WM, Cheng CY 2003 Sertoli-germ cell adherens junction dynamics in the testis are regulated by RhoB GTPase via the ROCK/LIMK signaling pathway. Biol Reprod 68:2189–2206[Abstract/Free Full Text]
  46. Chung SS, Mo MY, Silvestrini B, Lee WM, Cheng CY 1998 Rat testicular N-cadherin: its complementary deoxyribonucleic acid cloning and regulation. Endocrinology 139:1853–1862[Abstract/Free Full Text]
  47. Chung SS, Zhu LJ, Mo MY, Silvestrini B, Lee WM, Cheng CY 1998 Evidence for cross-talk between Sertoli and germ cells using selected cathepsins as markers. J Androl 19:686–703[Abstract/Free Full Text]
  48. Mruk DD, Siu MKY, Conway AM, Lee NPY, Lau ASN, Cheng CY 2003 Role of tissue inhibitor of metalloproteases-1 in junction dynamics in the testis. J Androl 24:510–523[Abstract/Free Full Text]
  49. Siu MKY, Mruk DD, Lee WM, Cheng CY 2003 Adhering junction dynamics in the testis are regulated by an interplay of ß1-integrin and focal adhesion complex (FAC)-associated proteins. Endocrinology 144:2141–2163[Abstract/Free Full Text]
  50. Lau ASN, Mruk DD 2003 Rab8B GTPase and junction dynamics in the testis. Endocrinology 144:1549–1563[Abstract/Free Full Text]
  51. Cameron DF, Muffly KE 1991 Hormonal regulation of spermatid binding. J Cell Sci 100:623–633[Abstract/Free Full Text]
  52. Enders GC, Millette CF 1988 Pachytene spermatocytes and round spermatid binding to Sertoli cells in vitro. J Cell Sci 90:105–114[Abstract/Free Full Text]
  53. Lee NPY, Mruk D, Lee WM, Cheng CY 2003 Is the cadherin/catenin complex a functional unit of cell-cell-actin-based adherens junctions (AJ) in the rat testis? Biol Reprod 68:489–508[Abstract/Free Full Text]
  54. Chen YM, Lee NPY, Mruk DD, Lee WM, Cheng CY 2003 Fer kinase/Fer T and adherens junction dynamics in the testis: an in vitro and in vivo study. Biol Reprod 69:656–672[Abstract/Free Full Text]
  55. McLachlan RI, O’Donnell L, Meachem SJ, Stanton PG, de Kretser DM, Pratis K, Robertson DM 2002 Hormonal regulation of spermatogenesis in primates and man: insights for development of the male hormonal contraceptive. J Androl 23:149–162[Medline]
  56. Zamir E, Geiger B 2001 Molecular complexity and dynamics of cell-matrix adhesions. J Cell Sci 114:3583–3590
  57. Grima J, Wong CCS, Zhu LJ, Zong SD, Cheng CY 1998 Testin secreted by Sertoli cells is associated with the cell surface, and its expression correlates with the disruption of Sertoli-germ cell junctions but not the inter-Sertoli tight junction. J Biol Chem 273:21040–21053[Abstract/Free Full Text]
  58. Tsukita S, Furuse M, Itoh M 2001 Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2:285–293[CrossRef][Medline]
  59. Nagafuchi A 2001 Molecular architecture of adherens junctions. Curr Opin Cell Biol 13:600–603[CrossRef][Medline]
  60. Lui WY, Mruk D, Lee WM, Cheng CY 2003 Adherens junction dynamics in the testis and spermatogenesis. J Androl 24:1–14[Free Full Text]
  61. Russell LD 1980 Sertoli-germ cell interrelations: a review. Gamete Res 3:179–202
  62. Bardin CW, Cheng CY, Musto NA, Gunsalus GL 1988 The Sertoli cell. In: Knobil E, Neill JD, Ewing LL, Greenwald GS, Markert CL, Pfaff DW, eds. The physiology of reproduction. New York: Raven Press; 933–974
  63. Bardin CW, Gunsalus GL, Cheng CY 1993 The cell biology of the Sertoli cell. In: Desjardins C, Ewing LL, eds. Cell and molecular biology of the testis. New York: Oxford University Press; 189–219
  64. Griswold MD, Morales C, Sylvester SR 1988 Molecular biology of the Sertoli cell. Oxf Rev Reprod Biol 10:124–161[Medline]
  65. de Kretser DM 1990 Germ cell-Sertoli cell interactions. Reprod Fertil Dev 2:225–235[CrossRef][Medline]
  66. Jegou B 1992 The Sertoli cell. Baillieres Clin Endocrinol Metab 6:273–311[CrossRef][Medline]
  67. Morales C, Clermont Y 1993 Structural changes of the Sertoli cell during the cycle of the seminiferous epithelium. In: Russell LD, Griswold MD, eds. The Sertoli cell. Clearwater, FL: Cache River Press; 305–329
  68. Wright WW 1993 Cellular interactions in the seminiferous epithelium. In: Desjardins C, Ewing LL, eds. Cell and molecular biology of the testis. New York: Oxford University Press; 377–399
  69. Griswold MD 1998 The central role of Sertoli cells in spermatogenesis. Semin Cell Dev Biol 9:411–416[CrossRef][Medline]
  70. Russell LD 1993 Form, dimensions, and cytology of mammalian Sertoli cells. In: Russell LD, Griswold MD, eds. The Sertoli cell. Clearwater, FL: Cache River Press; 1–37
  71. Wong V, Russell LD 1983 Three-dimensional reconstruction of a rat stage V Sertoli cell. I. Methods, basic configuration, and dimensions. Am J Anat 167:143–161[CrossRef][Medline]
  72. Russell LD, Ren HP, Sinha Hikim I, Schulze W, Sinha Hikim AP 1990 A comparative study in twelve mammalian species of volume densities, volumes, and numerical densities of selected testis components, emphasizing those related to the Sertoli cell. Am J Anat 188:21–30[CrossRef][Medline]
  73. Weber JE, Russell LD, Wong V, Paterson RN 1983 Three dimensional reconstruction of a rat stage V Sertoli cell. II. Morphometry of Sertoli-Sertoli and Sertoli-germ cell relationships. Am J Anat 167:163–179[CrossRef][Medline]
  74. Fawcett DW 1975 Ultrastructure and function of the Sertoli cell. In: Hamilton DW, Greep RO, eds. Handbook of physiology. Washington DC: American Physiological Society; 21–25
  75. Parvinen M 1982 Regulation of the seminiferous epithelium. Endocr Rev 3:404–417[Abstract/Free Full Text]
  76. Vogl AW 1989 Distribution and function of organized concentrations of actin filaments in mammalian spermatogenic cells and Sertoli cells. Int Rev Cytol 119:1–56[Medline]
  77. Pollard S 1990 Actin. Curr Opin Cell Biol 2:33–40[Medline]
  78. Theriot JA 2000 The polymerization motor. Traffic 1:19–28[CrossRef][Medline]
  79. Engel JN, Gunning PW, Kedes L 1981 Isolation and characterization of human actin genes. Proc Natl Acad Sci USA 78:4674–4678[Abstract/Free Full Text]
  80. Hightower RC, Meagher RB 1986 The molecular evolution of actin. Genetics 114:315–332[Abstract/Free Full Text]
  81. Ayscough KR 1998 In vivo functions of actin-binding proteins. Curr Opin Cell Biol 10:102–111[CrossRef][Medline]
  82. Chen H, Bernstein BW, Bamburg JR 2000 Regulating actin-filament dynamics in vivo. Trends Biochem Sci 25:19–23[CrossRef][Medline]
  83. Lee NPY, Mruk DD, Conway AM, Cheng CY 2004 Zyxin, axin, and Wiskott-Aldrich syndrome protein are adaptors that link the cadherin/catenin protein complex to the cytoskeleton at adherens junctions in the seminiferous epithelium of the rat testis. J Androl 25:200–215[Abstract/Free Full Text]
  84. Tanaka H, Iguchi N, de Carvalho C, Tadokoro Y, Yomogida K, Nishimune Y 2003 Novel actin-like proteins T-ACTIN and TACTIN 2 are differentially expressed in the cytoplasm and nucleus of mouse haploid germ cells. Biol Reprod 69:475–482[Abstract/Free Full Text]
  85. Fuchs E, Karakesisoglou I 2001 Bridging cytoskeletal intersections. Genes Dev 15:1–14[Free Full Text]
  86. Coulombe PA, Omary MB 2002 ‘Hard’ and ‘soft’ principles defining the structure, function, and regulation of keratin intermediate filaments. Curr Opin Cell Biol 14:110–122[CrossRef][Medline]
  87. Russell LD, Peterson RN 1985 Sertoli cell junctions: morphological and functional correlates. Int J Cytol 94:177–211[CrossRef]
  88. Goldman R, Goldman A, Green K, Jones J, Lieska N, Yang HY 1985 Intermediate filaments: possible functions as cytoskeletal connecting links between the nucleus and the cell surface. Ann NY Acad Sci 455:1–17[CrossRef][Medline]
  89. Klymkowsky MW, Bachant JB, Domingo A 1989 Functions of intermediate filaments. Cell Motil Cytoskeleton 14:309–331[CrossRef][Medline]
  90. Aumuller G, Schulze C, Viebahn C 1992 Intermediate filaments in Sertoli cells. Microsc Res Tech 20:50–72[CrossRef][Medline]
  91. Paranko J, Kallajoki M, Pelliniemi LJ, Lehto VP, Virtanen I 1986 Transient coexpression of cytokeratin and vimentin in differentiating rat Sertoli cells. Dev Biol 117:35–44[CrossRef][Medline]
  92. Stosiek P, Kasper M, Karsten U 1990 Expression of cytokeratins 8 and 18 in human Sertoli cells of immature and atrophic seminiferous tubules. Differentiation 43:66–70[CrossRef][Medline]
  93. Fridmacher V, Locquet O, Magre S 1992 Differential expression of acidic cytokeratins 18 and 19 during sexual differentiation of the rat gonad. Development 115:503–517[Abstract]
  94. Fridmacher V, Le Bert M, Guillou F, Magre S 1995 Switch in the expression of the K19/K18 keratin genes as a very early evidence of testicular differentiation in the rat. Mech Dev 52:199–207[CrossRef][Medline]
  95. Appert A, Fridmacher V, Locquet O, Magre S 1998 Patterns of keratins 8, 18 and 19 during gonadal differentiation in the mouse: sex- and time-dependent expression of keratin 19. Differentiation 63:273–284[Medline]
  96. Franke WW, Grund C, Schmid E 1979 Intermediate-sized filaments present in Sertoli cells are of the vimentin type. Eur J Cell Biol 19:269–275[Medline]
  97. Holash JA, Harik SI, Perry G, Stewart PA 1993 Barrier properties of testis microvessels. Proc Natl Acad Sci USA 90:11069–11073[Abstract/Free Full Text]
  98. Davidoff MS, Middendorff R, Muller D, Kofuncu E, Holstein AF 1997 Immunoreactivity for glial cell markers in the human testis. Adv Exp Med Biol 424:151–152[Medline]
  99. Frojdman K, Pelliniemi LJ, Lendahl U, Virtanen I, Eriksson JE 1997 The intermediate filament protein nestin occurs transiently in differentiating testis of rat and mouse. Differentiation 61:243–249[Medline]
  100. Zhu LJ, Zong SD, Phillips DM, Moo-Young AJ, Bardin CW 1997 Changes in the distribution of intermediate filaments in rat Sertoli cells during the seminiferous epithelium cycle and postnatal development. Anat Rec 248:391–405[CrossRef][Medline]
  101. Davidoff MS, Middendorff R, Pusch W, Muller D, Wichers S, Holstein AF 1999 Sertoli and Leydig cells of the human testis express neurofilament triplet proteins. Histochem Cell Biol 111:173–187[CrossRef][Medline]
  102. Benavente R, Krohne G 1985 Change in karyoskeleton during spermatogenesis of Xenopus: expression of lamin LIV, a nuclear lamina protein specific for the male germ line. Proc Natl Acad Sci USA 82:6176–6180[Abstract/Free Full Text]
  103. Moss SB, Burnham BL, Bellve AR 1993 The differential expression of lamin epitopes during mouse spermatogenesis. Mol Reprod Dev 34:164–174[CrossRef][Medline]
  104. Dutcher SK 2001 Motile organelles: the importance of specific tubulin isoforms. Curr Biol 11:R419–R422
  105. Oakley BR 2000 An abundance of tubulins. Trends Cell Biol 10:537–542[CrossRef][Medline]
  106. Small JV 1989 Microfilament-based motility in non-muscle cells. Curr Opin Cell Biol 1:75–79[CrossRef][Medline]
  107. Kelly RB 1990 Association between microtubules and intracellular organelles. Curr Opin Cell Biol 2:105–108[Medline]
  108. Kelly RB 1990 Microtubules, membrane traffic, and cell organization. Cell 61:5–7[CrossRef][Medline]
  109. Vogl AW 1988 Changes in the distribution of microtubules in rat Sertoli cells during spermatogenesis. Anat Rec 222:34–41[CrossRef][Medline]
  110. Amlani S, Vogl AW 1988 Changes in the distribution of microtubules and intermediate filaments in mammalian Sertoli cells during spermatogenesis. Anat Rec 220:143–160[CrossRef][Medline]
  111. Wine RN, Chapin RE 1999 Adhesion and signaling proteins spatiotemporally associated with spermiation in the rat. J Androl 20:198–213[Abstract/Free Full Text]
  112. Dym M, Fawcett DW 1970 The blood-testis barrier in the rat and the physiological compartmentation of the seminiferous epithelium. Biol Reprod 3:308–326[Abstract]
  113. Dym M, Cavicchia JC 1977 Further observations on the blood-testis barrier in monkeys. Biol Reprod 17:390–403[Abstract]
  114. Russell LD 1978 The blood-testis barrier and its formation relative to spermatocyte maturation in the adult rat: a lanthanum tracer study. Anat Rec 190:99–112[CrossRef][Medline]
  115. Pelletier RM, Byers SW 1992 The blood-testis barrier and Sertoli cell junctions: structural considerations. Microsc Res Tech 20:3–33[CrossRef][Medline]
  116. Gondos B, Berndston WE 1993 Postnatal and pubertal development. In: Russell LD, Griswold MD, eds. The Sertoli cell. Clearwater, FL: Cache River Press; 115–154
  117. Pelletier RM 1997 Blood-tissue barriers in the male reproductive system. In: Martinez-Garcia F, Regadera J, eds. Progress in biology and pathology on male reproduction. London: Churchill Livingstone; 183–195
  118. Pelletier RM 2001 The tight junctions in the testis, epididymis, and vas deferens. In: Cereijido M, Anderson J, eds. Tight junctions. New York: CRC Press; 599–628
  119. Cavicchia JC, Sacerdote FL 1988 Topography of the rat blood-testis barrier after intratubular administration of intercellular tracers. Tissue Cell 20:577–586[CrossRef][Medline]
  120. Setchell BP 1980 The functional significance of the blood-testis barrier. J Androl 1:3–10
  121. Setchell BP 1998 Blood-testis barrier. In: Knobil E, Neill JD, eds. Encyclopedia of reproduction. New York: Academic Press; 375–381
  122. Voglmayr JK, Waites GMH, Setchell BP 1966 Studies on spermatozoa and fluid collected directly from the testis of the conscious ram. Nature 210:861–863[Medline]
  123. Waites GM, Gladwell RT 1982 Physiological significance of fluid secretion in the testis and blood-testis barrier. Physiol Rev 62:624–671[Free Full Text]
  124. Turner TT, Jones CC, Howards SS, Ewing LL, Zegeye B, Gunsalus GL 1984 On the androgen microenvironment of maturing spermatozoa. Endocrinology 115:1925–1932[Abstract/Free Full Text]
  125. Waites GMH, Jones AR, Main SJ, Cooper TG 1973 The entry of antifertility and other drugs into the testis. Adv Biosci 10:101–106[Medline]
  126. Setchell BP, Hinton BT, Jacks F, Davies RV 1976 The restricted penetration of iodinated rat FSH and LH into the seminiferous tubules of the rat testis. Mol Cell Endocrinol 6:59–69[CrossRef][Medline]
  127. Setchell BP, Davies RV, Gladwell RT, Hinton BT, Main SJ, Pilsworth L, Waites GMH 1978 The movement of fluid in the seminiferous tubules and rete testis. Ann Biol Anim Biochim Biophys 18:623–632
  128. Setchell BP, Laurie MS, Main SJ, Goats GC 1978 The mechanism of transport of testosterone through the walls of the seminiferous tubules of the rat testis. Int J Androl (Suppl) 2:506–512
  129. Kissinger C, Skinner MK, Griswold MD 1982 Analysis of Sertoli cell-secreted proteins by two-dimensional gel electrophoresis. Biol Reprod 27:233–240[Abstract]
  130. Mather JP, Gunsalus GL, Musto NA, Cheng CY, Parvinen M, Wright W, Perez-Infante V, Margioris A, Liotta A, Becker R, Krieger DT, Bardin CW 1983 The hormonal and cellular control of Sertoli cell secretion. J Steroid Biochem 19:41–51[Medline]
  131. Griswold MD 1988 Protein secretions of Sertoli cells. Int Rev Cytol 110:133–156[Medline]
  132. de Kretser DM 1990 Germ cell-Sertoli cell interactions. Reprod Fertil Dev 2:225–235[CrossRef][Medline]
  133. Griswold MD 1993 Protein secretion by Sertoli cells: general considerations. In: Russell LD, Griswold MD, eds. The Sertoli cell. Clearwater, FL: Cache River Press; 195–200
  134. Griswold MD 1995 Interactions between germ cells and Sertoli cells in the testis. Biol Reprod 52:211–216[Abstract]
  135. Sharpe RM 1988 Bidirectional secretion by the Sertoli cell. Int J Androl 11:87–91[Medline]
  136. Sylvester SR, Griswold MD 1993 Molecular biology of iron transport in the testis. In: de Kretser D, ed. Molecular biology of the male reproductive system. San Diego; Academic Press; 311–326
  137. Thorbecke GJ, Liem HH, Knight S, Cox K, Muller-Eberhard U 1973 Sites of formation of the serum proteins transferrin and hemopexin. J Clin Invest 52:725–731[Medline]
  138. Skinner MK, Griswold MD 1980 Sertoli cells synthesize and secrete transferrin-like protein. J Biol Chem 255:9523–9525[Abstract/Free Full Text]
  139. Sylvester SR, Griswold MD 1994 The testicular iron shuttle: a "nurse" function of the Sertoli cells. J Androl 15:381–385[Abstract/Free Full Text]
  140. Djakiew D, Dym M 1988 Pachytene spermatocyte proteins influence Sertoli cell function. Biol Reprod 39:1193–1205[Abstract]
  141. Le Magueresse-Battistoni B, Pineau C, Guillou F, Jegou B 1988 Influence of germ cells upon transferrin secretion by rat Sertoli cells in vitro. J Endocrinol 118:R13–R16
  142. Stallard BJ, Griswold MD 1990 Germ cell regulation of Sertoli cell transferrin mRNA levels. Mol Endocrinol 4:393–401[Abstract/Free Full Text]
  143. Aravindan GR, Pineau C, Bardin CW, Cheng CY 1996 Ability of trypsin in mimicking germ cell factors that affect Sertoli cell secretory function. J Cell Physiol 168:123–133[CrossRef][Medline]
  144. Madara JL 1998 Regulation of the movement of solutes across tight junctions. Annu Rev Physiol 60:143–159[CrossRef][Medline]
  145. Dorrington JH, Fritz IB 1974 Cell types influenced by FSH in the rat testis. In: Moudgal N, ed. Gonadotropins and gonadal function. New York: Academic Press; 500–511
  146. Means AR, Huckins C 1974 Coupled events in the early biochemical actions of FSH on the Sertoli cells of the testis. Curr Top Mol Endocrinol 1:145–165[Medline]
  147. Means AR, Dedman JR, Tash TS, Tindall MJ, Van Sickle M, Welsh MJ 1980 Regulation of the testis Sertoli cell by follicle stimulating hormone. Annu Rev Physiol 42:59–70[CrossRef][Medline]
  148. Orth JM, Christensen AK 1979 Localization of 125I-labelled FSH in the testes of hypophysectomized rats by autoradiography at the light and electron microscope levels. Endocrinology 101:262–278
  149. Sprengel R, Braun T, Nikolics K, Segaloff DL, Seeburg PH 1990 The testicular receptor for follicle stimulating hormone: structure and functional expression of cloned cDNA. Mol Endocrinol 4:525–530[Abstract/Free Full Text]
  150. Heckert LL, Griswold MD 1991 Expression of follicle stimulating hormone receptor mRNA in rat testes and Sertoli cells. Mol Endocrinol 5:670–677[Abstract/Free Full Text]
  151. Heckert LL, Griswold MD 1992 Structural organization of the follicle stimulating hormone receptor gene. Mol Endocrinol 6:70–80[Abstract/Free Full Text]
  152. Maguire SM, Tribley WA, Griswold MD 1997 Follicle stimulating hormone (FSH) regulates the expression of FSH receptor messenger ribonucleic acid in cultured Sertoli cells and in hypophysectomized rat testis. Biol Reprod 56:1106–1111[Abstract]
  153. Dejucq N, Chousterman S, Jegou B 1997 The testicular antiviral defense system: localization, expression, and regulation of 2' 5' oligo adenylate synthetase, double-stranded RNA-activated protein kinase and Mx proteins in the rat seminiferous tubule. J Cell Biol 139:865–873[Abstract/Free Full Text]
  154. Dejucq N, Lienard MO, Jegou B 1998 Interferons and interferon-induced antiviral proteins in the testis. J Reprod Immunol 41:291–300[CrossRef][Medline]
  155. Beagley KW, Wu ZL, Pomering M, Jones RC 1998 Immune responses in the epididymis: implications for immunocontraception. J Reprod Fertil (Suppl) 53:235–245[Medline]
  156. Gumbiner B, Simons K 1986 A functional assay for proteins involved in establishing an epithelial occluding barrier: identification of a uvomorulin-like polypeptide. J Cell Biol 102:457–468[Abstract/Free Full Text]
  157. Balda MS, Gonzalez-Mariscal L, Cereijido M 1991 Assembly and sealing of tight junctions: possible participation of G-proteins, phospholipase C, protein kinase C and calmodulin. J Membr Biol 122:193–202[CrossRef][Medline]
  158. Balda MS, Gonzalez-Mariscal L, Matter K, Cereijido M, Anderson JM 1993 Assembly of the tight junction: the role of diacylglycerol. J Cell Biol 123:293–302[Abstract/Free Full Text]
  159. Mackay S, Booth SH, MacGowan A, Smith RA 1999 Ultrastructural studies demonstrate that epithelial polarity is established in cultured mouse pre-Sertoli cells by extracellular matrix components. J Electron Microsc (Tokyo) 48:159–165[Abstract/Free Full Text]
  160. Dym M 1994 Spermatogonial stem cells of the testis. Proc Natl Acad Sci USA 91:11287–11289[Free Full Text]
  161. Tung PS, Fritz IB 1993 Interactions of Sertoli cells with laminin are essential to maintain integrity of the cytoskeleton and barrier functions of cells in culture in the two-chambered assembly. J Cell Physiol 156:1–11[CrossRef][Medline]
  162. Hadley MA, Byers SW, Suarez-Quian CA, Kleinman HK, Dym M 1985 Extracellular matrix regulates Sertoli cell differentiation, testicular cord formation, and germ cell development in vitro. J Cell Biol 101:1511–1522[Abstract/Free Full Text]
  163. Siu MKY, Lee WM, Cheng CY 2003 The interplay of collagen IV, tumor necrosis factor-{alpha}, gelatinase B (matrix metalloprotease-9), and tissue inhibitor of metalloprotease-1 in the basal lamina regulates Sertoli cell-tight junction dynamics in the rat testis. Endocrinology 144:371–387[Abstract/Free Full Text]
  164. Hadley MA, Dym M 1987 Immunocytochemistry of extracellular matrix in the lamina propia of the rat testis: electron microscopic localization. Biol Reprod 37:1283–1289[Abstract]
  165. Ploen L, Setchell BP 1992 Blood-testis barriers revisited. Int J Androl 15:1–4[Medline]
  166. Ribeiro AF, David-Ferreira JF 1996 The inter-Sertoli cell tight junctions in germ cell-free seminiferous tubules from prenatally irradiated rats: a freeze-fracture study. Cell Biol Int 20:513–522[CrossRef][Medline]
  167. Nagano T, Suzuki F, Kitamura Y, Matsumoto K 1977 Sertoli cell junctions in the germ cell-free testis of the congenic mouse. Lab Invest 36:8–17[Medline]
  168. Jakubowiak A, Janecki A, Steinberger A 1990 Kinetics of inhibin secretion in static and superfused Sertoli cell cultures in response to follicle-stimulating hormone. Biol Reprod 43:939–945[Abstract]
  169. Turner TT, Giles RD, Howards SS 1981 Effect of oestradiol valerate on the rat blood-testis and blood-epididymal barriers to [3H]-inulin. J Reprod Fertil 63:355–358[Abstract/Free Full Text]
  170. Lynch RD, Tkachuk-Ross LJ, McCormack JM, McCarthy KM, Rogers RA, Schneeberger EE 1995 Basolateral but not apical application of protease results in a rapid rise of transepithelial electrical resistance and formation of aberrant tight junction strands in MDCK cells. Eur J Cell Biol 66:257–267[Medline]
  171. Bacher A, Griebl K, Mackamul S, Mitreiter R, Muckter H, Ben-Shaul Y 1992 Protease inhibitors suppress the formation of tight junctions in gastrointestinal cell lines. Exp Cell Res 200:97–104[CrossRef][Medline]
  172. Ben-Shaul Y, Ophir I 2001 Tight junctions and proteases. In: Cereijido M, Anderson J, eds. Tight junctions. 2nd ed. New York: CRC Press; 459–482
  173. Main SJ, Waites GM 1973 Proceedings: studies on some effects of temperature on the blood-testis barrier in rats. J Reprod Fertil 35:587–588[Medline]
  174. Setchell BP, Waites GMH 1970 Changes in the permeability of the testicular capillaries and of the "blood-testis barrier" after injection of cadmium chloride in the rat. J Endocrinol 47:81–86[Abstract/Free Full Text]
  175. Duizer E, Gilde AJ, Versantvoort CH, Groten JP 1999 Effects of cadmium chloride on the paracellular barrier function of intestinal epithelial cell lines. Toxicol Appl Pharmacol 155:117–126[CrossRef][Medline]
  176. Wiebe JP, Barr KJ 1984 The control of male fertility by 1,2,3-trihydroxypropane (THP; glycerol): rapid arrest of spermatogenesis without altering libido, accessory organs, gonadal steroidogenesis, and serum testosterone, LH, and FSH. Contraception 29:291–302[CrossRef][Medline]
  177. Wiebe JP, Barr KJ 1984 Suppression of spermatogenesis without inhibition of steroidogenesis by 1,2,3-trihydroxypropane solution. Life Sci 34:1747–1754[CrossRef][Medline]
  178. Wiebe JP, Barr KJ, Buckingham KD 1989 Sustained azoospermia in squirrel monkey, Saimiri sciureus, resulting from a single intratesticular glycerol injection. Contraception 39:447–457[CrossRef][Medline]
  179. Eng F, Wiebe JP, Alima LH 1994 Long-term alterations in the permeability of the blood-testis barrier following a single intratesticular injection of dilute aqueous glycerol. J Androl 15:311–317[Abstract/Free Full Text]
  180. Igdoura SA, Wiebe JP 1994 Suppression of spermatogenesis by low-level glycerol treatment. J Androl 15:234–243[Abstract/Free Full Text]
  181. Wiebe JP, Barr KJ, Buckingham KD, Gedded PD, Kudo PA 1986 Prospects of a male contraceptive based on selective antispermatogenic action of 1,2,3-trihydroxypropane (THP; glycerol). In: Zatuchni GI, Goldsmith A, Spiler AJM, Sciarra JJ, eds. Male contraception: advances and future prospects. Philadelphia: Harper and Row; 252–270
  182. Nusrat A, Turner JR, Madara JL 2000 Molecular physiology and pathophysiology of tight junctions. IV. Regulation of tight junctions by extracellular stimuli: nutrients, cytokines, and immune cells. Am J Physiol Gastrointest Liver Physiol 279:G851–G857
  183. Walsh SV, Hopkins AM, Nusrat A 2000 Modulation of tight junction structure and function by cytokines. Adv Drug Deliv Rev 41:303–313[CrossRef][Medline]
  184. Schulzke JD, Fromm M 2001 Tight junctions in intestinal inflammation. In: Cereijido M, Anderson J, eds. Tight junctions. New York: CRC Press; 553–574
  185. Van Itallie CM, Balda MS, Anderson JM 1995 Epidermal growth factor induces tyrosine phosphorylation and reorganization of the tight junction protein ZO-1 in A431 cells. J Cell Sci 108:1735–1742[Abstract]
  186. Chen MC, Goliger J, Bunnett N, Soll AH 2001 Apical and basolateral EGF receptors regulate gastric mucosal paracellular permeability. Am J Physiol Gastrointest Liver Physiol 280:G264–G272
  187. Jiang WG, Martin TA, Matsumoto K, Nakamura T, Mansel RE 1999 Hepatocyte growth factor/scatter factor decreases the expression of occludin and transendothelial resistance (TER) and increases paracellular permeability in human vascular endothelial cells. J Cell Physiol 181:319–329[CrossRef][Medline]
  188. Hollande F, Blanc EM, Bali JP, Whitehead RH, Pelegrin A, Baldwin GS, Choquet A 2001 HGF regulates tight junctions in new nontumorigenic gastric epithelial cell line. Am J Physiol Gastrointest Liver Physiol 280:G910–G921
  189. Nusrat A, Parkos CA, Bacarra AE, Godowski PJ, Delp-Archer C, Rosen EM, Madara JL 1994 Hepatocyte growth factor/scatter factor effects on epithelia. Regulation of intercellular junctions in transformed and nontransformed cell lines, basolateral polarization of c-met receptor in transformed and natural intestinal epithelia, and induction of rapid wound repair in a transformed model epithelium. J Clin Invest 93:2056–2065[Medline]
  190. Adams RB, Planchon SM, Roche JK 1993 IFN-{gamma} modulation of epithelial barrier function. Time course, reversibility, and site of cytokine binding. J Immunol 150:2356–2363[Abstract]
  191. Lechner J, Krall M, Netzer A, Radmayr C, Ryan MP, Pfaller W 1999 Effects of interferon {alpha}-2b on barrier function and junctional complexes of renal proximal tubular LLC-PK1 cells. Kidney Int 55:2178–2191[CrossRef][Medline]
  192. Madara JL, Stafford J 1989 Interferon-{gamma} directly affects barrier function of cultured intestinal epithelial monolayers. J Clin Invest 83:724–727[Medline]
  193. Youakim A, Ahdieh M 1999 Interferon-{gamma} decreases barrier function in T84 cells by reducing ZO-1 levels and disrupting apical actin. Am J Physiol Gastrointest Liver Physiol 276:G1279–G1288
  194. McRoberts JA, Riley NE 1992 Regulation of T84 cell monolayer permeability by insulin-like growth factors. Am J Physiol 262:C207–C213
  195. Nilsson M, Husmark J, Bjorkman U, Ericson LE 1998 Cytokines and thyroid epithelial integrity: interleukin-1{alpha} induces dissociation of the junctional complex and paracellular leakage in filter-cultured human thyrocytes. J Clin Endocrinol Metab 83:945–952[Abstract/Free Full Text]
  196. Ahdieh M, Vandenbos T, Youakim A 2001 Lung epithelial barrier function and wound healing are decreased by IL-4 and IL-13 and enhanced by IFN-{gamma}. J Cell Physiol 281:C2029–C2038
  197. Colgan SP, Resnick MB, Parkos CA, Delp-Archer C, McGuirk D, Bacarra AE, Weller PF, Madara JL 1994 IL-4 directly modulates function of a model human intestinal epithelium. J Immunol 153:2122–2129[Abstract]
  198. Ceponis PJ, Botelho F, Richards CD, McKay DM 2000 Interleukins 4 and 13 increase intestinal epithelial permeability by a phosphatidylinositol 3-kinase pathway. Lack of evidence for STAT 6 involvement. J Biol Chem 275:29132–29137[Abstract/Free Full Text]
  199. Desai TR, Leeper NJ, Hynes KL, Gewertz BL 2002 Interleukin-6 causes endothelial barrier dysfunction via the protein kinase C pathway. J Surg Res 104:118–123[CrossRef][Medline]
  200. Nishiyama R, Sakaguchi T, Kinugasa T, Gu X, MacDermott RP, Podolsky DK, Reinecker HC 2001 Interleukin-2 receptor ß subunit-dependent and -independent regulation of intestinal epithelial tight junctions. J Biol Chem 276:35571–35580[Abstract/Free Full Text]
  201. Stevens AC, Matthews J, Andres P, Baffis V, Zheng XX, Chae DW, Smith J, Strom TB, Maslinski W 1997 Interleukin-15 signals T84 colonic epithelial cells in the absence of the interleukin-2 receptor ß-chain. Am J Physiol 272:G1201–G1208
  202. Blum MS, Toninelli E, Anderson JM, Balda MS, Zhou J, O’Donnell L, Pardi R, Bender JR 1997 Cytoskeletal rearrangement mediates human microvascular endothelial tight junction modulation by cytokines. Am J Physiol Heart Circ Physiol 273:H286–H294
  203. Guan Y, Woo PL, Rubenstein NM, Firestone GL 2002 Transforming growth factor-{alpha} abrogates the glucocorticoid stimulation of tight junction formation and reverses the steroid-induced down-regulation of fascin in rat mammary epithelial tumor cells by a Ras-dependent pathway. Exp Cell Res 273:1–11[CrossRef][Medline]
  204. Woo PL, Cha HH, Singer KL, Firestone GL 1996 Antagonistic regulation of tight junction dynamics by glucocorticoids and transforming growth factor-ß in mouse mammary epithelial cells. J Biol Chem 271:404–412[Abstract/Free Full Text]
  205. Behzadian MA, Wang XL, Windsor LJ, Ghaly N, Caldwell RB 2001 TGF-ß increases retinal endothelial cell permeability by increasing MMP-9: possible role of glial cells in endothelial barrier function. Invest Ophthalmol Vis Sci 42:853–859[Abstract/Free Full Text]
  206. Lui WY, Lee WM, Cheng CY 2003 TGF-ßs: their role in testicular function and Sertoli cell tight junction dynamics. Int J Androl 26:147–160[CrossRef][Medline]
  207. Schmitz H, Fromm M, Bentzel CJ, Scholz P, Detjen K, Mankertz J, Bode H, Epple HJ, Riecken EO, Schulzke JD 1999 Tumor necrosis factor-{alpha} (TNF-{alpha}) regulates the epithelial barrier in the human intestinal cell line HT-29/B6. J Cell Sci 112:137–146[Abstract]
  208. Gitter AH, Bendfeldt K, Schmitz H, Schulzke JD, Bentzel CJ, Fromm M 2000 Epithelial barrier defects in HT-29/B6 colonic cell monolayers induced by tumor necrosis factor-{alpha}. Ann NY Acad Sci 915:193–203[Medline]
  209. Marano CW, Laughlin KV, Russo LM, Peralta Soler A, Mullin JM 1993 Long-term effects of tumor necrosis factor on LLC-PK1 transepithelial resistance. J Cell Physiol 157:519–527[CrossRef][Medline]
  210. Fish SM, Proujansky R, Reenstra WW 1999 Synergistic effects of interferon-{gamma} and tumour necrosis factor-{alpha} on T84 cell function. Gut 45:191–198[Abstract/Free Full Text]
  211. Coyne CB, Vanhook MK, Gambling TM, Carson JL, Boucher RC, Johnson LG 2002 Regulation of airway tight junctions by proinflammatory cytokines. Mol Biol Cell 13:3218–3234[Abstract/Free Full Text]
  212. Becker PM, Verin AD, Booth MA, Liu F, Birukova A, Garcia JGN 2001 Differential regulation of diverse physiological responses to VEGF in pulmonary endothelial cells. Am J Physiol Lung Cell Mol Physiol 281:L1500–L1511
  213. Pelletier RM, Friend DS 1983 The Sertoli cell junctional complex: structure and permeability to filipin in the neonatal and adult guinea pig. Am J Anat 168:213–228[CrossRef][Medline]
  214. Pelletier RM 1988 Cyclic modulation of the Sertoli cell junctional complexes in a seasonal breeder: the mink (Mustela vison). Am J Anat 183:68–102[CrossRef][Medline]
  215. Pelletier RM 1990 A novel perspective: the occluding zonule encircles the apex of the Sertoli cell as observed in birds. Am J Anat 188:87–108[CrossRef][Medline]
  216. Gutmann JA, Kimel GH, Vogl AW 2000 Dynein and plus-end microtubule-dependent motors are associated with specialized Sertoli cell junction plaques (ectoplasmic specializations). J Cell Sci 113:2167–2176[Abstract]
  217. Miller MG, Mulholland DJ, Vogl AW 1999 Rat testis motor proteins associated with spermatid translocation (dynein) and spermatid flagella (kinesin-II). Biol Reprod 60:1047–1056[Abstract/Free Full Text]
  218. Velichkova M, Guttman J, Warren C, Eng L, Kline K, Vogl AW, Hasson T 2002 A human homologue of Drosophila kelch associates with myosin-VIIa in specialized adhesion junctions. Cell Motil Cytoskeleton 51:147–164[CrossRef][Medline]
  219. Lui WY, Lee WM, Cheng CY 2002 Rho GTPases and spermatogenesis. Biochim Biophys Acta 1593:121–129
  220. Carr I, Clegg EJ, Meek GA 1968 Sertoli cells as phagocytes: an electron microscopic study. J Anat 102:501–509[Medline]
  221. Kerr JB, de Kretser DM 1974 Proceedings: the role of the Sertoli cell in phagocytosis of the residual bodies of spermatids. J Reprod Fertil 36:439–440[Medline]
  222. Clermont Y, Morales C, Hermo L 1987 Endocytic activities of Sertoli cells in the rat. Ann NY Acad Sci 513:1–15[CrossRef][Medline]
  223. Morales CR, Clermont Y 1991 Phagocytosis and endocytosis in Sertoli cells of the rat. Bull Assoc Anat (Nancy) 75:157–162
  224. Dai RX, Djakiew D, Dym M 1987 Endocytic activity of Sertoli cells grown in bicameral culture chambers. Anat Rec 218:306–312[CrossRef][Medline]
  225. Fritz IB, Tung PS, Ailenberg M 1993 Proteases and antiproteases in the seminiferous tubule. In: Russell LD, Griswold MD, eds. The Sertoli cell. Clearwater, FL: Cache River Press; 217–235
  226. Sylvester SR 1993 Secretion of transport of binding proteins. In: Russell LD, Griswold MD, eds. The Sertoli cell. Clearwater, FL: Cache River Press; 201–216
  227. Dorrington JH, Kahn SA 1993 Steroid production, metabolism, and release by Sertoli cells. In: Russell LD, Griswold MD, eds. The Sertoli cell. Clearwater, FL: Cache River Press; 537–549
  228. Griswold MD 1993 Unique aspects of the biochemistry and metabolism of Sertoli cells. In: Russell LD, Griswold MD, eds. The Sertoli cell. Clearwater, FL: Cache River Press; 485–492
  229. Lamb DJ 1993 Growth factors and testicular development. J Urol 150:583–592[Medline]
  230. Benahmed M 1996 Growth factors and cytokines in the testis. In: Comhaire FH, ed. Male infertility. London: Chapman and Hall Medical; 324–336
  231. Monsees TK, Schill WB, Miska W 1997 Protease-protease inhibitor interactions in Sertoli cell-germ cell cross-talk. Adv Exp Med Biol 424:111–123[Medline]
  232. Monsees TK, Gornig M, Schill WB, Miska W 1998 Possible involvement of proteases in the regulation of spermatogenesis. Andrologia 30:185–191[Medline]
  233. Wright WW, Zabludoff SD, Erickson-Lawrence M, Karzai AW 1989 Germ cell-Sertoli cell interactions. Studies of cyclic protein-2 in the seminiferous tubule. Ann NY Acad Sci 564:173–185[Medline]
  234. Penttila TL, Hakovirta H, Mali P, Wright WW, Parvinen M 1995 Follicle-stimulating hormone regulates the expression of cyclic protein-2/cathepsin L messenger ribonucleic acid in rat Sertoli cells in a stage-specific manner. Mol Cell Endocrinol 113:175–181[CrossRef][Medline]
  235. Vihko KK, Suominen JJ, Parvinen M 1984 Cellular regulation of plasminogen activator secretion during spermatogenesis. Biol Reprod 31:383–389[Abstract]
  236. Tsuruta JK, O’Brien DA, Griswold MD 1993 Sertoli cell and germ cell cystatin C: stage-dependent expression of two distinct messenger ribonucleic acid transcripts in rat testis. Biol Reprod 49:1045–1054[Abstract]
  237. Zhu LJ, Cheng CY, Phillips DM, Bardin CW 1994 The immunohistochemical localization of {alpha}2-macroglobulin in rat testes is consistent with its role in germ cell movement and spermiation. J Androl 15:575–582[Abstract/Free Full Text]
  238. Ohno T, Okigaki T 1984 Growth factors. Cell Struc Func (Suppl) 9:S91–S96
  239. St Georgiev V, Albright JF 1993 Cytokines and their role as growth factors and in regulation of immune responses. Ann NY Acad Sci 685:584–602[CrossRef][Medline]
  240. Sharpe RM 1986 Paracrine control of the testis. Clin Endocrinol Metab 15:185–207[CrossRef][Medline]
  241. Bellve AR, Zheng WX 1989 Different pleiotypic actions of seminiferous growth factor (SGF), acidic fibroblast growth factor (aFGF), and basic fibroblast growth factor (bFGF). Ann NY Acad Sci 564:116–131[CrossRef][Medline]
  242. Bellve AR, Zheng W 1989 Growth factors as autocrine and paracrine modulators of male gonadal functions. J Reprod Fertil 85:771–793[Abstract/Free Full Text]
  243. Heindel JJ, Treinen KA 1989 Physiology of the male reproductive system: endocrine, paracrine, and autocrine regulation. Toxicol Pathol 17:411–445[Medline]
  244. Giordano G, Del Monte P, Minuto F 1992 Growth factors and testis. J Endocrinol Invest 15:67–75[Medline]
  245. Robertson DM, Risbridger GP, Hedger M, McLachlan RI 1993 Growth factors in the control of testicular function. In: de Kretser D, ed. Molecular biology of the male reproductive system. San Diego: Academic Press; 411–438
  246. Spiteri-Grech J, Nieschlag E 1993 Paracrine factors relevant to the regulation of spermatogenesis: a review. J Reprod Fertil 98:1–14[Abstract/Free Full Text]
  247. Fritz IB 1994 Somatic cell-germ cell relationships in mammalian testes during development and spermatogenesis. Ciba Found Symp 182:271–281[Medline]
  248. Salomon DS, Kim N, Saeki T, Ciardiello F 1990 Transforming growth factor-{alpha}: an oncodevelopmental growth factor. Cancer Cells 2:389–397[Medline]
  249. Pandiella A, Massague J 1991 Transforming growth factor-{alpha}. Biochem Soc Trans 19:259–262[Medline]
  250. Kumar V, Bustin SA, McKay IA 1995 Transforming growth factor-{alpha}. Cell Biol Int 19:373–388[CrossRef][Medline]
  251. Cupp AS, Skinner MK 2001 Expression, action, and regulation of transforming growth factor-{alpha} and epidermal growth factor receptor during embryonic and perinatal rat testis development. J Androl 22:1019–1029[Abstract]
  252. Petersen C, Froysa B, Boitani C, Soder O 2000 Transforming growth factor-{alpha} stimulates Sertoli cell proliferation in vitro. Andrologia 32:62–63[Medline]
  253. Derynck R, Feng XH 1997 TGF-ß receptor signaling. Biochim Biophys Acta 1333:F105–F150
  254. Hu PPC, Datto MB, Wang XF 1998 Molecular mechanisms of transforming growth factor-ß signaling. Endocr Rev 19:349–363[Abstract/Free Full Text]
  255. Massague J, Chen YG 2000 Controlling TGF-ß signaling. Genes Dev 14:627–644[Free Full Text]
  256. Massague J 2000 How cells read TGF-ß signals. Nat Rev Mol Cell Biol 1:169–178[CrossRef][Medline]
  257. Attisano L, Wrana JL 2002 Signal transduction by the TGF-ß superfamily. Science 296:1646–1647[Abstract/Free Full Text]
  258. Mullaney BP, Skinner MK 1993 Transforming growth factor-ß (ß1, ß2, and ß3) gene expression and action during pubertal development of the seminiferous tubule: potential role at the onset of spermatogenesis. Mol Endocrinol 7:67–76[Abstract/Free Full Text]
  259. Teerds KJ, Dorrington JH 1993 Localization of transforming growth factor ß1 and ß2 during testicular development in the rat. Biol Reprod 48:40–45[Abstract]
  260. Le Magueresse-Battistoni B, Morera AM, Goddard I, Benahmed M 1995 Expression of mRNAs for transforming growth factor-ß receptors in the rat testis. Endocrinology 136:2788–2791[Abstract]
  261. Caussanel V, Tabone E, Hendrick JC, Dacheux F, Benahmed M 1997 Cellular distribution of transforming growth factor ßs 1, 2, and 3 and their types I and II receptors during postnatal development and spermatogenesis in the boar testis. Biol Reprod 56:357–367[Abstract]
  262. Olaso R, Pairault C, Habert R 1998 Expression of type I and II receptors for transforming growth factor-ß in the adult rat testis. Histochem Cell Biol 110:613–618[CrossRef][Medline]
  263. Lewis KA, Gray PC, Blount AL, MacConell LA, Wiater E, Bilezikjian LM, Vale W 2000 Betaglycan binds inhibin and can mediate functional antagonism of activin signaling. Nature 404:411–414[CrossRef][Medline]
  264. MacConell LA, Leal AM, Vale WW 2002 The distribution of betaglycan protein and mRNA in rat brain, pituitary, and gonads: implications for a role for betaglycan in inhibin-mediated reproductive functions. Endocrinology 143:1066–1075[Abstract/Free Full Text]
  265. Bernard DJ, Chapman SC, Woodruff TK 2002 Minireview, inhibin binding protein (InhBP/p120) betaglycan, and the continuing search for the inhibin receptor. Mol Endocrinol 16:207–212[Abstract/Free Full Text]
  266. Adashi EY, Reshick CE 1986 Antagonistic interactions of transforming growth factors in the regulation of granulosa cell differentiation. Endocrinology 119:1879–1881[Abstract/Free Full Text]
  267. Khan S, Teerds K, Dorrington J 1992 Growth factor requirements for DNA synthesis by Leydig cells from the immature rat. Biol Reprod 46:335–341[Abstract]
  268. Khan SA, Mirsafian M, Howdeshell K, Dorrington JH 1999 Transforming growth factor-ß inhibits DNA synthesis in immature rat Leydig cells in vitro. Mol Cell Endocrinol 148:21–28[CrossRef][Medline]
  269. Skinner MK, Tung PS, Fritz IB 1985 Cooperativity between Sertoli cells and testicular peritubular cells in the production and deposition of extracellular matrix components. J Cell Biol 100:1941–1947[Abstract/Free Full Text]
  270. Davis CM, Papadopoulos V, Sommers CL, Kleinman HK, Dym M 1990 Differential expression of extracellular matrix components in rat Sertoli cells. Biol Reprod 43:860–869[Abstract]
  271. Raychoudhury SS, Irving MG, Thompson EW, Blackshaw AW 1992 Collagen biosynthesis in cultured rat testicular Sertoli and peritubular myoid cells. Life Sci 51:1585–1596[CrossRef][Medline]
  272. Richardson LL, Kleinman HK, Dym M 1995 Basement membrane gene expression by Sertoli and peritubular myoid cells in vitro in the rat. Biol Reprod 52:320–330[Abstract]
  273. De SK, Chen HL, Pace JL, Hunt JS, Terranova PF, Enders GC 1993 Expression of tumor necrosis factor-{alpha} in mouse spermatogenic cells. Endocrinology 133:389–396[Abstract/Free Full Text]
  274. Boekelheide K, Fleming SL, Johnson KJ, Patel SR, Schoenfeld HA 2000 Role of Sertoli cells in injury-associated testicular germ cell apoptosis. Proc Soc Exp Biol Med 225:105–115[Abstract/Free Full Text]
  275. Yan W, Suominen J, Toppari J 2000 Stem cell factor protects germ cells from apoptosis in vitro. J Cell Sci 113:161–168[Abstract]
  276. Tres LL, Kierszenbaum AL 1983 Viability of rat spermatogenic cells in vitro is facilitated by their coculture with Sertoli cells in serum-free hormone supplemented medium. Proc Natl Acad Sci USA 80:3377–3381[Abstract/Free Full Text]
  277. Kim JM, Ghosh SR, Weil ACP, Zirkin BR 2001 Caspase-3 and caspase-activated deoxyribonuclease are associated with testicular germ cell apoptosis resulting from reduced intratesticular testosterone. Endocrinology 142:3809–3816[Abstract/Free Full Text]
  278. Pentikainen V, Erkkila K, Suomalainen L, Parvinen M, Dunkel L 2000 Estradiol acts as a germ cell survival factor in the human testis in vitro. J Clin Endocrinol Metab 85:2057–2067[Abstract/Free Full Text]
  279. Pentikainen V, Erkkila K, Suomalainen L, Otala M, Pentikainen MO, Parvinen M, Dunkel L 2001 TNF-{alpha} down-regulated the Fas ligand and inhibits germ cell apoptosis in the human testis. J Clin Endocrinol Metab 86:4480–4488[Abstract/Free Full Text]
  280. Robinson R, Fritz IB 1981 Metabolism of glucose by Sertoli cells in culture. Biol Reprod 24:1032–1041[Abstract/Free Full Text]
  281. Grootegoed JA, Oonk RB, Jansen R, Van der Molen HJ 1986 Metabolism of radiolabeled energy-yielding substrates by rat Sertoli cells. J Reprod Fertil 77:109–118[Abstract/Free Full Text]
  282. Stevenson BR, Anderson JM, Bullivant S 1988 The epithelial tight junction: structure, function, and preliminary biochemical characterization. Mol Cell Biochem 83:129–145[Medline]
  283. Anderson JM, Van Itallie CM 1995 Tight junctions and the molecular basis for the regulation of paracellular permeability. Am J Physiol 269:G467–G475
  284. Mitic LL, Anderson JM 1998 Molecular architecture of tight junctions. Annu Rev Physiol 60:121–142[CrossRef][Medline]
  285. Stevenson BR, Keon BH 1998 The tight junction: morphology to molecules. Annu Rev Cell Dev Biol 14:89–109[CrossRef][Medline]
  286. Madara JL 2000 Modulation of tight junctional permeability. Adv Drug Deliv Rev 41:251–253[CrossRef][Medline]
  287. Gonzalez-Mariscal L, Avila A, Betanzos A 2001 The relationship between structure and function of tight junctions. In: Cereijido M, Anderson J, eds. Tight junctions. New York: CRC Press; 89–119
  288. Reuss L 2001 Tight junction permeability to ions and water. In: Cereijido M, Anderson J, eds. Tight junctions. New York: CRC Press; 61–88
  289. Marrs JA, Molitoris BA 2001 Ischemia-induced tight junction dysfunction in the kidney. In: Cereijido M, Anderson J, eds. Tight junctions. New York: CRC Press; 533–551
  290. Nguyen DAD, Beeman N, Neville MC 2001 Regulation of tight junction permeability in the mammary gland. In: Cereijido M, Anderson J, eds. Tight junctions. New York: CRC Press; 395–414
  291. Wilt SD, Rizzolo LJ 2001 Unique aspects of the blood-brain barrier. In: Cereijido M, Anderson J, eds. Tight junctions. New York: CRC Press; 415–443
  292. Collares-Buzato CB, Jepson MA, Simmons NL, Hirst BH 1998 Increased tyrosine phosphorylation causes redistribution of adherens junction and tight junction proteins and perturbs paracellular barrier function in MDCK epithelia. Eur J Cell Biol 76:85–92[Medline]
  293. Li JCH, Mruk D, Cheng CY 2001 The inter-Sertoli tight junction permeability barrier is regulated by the inter-play of protein phosphatases and kinases: an in vitro study. J Androl 22:847–856[Abstract]
  294. Cereijido M, Valdes J, Shoshani L, Contreras R 1998 Role of tight junctions in establishing and maintaining cell polarity. Annu Rev Physiol 60:161–177[CrossRef][Medline]
  295. Yeaman C, Grindstaf KK, Nelson WJ 1999 New perspectives on mechanisms involved in generating epithelial cell polarity. Physiol Rev 79:73–98[Abstract/Free Full Text]
  296. Yeaman C, Grindstaff KK, Hansen MD, Nelson WJ 1999 Cell polarity: versatile scaffolds keep things in place. Curr Biol 9:R515–R517
  297. Kachar B, Reese TS 1982 Evidence for the lipidic nature of the tight junction strands. Nature 296:464–466[CrossRef][Medline]
  298. Pinto da Silva P, Kachar B 1982 On tight-junction structure. Cell 28:441–450[CrossRef][Medline]
  299. Verleij AJ 1984 Lipidic intramembranous particles. Biochim Biophys Acta 779:43–63[Medline]
  300. Calderon V, Lazaro A, Contreras RG, Shoshani L, Flores-Maldonado C, Gonzalez-Mariscal L, Zampighi G, Cereijido P 1998 Tight junctions and the experimental modifications of lipid content. J Membr Biol 164:59–69[CrossRef][Medline]
  301. Francis SA, Kelly JM, McCormack J, Rogers RA, Lai J, Schneeberger EE, Lynch RD 1999 Rapid reduction of MDCK cell cholesterol by methyl-ß-cyclodextrin alters steady state transepithelial electrical resistance. Eur J Cell Biol 78:473–484[Medline]
  302. Tsukita S, Furuse M 2000 Pores in the wall: claudins constitute tight junction strands containing aqueous pores. J Cell Biol 149:13–16[Free Full Text]
  303. Citi S, Cordenonsi M 1998 Tight junction proteins. Biochim Biophys Acta 1448:1–11[Medline]
  304. Garner CC, Nash J, Huganir RL 2000 PDZ domains in synapse assembly and signaling. Trends Cell Biol 10:274–280[CrossRef][Medline]
  305. Gonzalez-Mariscal L, Betanzos A, Avila-Flores A 2000 MAGUK proteins: structure and role in the tight junction. Semin Cell Dev Biol 11:315–324[CrossRef][Medline]
  306. Hung AY, Sheng M 2002 PDZ domains: structural modules for protein complex assembly. J Biol Chem 277:5699–5702[Free Full Text]
  307. Becamel C, Figge A, Poliak S, Dumuis A, Peles E, Bockaert J, Lubbert H, Ullmer C 2001 Interaction of serotonin 5-hydroxytryptamine type 2C receptors with PDZ10 of the multi-PDZ domain protein MUPP1. J Biol Chem 276:12974–12982[Abstract/Free Full Text]
  308. Hamazaki Y, Itoh M, Sasaki H, Furuse M, Tsukita S 2002 Multi-PDZ domain protein 1 (MUPP1) is concentrated at tight junctions through its possible interaction with claudin-1 and junctional adhesion molecule. J Biol Chem 277:455–461[Abstract/Free Full Text]
  309. Gregory M, Dufresne J, Hermo L, Cyr D 2001 Claudin-1 is not restricted to tight junctions in the rat epididymis. Endocrinology 142:854–863[Abstract/Free Full Text]
  310. Aurrand-Lions M, Johnson-Leger C, Wong C, Du Pasquier L, Imhof BA 2001 Heterogeneity of endothelial junctions is reflected by differential expression and specific subcellular localization of the three JAM family members. Blood 98:3699–3707[Abstract/Free Full Text]
  311. Stevenson BR, Siliciano JD, Mooseker MS, Goodenough DA 1986 Identification of ZO-1: a high molecular weight polypeptide associated with the tight junction (zonula occludens) in a variety of epithelia. J Cell Biol 103:755–766[Abstract/Free Full Text]
  312. Byers S, Graham R, Dai HN, Hoxter B 1991 Development of Sertoli cell junctional specializations and the distribution of the tight-junction associated protein ZO-1 in the mouse testis. Am J Anat 191:35–47[CrossRef][Medline]
  313. Anderson JM 1996 Cell signaling: MAGUK magic. Curr Biol 6:382–384[CrossRef][Medline]
  314. Dobrosotskaya I, Guy RK, James GL 1997 MAGI-1, a membrane-associated guanylate kinase with a unique arrangement of protein-protein interaction domains. J Biol Chem 272:31589–31597[Abstract/Free Full Text]
  315. Wu Y, Dowbenko D, Spencer S, Laura R, Lee J, Gu Q, Lasky LA 2000 Interaction of the tumor suppressor PTEN/MMAC with a PDZ domain of MAGI 3, a novel membrane associated guanylate kinase. J Biol Chem 275:21477–21485[Abstract/Free Full Text]
  316. Wu X, Hepner K, Castelino-Prabhu S, Do D, Kaye M, Yuan X, Wood J, Ross C, Sawyers C, Whang Y 2000 Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2. Proc Natl Acad Sci USA 97:4233–4238[Abstract/Free Full Text]
  317. Wu Y, Dowbenko D, Pisabarro MT, Dillard-Telm L, Koeppen H, Lasky LA 2001 PTEN 2, a Golgi-associated testis-specific homologue of the PTEN tumor suppressor lipid phosphatase. J Biol Chem 276:21745–21753[Abstract/Free Full Text]
  318. Tolkacheva T, Boddapati M, Sanfiz A, Tsuchida K, Kimmelman AC, Chan AM 2001 Regulation of PTEN binding to MAGI-2 by two putative phosphorylation sites at threonine 382 and 383. Cancer Res 61:4985–4989[Abstract/Free Full Text]
  319. Maehama T, Taylor GS, Dixon JE 2001 PTEN and myotubularin: novel phosphoinositide phosphatases. Annu Rev Biochem 70:247–279[CrossRef][Medline]
  320. Simpson L, Parsons R 2001 PTEN: life as a tumor suppressor. Exp Cell Res 264:29–41[CrossRef][Medline]
  321. Leslie NR, Downes CP 2002 PTEN: the down side of PI 3-kinase signalling. Cell Signal 14:285–295[CrossRef][Medline]
  322. Lilienthal J, Moon SY, Lesche R, Mamillapalli R, Li D, Zheng Y, Hon Sun, Wu H 2000 Genetic deletion of the PTEN tumor suppressor gene promotes cell motility by activation of Rac1 and Cdc42 GTPases. Curr Biol 10:401–404[CrossRef][Medline]
  323. Dobrosotskaya I, James G 2000 MAGI-1 interacts with ß-catenin and is associated with cell-cell adhesion structures. Biochim Biophys Acta 270:903–909
  324. Citi S 2001 The cytoplasmic plaque proteins of the tight junction. In: Cereijido M, Anderson J, eds. Tight junctions. New York: CRC Press; 231–264
  325. Furuse M, Itoh M, Hirase T, Nagafuchi A, Yonemura S, Tsukita S, Tsukita S 1994 Direct association of occludin with ZO-1 and its possible involvement in the localization of occludin at tight junctions. J Cell Biol 127:1617–1626[Abstract/Free Full Text]
  326. Fanning AS, Jameson BJ, Jesaitis LA, Anderson JM 1998 The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton. J Biol Chem 273:29745–29753[Abstract/Free Full Text]
  327. Howarth AG, Stevenson BR 1995 Molecular environment of ZO-1 in epithelial and non-epithelial cells. Cell Motil Cytoskeleton 31:323–332[CrossRef][Medline]
  328. Itoh M, Nagafuchi A, Moroi S, Tsukita S 1997 Involvement of ZO-1 in cadherin-based cell adhesion through its direct binding to {alpha}-catenin and actin filaments. J Cell Biol 138:181–192[Abstract/Free Full Text]
  329. Imamura Y, Itoh M, Maeno Y, Tsukita S, Nagafuchi A 1999 Functional domains of {alpha}-catenin required for the strong state of cadherin-based cell adhesion. J Cell Biol 144:1311–1322[Abstract/Free Full Text]
  330. Islas S, Vega J, Ponce L, Gonzalez-Mariscal L 2002 Nuclear localization of the tight junction protein ZO-2 in epithelial cells. Exp Cell Res 274:138–148[CrossRef][Medline]
  331. Willott E, Balda MS, Heintzelman M, Jameson B, Anderson JM 1992 Localization and differential expression of two isoforms of the tight junction protein ZO-1. Am J Physiol 262:C1119–C1124
  332. Balda MS, Anderson JM 1993 Two classes of tight junctions are revealed by ZO-1 isoforms. Am J Physiol 264:C918–C924
  333. Pelletier RM, Okawara Y, Vitale ML, Anderson JM 1997 Differential distribution of the tight-junction-associated protein ZO-1 isoforms {alpha}+ and {alpha}- in guinea pig Sertoli cells: a possible association with F-actin and G-actin. Biol Reprod 57:367–376[Abstract]
  334. Wei X, Ellis HM 2001 Localization of the Drosophila MAGUK protein Polychaetoid is controlled by alternative splicing. Mech Dev 100:217–231[CrossRef][Medline]
  335. Haskins J, Gu L, Wittchen E, Hibbard J, Stevenson BR 1998 ZO-3, a novel member of the MAGUK protein family found at the tight junction, interacts with ZO-1 and occludin. J Cell Biol 141:199–208[Abstract/Free Full Text]
  336. Wittchen ES, Haskins J, Stevenson BR 1999 Protein interactions at the tight junction. Actin has multiple binding partners, and ZO-1 forms independent complexes with ZO-2 and ZO-3. J Biol Chem 274:35179–35185[Abstract/Free Full Text]
  337. Balda MS, Anderson JM, Matter K 1996 The SH3 domain of the tight junction protein ZO-1 binds to a serine protein kinase that phosphorylates a region C-terminal to this domain. FEBS Lett 399:326–332[CrossRef][Medline]
  338. Balda MS, Matter K 2000 The tight junction protein ZO-1 and an interacting transcription factor regulate ErbB-2 expression. EMBO J 19:2024–2033[CrossRef][Medline]
  339. Balda MS, Garrett MD, Matter K 2003 The ZO-1-associated Y-box factor ZONAB regulates epithelial cell proliferation and cell density. J Cell Biol 160:423–432[Abstract/Free Full Text]
  340. Giepmans BN, Moolenaar WH 1998 The gap junction protein connexin43 interacts with the second PDZ domain of the zona occludens-1 protein. Curr Biol 8:931–934[CrossRef][Medline]
  341. Bazzoni G, Martinez-Estrada OM, Orsenigo F, Cordenonsi M, Citi S, Dejana E 2000 Interaction of junctional adhesion molecule with the tight junction components ZO-1, cingulin, and occludin. J Biol Chem 275:20520–20526[Abstract/Free Full Text]
  342. Itoh M, Furuse M, Morita K, Kubota K, Saitou M, Tsukita S 1999 Direct binding of three tight junction-associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH termini of claudins. J Cell Biol 147:1351–1363[Abstract/Free Full Text]
  343. Cordenonsi M, D’Atri F, Hammar E, Parry DA, Kendrick-Jones J, Shore D, Citi S 1999 Cingulin contains globular and coiled-coil domains and interacts with ZO-1, ZO-2, ZO-3, and myosin. J Cell Biol 147:1569–1582[Abstract/Free Full Text]
  344. Mattagajasingh SN, Huang SC, Hartenstein JS, Benz Jr EZ 2000 Characterization of the interaction between protein 4.1R and ZO-2: a possible link between the tight junction and the actin cytoskeleton. J Biol Chem 275:30573–30585[Abstract/Free Full Text]
  345. Johansson A, Driessens M, Aspenstrom P 2000 The mammalian homologue of the Caenorhabditis elegans polarity protein PAR-6 is a binding partner for the Rho GTPases Cdc42 and Rac1. J Cell Sci 113:3267–3275[Abstract]
  346. Yamamoto T, Harada N, Kano K, Taya S, Canaani E, Matsuura Y, Mizoguchi A, Ide C, Kaibuchi K 1997 The Ras target AF-6 interacts with ZO-1 and serves as a peripheral component of tight junctions in epithelial cells. J Cell Biol 139:785–795[Abstract/Free Full Text]
  347. Huber LA, Pimplikar S, Parton RG, Virta H, Zerial M, Simons K 1993 Rab8, a small GTPase involved in vesicular traffic between the TGN and the basolateral plasma membrane. J Cell Biol 123:35–45[Abstract/Free Full Text]
  348. Zahraoui A, Joberty G, Arpin M, Fontaine JJ, Hellio R, Tavitian A, Louvard D 1994 A small Rab GTPase is distributed in cytoplasmic vesicles in non polarized cells but colocalizes with the tight junction marker ZO-1 in polarized epithelial cells. J Cell Biol 124:101–115[Abstract/Free Full Text]
  349. Merzdorf CS, Goodenough DA 1997 Localization of a novel 210 kDa protein in Xenopus tight junctions. J Cell Sci 110:1005–1012[Abstract]
  350. Izumi Y, Hirose T, Tamai Y, Hirai S, Nagashima Y, Fujimoto T, Tabuse Y, Kemphues KJ, Ohno S 1998 An atypical PKC directly associates and colocalizes at the epithelial tight junction with ASIP, a mammalian homologue of Caenorhabditis elegans polarity protein PAR-3. J Cell Biol 143:95–106[Abstract/Free Full Text]
  351. Denker BM, Saha C, Khawaja S, Nigam SK 1996 Involvement of heterotrimeric G protein {alpha} subunit in tight junction biogenesis. J Biol Chem 271:25750–25753[Abstract/Free Full Text]
  352. Saha C, Nigam SK, Denker BM 1998 Involvement of G{alpha}i2 in the maintenance and biogenesis of epithelial cell tight junctions. J Biol Chem 273:21629–21633[Abstract/Free Full Text]
  353. Meyer TN, Schwesinger C, Denker BM 2002 Zonula occludens-1 is a scaffolding protein for signaling molecules. G{alpha}12 directly binds to the Src homology 3 domain and regulates paracellular permeability in epithelial cells. J Biol Chem 277:24855–24858[Abstract/Free Full Text]
  354. Nakamura T, Blechman J, Tada S, Rozovskaia T, Itoyama T, Bullrich F, Mazo A, Croce CM, Geiger B, Canaani E 2000 huASH1 protein, a putative transcription factor encoded by a human homologue of the Drosophila ash1 gene, localizes to both nuclei and cell-cell tight junctions. Proc Natl Acad Sci USA 97:7284–7289[Abstract/Free Full Text]
  355. Laura RP, Ross S, Koeppen H, Lasky LA 2002 MAGI-1: a widely expressed, alternatively spliced tight junction protein. Exp Cell Res 275:155–170[CrossRef][Medline]
  356. Nishimura M, Kakizaki M, Ono Y, Morimoto K, Takeuchi M, Inoue Y, Imai T, Takai Y 2002 JEAP, a novel component of tight junctions in exocrine cells. J Biol Chem 277:5583–5587[Abstract/Free Full Text]
  357. Notterpek L, Roux KJ, Amici SA, Yazdanpour A, Rahner C, Fletcher BS 2001 Peripheral myelin protein 22 is a constituent of intercellular junctions in epithelia. Proc Natl Acad Sci USA 98:14404–14409[Abstract/Free Full Text]
  358. Lawrence DW, Comerford KM, Colgan SP 2002 Role of VASP in reestablishment of epithelial tight junction assembly after Ca2+ switch. Am J Physiol Cell Physiol 282:C1235–C1245
  359. Kamberov E, Makarova O, Roh M, Liu A, Karnak D, Straight S, Margolis B 2000 Molecular cloning and characterization of Pals, proteins associated with mLin-7. J Biol Chem 275:11425–11431[Abstract/Free Full Text]
  360. Roh MH, Makarova O, Liu CJ, Shin KY, Lee S, Laurinec S, Goyal M, Wiggins R, Margolis B 2002 The MAGUK protein, Pals1, functions as an adapter, linking mammalian homologues of Crumbs and Discs Lost. J Cell Biol 157:161–172[Abstract/Free Full Text]
  361. Grindstaff KK, Yeaman C, Anandasabapathy N, Hsu SC, Rodriguez-Boulan E, Scheller RH, Nelson WJ 1998 Sec6/8 complex is recruited to cell-cell contacts and specifies transport vesicle delivery to the basal-lateral membrane in epithelial cells. Cell 93:731–740[CrossRef][Medline]
  362. Gumbiner BM, Lowenkopf T, Apatira D 1991 Identification of 160-kDa polypeptide that binds to the tight junction protein ZO-1. Proc Natl Acad Sci USA 88:3460–3464[Abstract/Free Full Text]
  363. Jesaitis LA, Goodenough DA 1994 Molecular characterization and tissue distribution of ZO-2, a tight junction protein homologous to ZO-1 and the Drosophila discs-large tumor suppressor protein. J Cell Biol 124:949–961[Abstract/Free Full Text]
  364. Beatch M, Jesaitis LA, Gallin WJ, Goodenough DA, Stevenson BR 1996 The tight junction protein ZO-2 contains three PDZ (PSD-95/Discs-Large/ZO-1) domains and an alternatively spliced region. J Biol Chem 271:25723–25726[Abstract/Free Full Text]
  365. Collins JR, Rizzolo LJ 1998 Protein-binding domains of the tight junction protein, ZO-2, are highly conserved between avian and mammalian species. Biochem Biophys Res Commun 252:617–622[CrossRef][Medline]
  366. Avila-Flores A, Rendon-Huerta E, Moreno J, Islas S, Betanzos A, Robles-Flores M, Gonzalez-Mariscal L 2001 Tight-junction protein zonula occludens 2 is a target of phosphorylation by protein kinase C. Biochem J 360:295–304[CrossRef][Medline]
  367. Itoh M, Morita K, Tsukita S 1999 Characterization of ZO-2 as a MAGUK family member associated with tight as well as adherens junctions with a binding affinity to occludin and {alpha}-catenin. J Biol Chem 274:5981–5986[Abstract/Free Full Text]
  368. Anderson JM, Stevenson BR, Jesaitis LA, Goodenough DA, Mooseker MS 1988 Characterization of ZO-1, a protein component of the tight junction from mouse liver and Madin-Darby canine kidney cells. J Cell Biol 106:1141–1149[Abstract/Free Full Text]
  369. Benais-Pont G, Matter K, Balda MS 2001 Intracellular signaling in classical and new tight junction functions. In: Cereijido M, Anderson J, eds. Tight junctions. New York: CRC Press; 367–394
  370. Fanning AS, Mitic LL, Anderson JA 1999 Transmembrane proteins in the tight junction barrier. J Am Soc Nephrol 10:1337–1345[Abstract/Free Full Text]
  371. Tsukita S, Furuse M 1999 Occludin and claudins in tight-junction strands: leading or supporting players? Trends Cell Biol 9:268–273[CrossRef][Medline]
  372. Balda MS, Matter K 2000 Transmembrane proteins of tight junctions. Cell Dev Biol 11:281–289
  373. Mitic LL, Van Itallie CM 2002 Occludin and claudins: transmembrane proteins of the tight junction. In: Cereijido M, Anderson J, eds. Tight junctions. 2nd ed. New York: CRC Press; 213–230
  374. Sakakibara A, Furuse M, Saitou M, Ando-Akatsuka Y, Tsukita S 1997 Possible involvement of phosphorylation of occludin in tight junction formation. J Cell Biol 137:1393–1401[Abstract/Free Full Text]
  375. Lacaz-Vieria F, Jaeger MM, Farshori P, Kachar B 1999 Small synthetic peptides homologous to segments of the first external loop occludin impair tight junction resealing. J Membr Biol 168:289–297[CrossRef][Medline]
  376. Balda MS, Whitney JA, Flores C, Gonzalez S, Cereijido M, Matter K 1996 Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical-basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein. J Cell Biol 134:1031–1049[Abstract/Free Full Text]
  377. Wong V, Gumbiner BM 1997 A synthetic peptide corresponding to the extracellular domain of occludin perturbs the tight junction permeability barrier. J Cell Biol 136:399–409[Abstract/Free Full Text]
  378. Medina R, Rahner C, Mitic LL, Anderson JM, Van Itallie CM 2000 Occludin localization at the tight junction requires the second extracellular loop. J Membr Biol 178:235–247[CrossRef][Medline]
  379. McCarthy KM, Skare IB, Stankewich MC, Furuse M, Tsukita S, Rogers RA, Lynch RD, Schneeberger EE 1996 Occludin is a functional component of the tight junction. J Cell Sci 109:2287–2298[Abstract]
  380. Saitou M, Fujimoto K, Doi Y, Itoh M, Fujimoto T, Furuse M, Takano H, Noda T, Tsukita S 1998 Occludin-deficient embryonic stem cells can differentiate into polarized epithelial cells bearing tight junctions. J Cell Biol 141:397–408[Abstract/Free Full Text]
  381. Saitou M, Furuse M, Sasaki H, Schulzke JD, Fromm M, Takano H, Noda T, Tsukita S 2000 Complex phenotype of mice lacking occludin, a component of tight junction strands. Mol Biol Cell 11:4131–4142[Abstract/Free Full Text]
  382. Van Itallie CM, Anderson JM 1997 Occludin confers adhesiveness when expressed in fibroblasts. J Cell Sci 110:1113–1121[Abstract]
  383. Blaschuk OW, Oshima T, Sasaki M, Gour BJ, Symonds JM, Park JH, Kevil CG, Trocha SD, Michaud S, Okayama N, Elrod JW, Alexander JS 2002 Identification of an occludin cell adhesion recognition sequence. Inflammation 26:193–198[CrossRef][Medline]
  384. Huber D, Balda MS, Matter K 2000 Occludin modulates transepithelial migration of neutrophils. J Biol Chem 275:5773–5778[Abstract/Free Full Text]
  385. Lapierre LA, Tuma PL, Navarre J, Goldenring JR, Anderson JM 1999 VAP-33 localizes to both an intracellular vesicle population and with occludin at the tight junction. J Cell Sci 112:3723–3732[Abstract]
  386. Tsukamoto T, Nigam SK 1999 Role of tyrosine phosphorylation in the reassembly of occludin and other tight junction proteins. Am J Physiol 276:F737–F750
  387. Andreeva AY, Krause E, Muller EC, Blasig IE, Utepbergenov DI 2001 Protein kinase C regulates the phosphorylation and cellular localization of occludin. J Biol Chem 276:38480–38486[Abstract/Free Full Text]
  388. Nusrat A, Chen JA, Foley CS, Liang TW, Tom J, Cromwell M, Quan C, Mrsny RJ 2000 The coiled-coil domain of occludin can act to organize structural and functional elements of the epithelial tight junction. J Biol Chem 275:29816–29822[Abstract/Free Full Text]
  389. Moroi S, Saitou M, Fujimoto K, Sakakibara A, Furuse M, Yoshida O, Tsukita S 1998 Occludin is concentrated at tight junctions of mouse/rat but not human/guinea pig Sertoli cell testes. Am J Physiol 274:C1708–C1717
  390. Cyr DG, Hermo L, Egenberger N, Mertineit C, Transler JM, Laird DW 1999 Cellular immunolocalization of occludin during embryonic and postnatal development of the mouse testis and epididymis. Endocrinology 140:3815–3825[Abstract/Free Full Text]
  391. Muresan Z, Paul DL, Goodenough DA 2000 Occludin 1B, a variant of the tight junction protein occludin. Mol Biol Cell 11:627–634[Abstract/Free Full Text]
  392. Mitic LL, Van Itallie CM, Anderson JM 2000 Molecular physiology and pathophysiology of tight junctions I. Tight junction structure and function: lessons from mutant animals and proteins. Am J Physiol Gastrointest Liver Physiol 279:G250–G254
  393. Tsukita S, Furuse M 2000 The structure and function of claudins, cell adhesion molecules at tight junctions. Ann NY Acad Sci 915:129–135[CrossRef][Medline]
  394. Heiskala M, Peterson PA, Yang Y 2001 The roles of claudin superfamily proteins in paracellular transport. Traffic 2:92–98[CrossRef]
  395. D’Atri F, Citi S 2002 Molecular complexity of vertebrate tight junctions (Review). Mol Membr Biol 19:103–112[CrossRef][Medline]
  396. Tsukita S, Furuse M 2002 Claudin-based barrier in simple and stratified cellular sheets. Curr Opin Cell Biol 14:531–536[CrossRef][Medline]
  397. Morita K, Furuse M, Fujimoto K, Tsukita S 1999 Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands. Proc Natl Acad Sci USA 96:511–516[Abstract/Free Full Text]
  398. Furuse M, Sasaki T, Fugimoto K, Tsukita S 1998 A single gene product, claudin-1 or -2 reconstitutes tight junction strands and recruits occludin in fibroblasts. J Cell Biol 143:391–401[Abstract/Free Full Text]
  399. Morita K, Sasaki H, Fujimoto K, Furuse M, Tsukita S 1999 Claudin-11/OSP-based tight junctions of myelin sheaths in brain and Sertoli cells in the testis. J Cell Biol 145:579–588[Abstract/Free Full Text]
  400. Furuse M, Furuse K, Sasaki H, Tsukita S 2001 Conversion of zonulae occludentes from tight to leaky strand type by introducing claudin-2 into Madin-Darby canine kidney I cells. J Cell Biol 153:263–272[Abstract/Free Full Text]
  401. Van Itallie C, Rahner C, Anderson JM 2001 Regulated expression of claudin-4 decreases paracellular conductance through a selective decrease in sodium permeability. J Clin Invest 107:1319–1327[Medline]
  402. Hellani A, Ji JW, Mauduit C, Deschildre C, Tabone E, Benahmed M 2000 Developmental and hormonal regulation of the expression of oligodendrocyte-specific protein/claudin 11 in mouse testis. Endocrinology 141:3012–3019[Abstract/Free Full Text]
  403. Gow A, Southwood CM, Li JS, Pariali M, Riordan GP, Brodie SE, Danias J, Bronstein JM, Kachar B, Lazzarini RA 1999 CNS myelin and Sertoli cell tight junction strands are absent in Osp/claudin-11 null mice. Cell 99:649–659[CrossRef][Medline]
  404. Martin-Padura I, Lostaglio S, Schneemann M, Williams L, Romano M, Fruscella P, Panzeri C, Stoppacciaro A, Rucco L, Villa A, Simmons D, Dejana E 1998 Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J Cell Biol 142:117–127[Abstract/Free Full Text]
  405. Liu Y, Nusrat A, Schnell FJ, Reaves TA, Walsh S, Pochet M, Parkos CA 2000 Human junction adhesion molecule regulates tight junction resealing in epithelia. J Cell Sci 113:2363–2374[Abstract]
  406. Itoh M, Sasaki H, Furuse M, Ozaki H, Kita T, Tsukita S 2001 Junctional adhesion molecule (JAM) binds to PAR-3: a possible mechanism for the recruitment of PAR-3 to tight junctions. J Cell Biol 154:491–497[Abstract/Free Full Text]